PD Source: Observable or Programmable,Protocol ID,Trial ID,Country,Site Number,PI Name,Subject ID,IH Number,EDC Record ID,Janssen Classification/DVDECOD,PD Term/DVTERM Other,PD Term/DVTERM,PD Description,Additional PD Information,PD Occured Date,PD End Date,Confirmed Category,Action_Taken,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,V175,,,,,SAE report submitted to sponsor outside the 24hs window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-11,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100235,V84,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-02-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,V84,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-03-12,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100246,V83,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-25,2024-03-26,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100227,V84,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-08,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100117,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-07,2024-01-29,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,V197,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-13,2024-02-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100134,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-02-23,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-05,2024-04-03,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100118,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-02-12,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-19,2024-01-25,MAJOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100300,,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-02-04,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V197,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 16 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100296,V197,,,,,W48 visit was performed 5 days out of window,,2024-01-21,2024-01-31,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V84,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-06,2024-01-23,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100153,,,,,,W96 visit was performed 3 days out of window,,2024-01-12,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100250,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-19,2024-02-01,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,,,Entered but did not satisfy criteria,,,Week 104 visit occurred 2 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-18,2024-01-24,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100269,V197,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100298,,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-16,2024-02-01,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-12,2024-01-30,MINOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100163,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-24,2024-02-24,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V186,,,,,Randomized but did not receive study drug,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-13,2024-02-25,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-25,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V175,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-03,2024-02-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V197,,Other _ Major Disruption,,,Week 88 visit occurred 19 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-17,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 28 days out of window,,2024-01-05,2024-02-08,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100176,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-06,2024-02-21,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-18,2024-03-22,MINOR-COVID-19,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-12,2024-03-08,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V197,,Entered but did not satisfy criteria,,,Subject US10008007-IP was not administered at week 12.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-02-13,MAJOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-02-27,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100196,V83,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-27,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100281,,,,,,Week 88 visit occurred 14 days out of window.,"SM, Megan McMahon, 15Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-03,2024-03-26,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V186,,,,,Tummy-UC not completed at Early Termination,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-04-17,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-05,2024-03-19,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100206,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-24,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V186,,,,,Week 96 visit occurred 7 days out of window.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-26,2024-03-17,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V175,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-08,2024-03-22,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V175,,Other _ Major Disruption,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-24,MAJOR,16dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V175,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V197,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-28,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100171,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-22,2024-02-16,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100147,V197,,,,,Week 108 visit occurred 7 days out of window.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-21,2024-03-16,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100166,V84,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-21,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-30,2024-04-20,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V84,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-09,2024-02-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100293,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-23,2024-02-26,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100294,V175,,,,,US10008005: Week 80 visit completed 6 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-04-09,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,V83,,,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-15,2024-04-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100173,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-19,2024-02-20,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-03,2024-01-15,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100204,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-14,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V186,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008007 screened on 16Feb2021 and was randomized on 20May2021 which is 3 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-03-05,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,V197,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-22,2024-03-15,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100263,V186,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-02,2024-01-26,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-02-14,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100289,V186,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-15,2024-04-13,MAJOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-27,2024-02-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100177,V83,,Other*,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-03-28,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100185,,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-14,2024-02-15,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100131,V197,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-01,2024-01-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100135,V186,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,CNS-acting con med dose change post-randomization.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-03-30,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-05,2024-03-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100226,V186,,,,,US10008007: Week 80 visit completed 19 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-10,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-31,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100198,,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-21,2024-02-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-20,2024-03-29,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V186,,Developed withdrawal criteria but not withdrawn,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-01,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-16,2024-01-17,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100297,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-13,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V197,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-18,2024-03-11,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-11,2024-02-23,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-01-18,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V186,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-03-18,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V83,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-11,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100154,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-04-18,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-25,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V175,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-18,2024-01-21,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-25,2024-03-13,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V175,,,,,W36 visit was performed 22 days out of window,,2024-01-07,2024-02-07,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100214,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-03-06,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-02-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100237,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-28,2024-03-01,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V175,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-19,2024-01-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V197,,,,,Week 52 Tau PET performed 10 days outside of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V186,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-24,2024-02-12,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V197,,,,,W60 visit was performed 10 days out of window,,2024-01-22,2024-03-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100195,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-22,2024-04-04,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-02-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100199,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-03-08,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-30,2024-01-31,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100229,,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,PDIE 4JUN2020: Minor PD.,2024-01-29,2024-04-07,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100121,V84,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-04,2024-02-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V175,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-09,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V197,,,,,W64 visit was performed 1 day out of window,,2024-01-29,2024-02-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-05,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V175,,,,,Blood for Nutritional parameters not collected at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-03,2024-02-19,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V84,,,,,W108 visit was performed 4 days out of window,,2024-01-29,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V197,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-20,2024-03-11,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-29,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100258,V83,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-23,2024-04-05,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-02,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 6 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-30,2024-02-18,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-19,2024-04-18,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-04-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100232,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008006's Week 76 visit occurred 3 days out of window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-02,2024-01-15,MAJOR,17Oct22 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-02-29,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,,,,,,"Missed assessments, M-24, Patient's diary not completed regularly","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-14,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100158,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-10,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100223,V84,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,,2024-01-28,2024-04-10,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-17,2024-02-01,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100279,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-21,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100146,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-25,2024-03-11,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100136,V197,,Other _ Major Disruption,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-01-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V186,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-13,2024-04-12,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-02,2024-02-18,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-17,2024-03-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100171,,,,,,Missing MVV by mistake,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-18,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-24,2024-03-29,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-02,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100143,V84,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-30,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100226,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-28,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-17,2024-02-09,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-14,2024-02-15,MINOR-COVID-19,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-25,2024-03-02,MINOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V83,,,,,Week 92 visit occurred 8 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-03-18,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-17,2024-03-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100158,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-01,2024-01-22,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V84,,,,,PI reported SAE greater than 24 hours of notification,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,V83,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 12 (counting breaths) on RTI form dated 11Sep2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-03-25,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100263,V197,,,,,Week 92 visit occurred 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-25,2024-03-01,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100118,,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-22,2024-02-22,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,V175,,,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-18,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V83,,Entered but did not satisfy criteria,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-30,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100152,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,,2024-01-12,2024-01-18,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-12,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-12,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100295,V84,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-22,2024-03-31,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100278,V83,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-02-28,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100158,V83,,Entered but did not satisfy criteria,,,Week 88 visit occurred 10 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-07,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V84,,,,,Week 104 MRI occurred -8 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-17,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-01-30,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Stool sample not provided at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-30,2024-02-18,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100269,V83,,,,,Stool sample not provided by the patient at M-44,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-03,2024-03-23,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V84,,Entered but did not satisfy criteria,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,,2024-01-12,2024-03-06,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-16,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100230,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-24,2024-03-08,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100229,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-24,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V175,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-07,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100229,V186,,Other*,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-03-31,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,V197,,,,,CD4 count was not completed at the JNJ-90014496 Post-infusion Day 8 Visit,,2024-01-24,2024-02-29,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,V186,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-12,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-17,2024-03-06,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-14,2024-04-07,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100269,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-18,2024-03-09,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100199,,,,,,Visit 25 / Week 76 MRI completed -5 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-21,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,V84,,,,,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,V197,,,,,Week 76 completed 12 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-04,MINOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V186,,,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-01,2024-01-17,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V83,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-03-18,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,V197,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-12,2024-01-21,MINOR-COVID-19,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100278,V197,,Other _ COVID-19,,,Week 24 completed 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V175,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-02-18,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V84,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-01-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V197,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-24,MINOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100130,,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100225,V84,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-07,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-06,2024-02-29,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100199,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",,2024-01-28,2024-04-13,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-24,2024-03-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100218,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,,2024-01-19,2024-03-15,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-09,2024-02-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,V84,,,,,Week 48 completed 2 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-02-19,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-24,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,V83,,,,,W84 visit was performed 13 days out of window,,2024-01-21,2024-02-22,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100182,V175,,,,,W48 visit was performed 16 days out of window,,2024-01-05,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100117,V197,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,,2024-01-18,2024-02-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V186,,Entered but did not satisfy criteria,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-24,2024-04-16,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W96 visit was performed 12 days out of window,,2024-01-28,2024-04-23,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100229,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-01,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,,2024-01-16,2024-03-29,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100238,V197,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-09,2024-01-25,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100202,V186,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-09,2024-03-31,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V197,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1",,2024-01-24,2024-03-07,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",,2024-01-17,2024-03-12,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-27,2024-02-10,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,V175,,Entered but did not satisfy criteria,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-24,2024-02-22,MAJOR,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V197,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,,2024-01-03,2024-03-21,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,V175,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-12,2024-03-08,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,V175,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​",,2024-01-28,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100270,,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,,2024-01-19,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-13,2024-02-11,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V175,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,,2024-01-15,2024-04-09,MINOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,V197,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-30,2024-04-15,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V197,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-14,2024-02-29,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V84,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-27,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100134,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-02-12,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100297,V197,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.",,2024-01-22,2024-02-29,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100224,V186,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@",,2024-01-23,2024-03-05,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100225,,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-12,2024-01-25,MINOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100238,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-21,2024-04-16,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,V186,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-28,2024-04-25,MINOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100151,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-16,2024-01-27,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V84,,,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-29,2024-03-02,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-11,2024-04-08,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V197,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-03,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,,,,,,Week 92 visit occurred 4 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-10,2024-02-14,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100241,V84,,Other _ COVID-19,,,Stool sample not provided by the patient at M-44,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-03,2024-03-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V175,,,,,Week 92 visit occurred 8 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-01,2024-01-11,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100173,V175,,,,,Week 92 visit occurred 6 days out of window.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-29,2024-02-02,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100147,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-22,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-24,2024-02-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-13,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100223,V83,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-02,2024-03-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V197,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-17,2024-03-27,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,V83,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017",,2024-01-22,2024-02-15,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V186,,,,,Week 76 completed 12 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100139,V84,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-19,2024-01-21,MINOR-COVID-19,17Oct22 - LB - LTM: Reviewed.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-03,2024-02-04,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100230,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-04,2024-03-02,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100289,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-28,2024-02-02,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-07,2024-03-21,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V175,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-30,2024-04-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100250,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V175,,,,,US10008006: Week 84 visit completed 2 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-22,2024-02-26,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,,,,,,Week 96 visit occurred 7 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-06,2024-01-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100295,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-07,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-27,2024-03-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-04-11,MAJOR,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,V175,,,,,US10008007: Week 80 visit completed 19 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-17,2024-03-04,MINOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,V197,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-30,2024-02-04,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100296,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V175,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-21,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100223,V197,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-07,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,,,,,,Week 92 visit occurred 6 days out of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-02-12,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V83,,Entered but did not satisfy criteria,,,CNS-acting con med dose change post-randomization.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-28,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V186,,Entered but did not satisfy criteria,,,Week 28 completed 1 day out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-03-28,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-14,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100225,V83,,Received wrong treatment or incorrect dose,,,W96 visit was performed 3 days out of window,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-04,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100194,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-07,2024-03-15,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-13,2024-02-28,MAJOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V84,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100227,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-25,2024-02-14,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V186,,,,,SAE report submitted to sponsor outside the 24hs window,,2024-01-11,2024-02-27,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100127,V186,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-12,2024-01-17,MINOR-COVID-19,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V84,,Other*,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,,,,,,Week 28 completed 1 day out of window.,,2024-01-14,2024-03-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 24 completed 7 days out of window.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-10,2024-02-05,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V83,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-04-23,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V84,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-29,2024-04-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100161,V83,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-25,2024-01-26,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100274,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-17,2024-03-06,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-29,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100135,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-15,2024-03-02,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-07,2024-01-17,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-02-10,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,,2024-01-15,2024-03-16,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V84,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-14,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100173,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-16,2024-03-12,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-04,2024-03-25,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V83,,Entered but did not satisfy criteria,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-09,2024-01-14,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-03-16,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100154,V83,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-19,2024-02-01,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V83,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-01-24,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Visit was performed OOVW due to subject's mother COVID-19 infection.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-04-09,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100165,V186,,Entered but did not satisfy criteria,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-02-17,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100194,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-01-25,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100250,V197,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-25,2024-02-25,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-27,2024-03-08,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100196,V197,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-01-10,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100214,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-18,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100239,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-01-24,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V197,,,,,Week 88 visit occurred 19 days out of window.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-03-15,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100169,V186,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-21,2024-04-02,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V186,,,,,Week 24 completed 7 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-19,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-19,2024-04-15,MINOR,19AUg21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-30,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100162,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-26,2024-02-19,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-01-20,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V83,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-08,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100198,V84,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-28,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100224,,,,,,Stool sample not provided at M-44,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-07,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-23,2024-03-10,MINOR-COVID-19,Sponsor and study staff were informed. Deviation was discussed with the PI.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100295,V175,,,,,Week 76 completed 12 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-11,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-20,2024-04-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-04-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V84,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-04-06,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Week 52 Tau PET performed 10 days outside of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-03-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100281,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-01,2024-01-18,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-02-06,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-28,2024-02-04,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 92 visit occurred 6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-10,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V175,,Other*,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-11,2024-01-17,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-14,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100279,V84,,Entered but did not satisfy criteria,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-30,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V83,,,,,Tummy-UC not completed at Early Termination,,2024-01-11,2024-04-03,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100188,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-26,2024-02-05,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,V83,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-18,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,,,,,,W48 visit was performed 15 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-02-01,MINOR,16Dec22: LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-01,2024-02-28,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V84,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-18,2024-03-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,V186,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-04,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100162,V197,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-19,2024-03-29,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-29,2024-02-03,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100269,V83,,Entered but did not satisfy criteria,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-03,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100276,V186,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-04,2024-02-14,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100163,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V186,,,,,Blood for Nutritional parameters not collected at M-44,,2024-01-13,2024-04-08,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-03,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,V186,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-04-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V186,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-29,2024-03-22,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-23,2024-03-15,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-01-19,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,V197,,,,,Week 88 visit occurred 14 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-03,2024-02-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V84,,,,,CNS-acting con med dose change post-randomization.,,2024-01-20,2024-02-27,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-23,2024-03-27,MAJOR,19AUg21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,,,Entered but did not satisfy criteria,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-01-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,V186,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-25,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,,2024-01-19,2024-03-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100118,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-02-09,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-01-09,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-20,2024-01-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-08,2024-01-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,V186,,Entered but did not satisfy criteria,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-15,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,V197,,Other*,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-10,2024-02-20,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-08,2024-02-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100139,V83,,Entered but did not satisfy criteria,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-30,2024-04-18,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100154,V83,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-25,2024-03-22,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100281,V83,,Other*,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-05,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100213,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-21,2024-04-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,V186,,Entered but did not satisfy criteria,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-02,2024-02-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,V175,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-02-18,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-25,2024-03-18,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,V175,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-02-23,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-15,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V186,,,,,Week 108 visit occurred 7 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-21,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100117,,,Entered but did not satisfy criteria,,,Subject US10008007- Laboratory samples were not collected at week 12.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-13,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100150,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-03-31,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V83,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-26,2024-04-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100200,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-05,2024-01-14,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,V84,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-24,2024-03-01,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100246,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-30,2024-04-20,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,,,,W84 visit was performed 13 days out of window,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-04,2024-01-25,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,,,Entered but did not satisfy criteria,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V186,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-29,2024-04-05,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100277,V84,,Other _ COVID-19,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-07,2024-01-10,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100226,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-27,2024-03-28,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-03,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,V84,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-16,2024-02-01,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V175,,Other*,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-22,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V84,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-30,2024-03-12,MAJOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100219,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-11,2024-02-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-12,2024-03-21,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-02,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100119,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-17,2024-02-25,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100150,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-10,2024-02-16,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,V83,,,,,Week 92 visit occurred 8 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-27,2024-04-15,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,V83,,,,,Week 92 visit occurred 6 days out of window.,,2024-01-26,2024-04-05,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V186,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-17,2024-02-06,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100121,,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-13,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,,,Other*,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-03-09,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100204,V197,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-16,2024-03-03,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100279,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-22,2024-01-30,MAJOR,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,V175,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-30,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100118,V197,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-04,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100248,V84,,Entered but did not satisfy criteria,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-17,2024-02-27,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V186,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,V186,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-19,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V175,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-04,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-15,2024-03-12,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-06,2024-03-06,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100195,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-23,2024-02-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-20,2024-02-23,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V197,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-28,2024-02-18,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-15,2024-03-26,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100300,,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-01-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-12,2024-03-15,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V197,,,,,W72 visit was performed 7 days out of window,,2024-01-04,2024-02-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V186,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-28,2024-04-11,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100226,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-24,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-03-23,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-08,2024-01-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-03-22,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V175,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-19,2024-02-11,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V186,,,,,W60 visit was performed 28 days out of window,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-29,2024-04-27,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100188,V83,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-16,2024-03-06,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100277,,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-09,2024-04-06,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100194,V186,,Received wrong treatment or incorrect dose,,,US10008007: Week 80 visit completed 19 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-03-09,MAJOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100298,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-20,2024-03-08,MINOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-09,MAJOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V186,,Other*,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-24,2024-04-09,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100194,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-08,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V197,,Entered but did not satisfy criteria,,,W48 visit was performed 5 days out of window,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-24,2024-03-28,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-12,2024-02-20,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100147,V186,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-03-23,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100294,V83,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-02,2024-02-27,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-03-13,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100144,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-16,2024-02-22,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100276,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",,2024-01-29,2024-02-07,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-28,2024-03-24,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V197,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,,2024-01-10,2024-02-24,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-02,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V197,,Entered but did not satisfy criteria,,,Week 88 visit occurred 19 days out of window.,,2024-01-22,2024-04-02,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100143,,,,,,Randomized but did not receive study drug,,2024-01-25,2024-02-07,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V175,,Other _ Major Disruption,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-09,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V197,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-15,2024-02-20,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100117,,,,,,Week 28 completed 1 day out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-03-24,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,V175,,,,,Subject US10008007-IP was not administered at week 12.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-02-26,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100296,V83,,Other _ COVID-19,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-21,2024-03-29,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-19,2024-01-29,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-03-09,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-02,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.",,2024-01-05,2024-02-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V197,,,,,W96 visit was performed 12 days out of window,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-12,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,V186,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-18,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100248,V84,,,,,Week 16 completed 1 day out of window.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100277,V84,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-05,2024-02-26,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100171,,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-02,MINOR,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100123,V83,,Received wrong treatment or incorrect dose,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-11,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V197,,,,,Blood for Nutritional parameters not collected at M-44,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-22,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100185,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-27,2024-01-31,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V83,,,,,W48 visit was performed 16 days out of window,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-05,2024-03-24,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V84,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-29,2024-04-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-07,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100204,V197,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-17,2024-02-15,MINOR-COVID-19,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100278,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-18,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100246,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-03-09,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V197,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100298,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-21,2024-04-06,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,,,,,,Week 108 visit occurred 7 days out of window.,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-05,2024-02-03,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-04-12,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V84,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-10,2024-03-20,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V84,,,,,Week 48 completed 2 days out of window.,,2024-01-14,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,,2024-01-25,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V175,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-10,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-24,2024-04-06,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100298,V175,,,,,Week 92 visit occurred 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-25,2024-03-28,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100278,V84,,Other*,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-21,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100219,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-26,2024-02-19,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-01-28,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-09,2024-01-28,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-28,2024-03-06,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100144,,,,,,W84 visit was performed 13 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-01-27,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100169,V84,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-04-03,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-04-03,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100233,V186,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-16,2024-04-14,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100292,V197,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-11,2024-03-09,MINOR,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100188,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-03,2024-03-24,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,V186,,Entered but did not satisfy criteria,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-02,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100146,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V197,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,,2024-01-12,2024-01-22,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V197,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-27,2024-03-28,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100274,V197,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,,2024-01-24,2024-02-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,,,,,,Week 52 Tau PET performed 10 days outside of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V186,,,,,W64 visit was performed 1 day out of window,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-12,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,,,,,,W84 visit was performed 13 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-28,2024-04-04,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100123,V84,,,,,W64 visit was performed 1 day out of window,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-08,2024-01-27,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100121,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 5 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-11,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-24,2024-03-17,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.",,2024-01-30,2024-02-11,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-01,2024-03-28,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100176,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100129,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008007- Laboratory samples were not collected at week 12.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-02,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100248,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-02,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V186,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-01-26,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-21,2024-02-08,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V84,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-18,2024-02-03,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100127,,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-25,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",,2024-01-10,2024-03-15,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100276,V175,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-02,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100247,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-19,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-05,2024-02-08,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,V84,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-29,2024-03-30,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V175,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-03-24,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100182,V186,,,,,Week 92 visit occurred 8 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-18,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-07,2024-02-07,MINOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100134,V84,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-29,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-16,2024-04-03,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100137,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-08,2024-04-05,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100216,V197,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V197,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-03,2024-03-28,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100150,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-03-17,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100215,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,SAE follow up report submitted to sponsor outside the 24hs window,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-26,2024-02-05,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100200,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-26,2024-04-24,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100192,V84,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-16,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100174,,,,,,Tummy-UC not completed at Early Termination,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-02-17,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100270,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-06,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100139,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,,2024-01-08,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-06,2024-03-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100206,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-30,2024-03-18,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-21,2024-01-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-02-29,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,V197,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-05,2024-02-14,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-03-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100199,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-12,2024-04-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V84,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-02-27,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-15,2024-03-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,V197,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-16,2024-03-03,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-12,2024-03-31,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100231,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-01-13,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-25,2024-03-15,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-12,2024-04-10,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100136,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-09,2024-03-16,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V83,,,,,W48 visit was performed 5 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-12,2024-03-10,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,,,Other _ COVID-19,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,,,Entered but did not satisfy criteria,,,Serum biomarkers sample at I-0 was collected in error however not destroyed,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-01-27,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-09,2024-03-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100258,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-27,2024-02-12,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,V175,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,,2024-01-06,2024-01-27,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100233,V83,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-01-15,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V83,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-21,2024-01-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100233,V175,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-01,2024-01-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100185,V186,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-18,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100165,V197,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-23,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100246,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-06,2024-01-29,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100285,V186,,,,,W64 visit was performed 1 day out of window,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-18,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100162,V175,,,,,PI reported SAE greater than 24 hours of notification,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-02-14,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100177,V175,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-12,2024-04-02,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100163,V175,,,,,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-03-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100134,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-16,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-04,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100250,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-26,2024-03-25,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100135,V83,,,,,Week 76 completed 12 days out of window.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-23,2024-02-10,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100143,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-11,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100124,V186,,Entered but did not satisfy criteria,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-20,2024-01-23,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100182,V175,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-23,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,V186,,,,,W48 visit was performed 15 days out of window,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-25,2024-03-04,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100173,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",,2024-01-14,2024-02-14,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-08,MAJOR,17Oct22 - LB - LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V197,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,,,,,,Subject US10008007-IP was not administered at week 12.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-16,2024-03-05,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-05,2024-02-12,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-20,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-03-16,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100195,V84,,Entered but did not satisfy criteria,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-21,2024-03-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-20,2024-01-27,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-25,2024-04-04,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V175,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-17,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100213,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-09,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-01-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,V197,,,,,Week 76 completed 12 days out of window.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-21,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100136,V186,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-23,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100206,V84,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-04-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-02-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-01,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-12,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-27,2024-03-25,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V83,,Other*,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-02,2024-02-20,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V83,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-02,2024-01-15,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V175,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,V84,,Entered but did not satisfy criteria,,,"Calprotectin not measured at I-0, Quantity not sufficient",,2024-01-19,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-22,2024-02-03,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100137,V197,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-18,2024-02-22,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V197,,Entered but did not satisfy criteria,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-26,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100281,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-20,2024-03-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V83,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,,2024-01-17,2024-04-02,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V83,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-03-15,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,V197,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.",,2024-01-01,2024-03-11,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100292,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-10,2024-01-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100224,,,,,,W96 visit was performed 5 days out of window,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100135,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-04-04,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-25,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100137,V197,,Received wrong treatment or incorrect dose,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-21,2024-03-30,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100166,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-29,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,,2024-01-24,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V83,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-03-10,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100165,V197,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-01,2024-01-10,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,V83,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-17,2024-02-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100289,,,,,,Week 84 visit occurred 21 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-02-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-01,2024-03-07,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-06,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100263,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-12,2024-02-14,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100169,,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-18,2024-03-31,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-30,2024-03-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V175,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-08,2024-02-10,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100200,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-14,2024-01-30,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Missing MVV by mistake,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-25,2024-03-13,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100224,,,,,,W96 visit was performed 3 days out of window,,2024-01-29,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100227,V84,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-04,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-20,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100152,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-02,MINOR,THE SITE STAFF WAS RE-TRAINING.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100131,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-11,2024-01-13,MINOR-COVID-19,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-26,2024-02-11,MINOR-COVID-19,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-30,2024-02-28,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V186,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-17,2024-01-29,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V175,,,,,W84 visit was performed 13 days out of window,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-10,2024-01-31,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-05,2024-03-19,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-01,2024-01-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100129,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-12,2024-01-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100297,V197,,Entered but did not satisfy criteria,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-04-05,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100210,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-07,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V83,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-13,2024-02-13,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100131,V197,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-01-27,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,V175,,,,,Tummy-UC not completed at Early Termination,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-30,2024-04-17,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V186,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-06,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V175,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-22,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-08,2024-01-30,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 24 completed 7 days out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-13,2024-04-03,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V84,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-14,2024-01-25,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100124,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-04-01,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100231,,,,,,Week 92 visit occurred 4 days out of window.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-06,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100238,V84,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-29,2024-01-30,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-03-30,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-08,2024-01-29,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,V186,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-12,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,V197,,,,,Stool sample not provided at M-44,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-23,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-08,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V83,,Entered but did not satisfy criteria,,,W96 visit was performed 12 days out of window,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-17,2024-03-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-18,2024-04-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100230,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-12,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100194,V84,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-05,2024-03-24,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",,2024-01-18,2024-04-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,V84,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-04-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V83,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-19,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V84,,,,,W72 visit was performed 7 days out of window,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-01-25,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-11,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V84,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-04-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-24,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V175,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-24,2024-02-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,V83,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-06,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,V175,,Other*,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-01-25,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100292,V83,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-03-03,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V84,,Received wrong treatment or incorrect dose,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-16,2024-03-04,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100134,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-06,2024-02-24,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008007- Laboratory samples were not collected at week 12.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-16,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100196,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-24,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,V175,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,V186,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-03,2024-01-30,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V175,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-09,2024-03-06,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V197,,Entered but did not satisfy criteria,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-08,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100247,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-22,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-02-02,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100293,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-27,2024-02-04,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-07,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100146,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-03-15,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100258,V83,,,,,Week 92 visit occurred 4 days out of window.,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-26,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V83,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-04-01,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V84,,,,,W108 visit was performed 4 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-13,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100167,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-02,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100276,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-26,2024-04-09,MINOR-COVID-19,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100210,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-22,2024-03-01,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100203,V83,,Other*,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-29,2024-03-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,,,,,,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-02-16,MINOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100241,V197,,,,,Week 108 visit occurred 7 days out of window.,,2024-01-04,2024-02-07,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V175,,,,,Missing MVV by mistake,,2024-01-20,2024-02-19,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V175,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-25,2024-04-20,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100236,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-02-08,MAJOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-27,2024-03-01,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100122,,,Received wrong treatment or incorrect dose,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-01-25,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-01-27,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-30,2024-02-10,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100147,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-26,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-20,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V175,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-15,2024-04-12,MAJOR,11Apr21 - LB LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100276,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-23,2024-02-24,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V186,,,,,Visit 25 / Week 76 completed 4 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-03,MINOR-COVID-19,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,V197,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,,2024-01-05,2024-02-27,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,V175,,,,,W84 visit was performed 13 days out of window,,2024-01-20,2024-02-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100195,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 13 days out of window.,,2024-01-25,2024-03-12,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V83,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-04,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V175,,,,,W64 visit was performed 1 day out of window,,2024-01-17,2024-03-29,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100176,,,,,,W48 visit was performed 16 days out of window,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100171,,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100130,,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-09,2024-03-17,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-10,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,V84,,Received wrong treatment or incorrect dose,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-28,2024-04-24,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100195,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-02,2024-02-15,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100137,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,,2024-01-26,2024-04-06,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V197,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-29,2024-02-18,MINOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-03,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100201,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-02-07,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V175,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-27,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100214,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-20,2024-04-06,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100193,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-20,2024-03-03,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100193,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-17,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100232,,,Other _ COVID-19,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-04-03,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-01-21,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100187,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",,2024-01-14,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,V83,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-21,2024-03-12,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100285,V84,,,,,Week 92 visit occurred 4 days out of window.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-27,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V197,,Received wrong treatment or incorrect dose,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-12,2024-01-25,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V84,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-31,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100214,V186,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-28,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100266,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-29,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100233,,,,,,Stool sample not provided at M-44,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-17,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V83,,,,,US10008007: Week 80 visit completed 19 days out of window.,,2024-01-19,2024-03-29,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,,2024-01-15,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100235,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-02,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100182,V84,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-29,2024-04-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100214,V186,,,,,"At screening, respiratory rate not captured as part of vital signs","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-15,2024-01-17,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100279,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-31,MINOR,19Aug21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100190,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-29,2024-02-15,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-03-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-02-01,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V197,,,,,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-04-01,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-01-20,MAJOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-20,2024-03-03,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100172,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-21,2024-02-13,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-01-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100285,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-24,2024-02-24,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100196,V197,,,,,Stool sample not provided at M-44,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-06,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100230,V83,,,,,Stool sample not provided by the patient at M-44,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-23,2024-03-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100153,,,Other*,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-19,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100296,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-04,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100289,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-02-15,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-02,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100227,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-02-09,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-26,2024-03-19,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-21,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V83,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-18,2024-01-21,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100241,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-21,MAJOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100215,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-13,2024-03-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100148,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-01,2024-03-16,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-10,2024-03-25,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100246,,,,,,W60 visit was performed 10 days out of window,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-04,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-22,2024-03-26,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100223,V186,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-05,2024-03-23,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100154,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-03,2024-02-26,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,,,,,,Week 52 Tau PET performed 10 days outside of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-15,2024-01-27,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100177,V175,,Received wrong treatment or incorrect dose,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-03,2024-02-04,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V175,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-26,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100219,V175,,Entered but did not satisfy criteria,,,Week 92 visit occurred 6 days out of window.,,2024-01-16,2024-03-26,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,V83,,Entered but did not satisfy criteria,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-03,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100293,V84,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-09,2024-03-06,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100294,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-26,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-01-29,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100145,V175,,,,,W108 visit was performed 4 days out of window,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100116,V175,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-18,2024-03-31,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100223,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-03,2024-01-26,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V84,,,,,US10008007: Week 80 visit completed 19 days out of window.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-05,2024-03-01,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100297,V84,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-03-28,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,V186,,,,,Week 52 Tau PET performed 10 days outside of window.,,2024-01-03,2024-02-26,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100169,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W84 visit was performed 13 days out of window,,2024-01-21,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100163,V83,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -5 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-15,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100124,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-16,2024-03-31,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V175,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-03-04,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V83,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-03-20,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100255,V83,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-14,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100275,V186,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-12,2024-02-29,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-31,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,,,Entered but did not satisfy criteria,,,Week 16 completed 1 day out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-02,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100162,V197,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,W108 visit was performed 4 days out of window,,2024-01-16,2024-02-25,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100124,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-27,2024-02-03,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100248,V83,,,,,Week 52 Tau PET performed 10 days outside of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-04-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-05,2024-03-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100165,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V197,,Entered but did not satisfy criteria,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-05,MAJOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100247,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-01-06,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100143,V175,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",,2024-01-01,2024-01-27,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100262,V84,,,,,W48 visit was performed 16 days out of window,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-04-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100225,,,,,,W60 visit was performed 28 days out of window,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-04-10,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-02,2024-01-16,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100139,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-11,MAJOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-20,2024-03-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-02-29,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-19,2024-03-30,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100300,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,W36 visit was performed 22 days out of window,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-12,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-13,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100119,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-10,2024-02-28,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-12,2024-04-03,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100173,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-24,2024-03-18,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100298,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-03,2024-02-24,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100300,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-06,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100238,V197,,,,,W60 visit was performed 28 days out of window,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-16,2024-03-19,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100211,V83,,,,,Randomized but did not receive study drug,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-22,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100176,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-10,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V83,,Received wrong treatment or incorrect dose,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-01-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V186,,Entered but did not satisfy criteria,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-14,2024-03-02,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100197,V84,,,,,W48 visit was performed 16 days out of window,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-15,2024-02-02,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100121,V175,,,,,Week 88 visit occurred 10 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-01-21,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100221,V83,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-21,2024-04-20,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100133,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-12,2024-01-17,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100293,V175,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-13,2024-02-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100243,V175,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-14,2024-03-22,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100295,V84,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-10,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100257,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-01-31,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100285,V175,,,,,Subject US10008007-IP was not administered at week 12.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-17,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100262,V186,,,,,Stool sample not provided at M-44,,2024-01-26,2024-03-29,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100143,V186,,,,,Week 104 visit occurred 2 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-06,2024-02-09,MINOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-14,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100253,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-17,2024-04-09,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-27,2024-04-07,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample",,2024-01-21,2024-04-17,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100145,V83,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-21,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100219,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-20,2024-03-30,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100254,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-10,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-05,2024-02-10,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-21,2024-03-17,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-02-18,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",,2024-01-03,2024-01-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-01-11,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100128,V175,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-03-04,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V197,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-27,2024-03-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100274,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-13,2024-02-09,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100239,V84,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-01-25,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100288,,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-23,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V84,,,,,W96 visit was performed 5 days out of window,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-09,2024-02-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100285,V197,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-19,2024-03-10,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-02-06,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V186,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-25,2024-02-20,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V175,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-14,2024-01-18,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,V83,,,,,Week 104 visit occurred 2 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-26,2024-02-01,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100274,V84,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-14,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-18,2024-03-12,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 10 days out of window,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-02-14,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100145,V175,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-24,2024-03-03,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-03-22,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-06,2024-01-08,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100152,V83,,,,,W72 visit was performed 7 days out of window,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-18,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100198,V83,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-30,2024-03-21,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-27,2024-04-11,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100273,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-28,2024-04-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100224,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-02,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V197,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-21,2024-03-29,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-25,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-11,2024-03-20,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,,,Other*,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100193,,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V83,,Entered but did not satisfy criteria,,,Visit was performed OOVW due to subject's COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-30,2024-02-15,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V83,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-07,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V84,,Received wrong treatment or incorrect dose,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-04,2024-03-02,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-04-27,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100166,V197,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V186,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-14,2024-02-06,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100123,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-25,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100162,,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-04-01,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100165,V84,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-03,2024-02-21,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100189,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-18,2024-01-26,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,V186,,,,,W72 visit was performed 7 days out of window,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-01-29,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-02,2024-01-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100271,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-15,2024-01-27,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V186,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-19,2024-03-15,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100170,V83,,,,,W108 visit was performed 4 days out of window,,2024-01-17,2024-03-09,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-27,2024-02-19,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-04-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V175,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-23,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-04,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,,,,,,Stool sample not provided at M-44,,2024-01-21,2024-03-15,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100297,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.",,2024-01-29,2024-02-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-29,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-21,2024-04-07,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 108 visit occurred 7 days out of window.,,2024-01-06,2024-01-07,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V197,,,,,W84 visit was performed 13 days out of window,PDIE 4JUN2020: Minor PD.,2024-01-09,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,V83,,,,,Week 96 visit occurred 7 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-09,2024-04-08,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100240,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",,2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100211,V175,,,,,W60 visit was performed 10 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-04-08,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 52 Tau PET performed 10 days outside of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-05,2024-02-21,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-30,2024-02-06,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V83,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-12,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,Entered but did not satisfy criteria,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-17,2024-02-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,V83,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-28,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100119,,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-18,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-10,2024-02-07,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,,,,,,W48 visit was performed 5 days out of window,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-29,2024-03-04,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,V175,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100204,,,,,,Missing MVV by mistake,,2024-01-21,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100146,,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100244,V186,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-22,2024-01-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100222,,,Other*,,,Week 92 visit occurred 6 days out of window.,,2024-01-27,2024-04-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100118,V175,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-04-03,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100150,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-15,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100140,V84,,Other*,,,Blood for Nutritional parameters not collected at M-44,,2024-01-27,2024-03-18,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100166,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-10,2024-02-10,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100258,,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-01,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-28,2024-04-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Week 76 completed 12 days out of window.,,2024-01-25,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100211,,,,,,W64 visit was performed 1 day out of window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-25,2024-01-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100220,V84,,Other _ Major Disruption,,,Visit 25 / Week 76 MRI completed -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-21,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-21,2024-03-13,MINOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,V175,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-26,2024-04-10,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100175,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-13,2024-01-22,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100291,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,,2024-01-11,2024-03-20,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-10,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100277,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-07,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100199,V84,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-08,2024-02-14,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100274,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-22,2024-01-28,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100125,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-07,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100256,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-01,2024-03-20,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100150,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-28,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100196,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-10,2024-02-02,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V186,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-19,2024-03-30,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100237,V84,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100210,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.",,2024-01-17,2024-04-12,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100237,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-01-17,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-15,2024-02-25,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V84,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-13,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100132,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",,2024-01-10,2024-02-02,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-03-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100182,V83,,,,,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-08,2024-01-24,MINOR,20Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V197,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-21,2024-04-05,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-13,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100180,V84,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-07,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100138,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-25,2024-03-18,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100207,V175,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-24,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100161,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-22,2024-03-09,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100262,V197,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-13,2024-03-10,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100169,,,Other*,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-03,2024-02-10,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100127,V175,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-25,2024-03-24,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100242,V175,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-21,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100280,V84,,Entered but did not satisfy criteria,,,Week 88 visit occurred 14 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-04-19,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100284,V83,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-12,2024-03-19,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-22,2024-04-21,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100155,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-25,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V84,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-18,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,Other _ Major Disruption,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-25,2024-04-21,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100183,V175,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-21,2024-02-23,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100237,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-02,2024-01-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V175,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-26,MAJOR,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100119,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-02-18,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-21,2024-04-17,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100145,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100218,V84,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-13,2024-03-12,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100287,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-04-05,MINOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100259,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-03-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100152,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100177,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-02,2024-01-04,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100215,V175,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-07,2024-03-23,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100299,,,,,,Visit 25 / Week 76 completed 4 days out of window.,,2024-01-02,2024-01-18,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V175,,,,,Week 48 completed 2 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-01-23,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V197,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-17,2024-03-14,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100282,,,,,,Week 16 completed 1 day out of window.,,2024-01-08,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.",,2024-01-21,2024-03-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-24,2024-04-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100268,V186,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-22,2024-04-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-11,2024-04-03,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100289,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-19,2024-03-05,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100292,,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100217,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,CNS-acting con med dose change post-randomization.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-02,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100245,V175,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-24,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-03-10,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100235,V83,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-14,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100251,V83,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",,2024-01-10,2024-01-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100293,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-28,2024-03-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100200,V83,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-09,2024-03-12,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-15,2024-03-22,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100124,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-03-22,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100136,V186,,,,,Week 84 visit occurred 21 days out of window.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-04-03,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100265,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-02-06,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100270,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",,2024-01-11,2024-01-15,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100267,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-06,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100272,V186,,,,,Week 104 MRI occurred -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-01-21,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100179,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-06,2024-02-14,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100144,V83,,,,,SAE report submitted to sponsor outside the 24hs window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-03-13,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100130,V186,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-03-17,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100117,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",,2024-01-04,2024-03-21,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-03,2024-04-01,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100212,,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100185,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-11,2024-03-01,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V83,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",,2024-01-22,2024-02-03,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-18,2024-02-13,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V186,,,,,CNS-acting con med dose change post-randomization.,,2024-01-30,2024-03-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100261,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,,2024-01-12,2024-01-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100141,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-09,2024-01-29,MAJOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100171,V197,,Received wrong treatment or incorrect dose,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-04-06,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-06,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100228,V84,,,,,US10008005: Week 80 visit completed 6 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-20,2024-04-17,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100159,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-23,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100237,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,,2024-01-06,2024-03-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100142,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-21,2024-02-23,MINOR,11Apr21 - LB LTM: Reviewed.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100286,,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-11,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100209,,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-02-15,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100210,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-12,2024-01-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100252,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-30,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-02-01,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V83,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-15,2024-04-07,MINOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100260,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-03-18,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100120,V175,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-12,2024-03-04,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100205,V197,,,,,Week 84 visit occurred 21 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-03-24,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100226,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-03-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100262,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Randomized but did not receive study drug,,2024-01-02,2024-01-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,,,,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-17,2024-01-27,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100147,V84,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-10,2024-02-13,MINOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100121,V84,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-03-21,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100178,V197,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-01,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100168,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-25,2024-03-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-11,MAJOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100208,V83,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-31,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,,2024-01-17,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100184,V175,,,,,Week 108 visit occurred 7 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-02-11,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100235,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-24,2024-02-20,MINOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100213,V83,,Other _ Major Disruption,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-03-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100149,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-13,2024-03-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100123,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-03-03,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100290,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-02-11,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100186,V197,,Entered but did not satisfy criteria,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-06,2024-02-23,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100264,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-04-06,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100191,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-01-28,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100249,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-07,2024-03-01,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100164,V175,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-28,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100156,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-23,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100126,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-01-30,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100232,,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-02-25,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100181,V175,,Other _ Major Disruption,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-02-13,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100158,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.",,2024-01-01,2024-03-25,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100160,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100229,V84,,Entered but did not satisfy criteria,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-10,2024-01-18,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10007,Smith Adam,100234,,,,,,CNS-acting con med dose change post-randomization.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-10,2024-04-01,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,V175,,,,,SAE report submitted to sponsor outside the 24hs window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-11,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100235,V84,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-02-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,V84,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-03-12,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100246,V83,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-25,2024-03-26,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100227,V84,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-08,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100117,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-07,2024-01-29,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,V197,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-13,2024-02-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100134,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-02-23,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-05,2024-04-03,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100118,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-02-12,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-19,2024-01-25,MAJOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100300,,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-02-04,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V197,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 16 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100296,V197,,,,,W48 visit was performed 5 days out of window,,2024-01-21,2024-01-31,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V84,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-06,2024-01-23,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100153,,,,,,W96 visit was performed 3 days out of window,,2024-01-12,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100250,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-19,2024-02-01,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,,,Entered but did not satisfy criteria,,,Week 104 visit occurred 2 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-18,2024-01-24,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100269,V197,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100298,,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-16,2024-02-01,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-12,2024-01-30,MINOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100163,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-24,2024-02-24,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V186,,,,,Randomized but did not receive study drug,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-13,2024-02-25,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-25,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V175,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-03,2024-02-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V197,,Other _ Major Disruption,,,Week 88 visit occurred 19 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-17,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 28 days out of window,,2024-01-05,2024-02-08,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100176,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-06,2024-02-21,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-18,2024-03-22,MINOR-COVID-19,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-12,2024-03-08,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V197,,Entered but did not satisfy criteria,,,Subject US10008007-IP was not administered at week 12.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-02-13,MAJOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-02-27,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100196,V83,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-27,MINOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100281,,,,,,Week 88 visit occurred 14 days out of window.,"SM, Megan McMahon, 15Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-03,2024-03-26,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V186,,,,,Tummy-UC not completed at Early Termination,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-04-17,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-05,2024-03-19,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100206,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-24,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V186,,,,,Week 96 visit occurred 7 days out of window.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-26,2024-03-17,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V175,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-08,2024-03-22,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V175,,Other _ Major Disruption,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-24,MAJOR,16dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V175,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V197,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-28,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100171,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-22,2024-02-16,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100147,V197,,,,,Week 108 visit occurred 7 days out of window.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-21,2024-03-16,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100166,V84,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-21,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-30,2024-04-20,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V84,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-09,2024-02-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100293,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-23,2024-02-26,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100294,V175,,,,,US10008005: Week 80 visit completed 6 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-04-09,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,V83,,,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-15,2024-04-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100173,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-19,2024-02-20,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-18,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-03,2024-01-15,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100204,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-14,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V186,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008007 screened on 16Feb2021 and was randomized on 20May2021 which is 3 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-03-05,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,V197,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-22,2024-03-15,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100263,V186,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-02,2024-01-26,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-02-14,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100289,V186,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-15,2024-04-13,MAJOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-27,2024-02-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100177,V83,,Other*,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-03-28,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100185,,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-14,2024-02-15,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100131,V197,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-01,2024-01-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100135,V186,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,CNS-acting con med dose change post-randomization.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-03-30,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-05,2024-03-16,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100226,V186,,,,,US10008007: Week 80 visit completed 19 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-10,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-31,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100198,,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-21,2024-02-25,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-20,2024-03-29,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V186,,Developed withdrawal criteria but not withdrawn,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-01,2024-01-29,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-16,2024-01-17,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100297,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-13,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V197,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-18,2024-03-11,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-11,2024-02-23,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-01-18,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V186,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-03-18,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V83,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-11,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100154,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-04-18,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-25,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V175,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-18,2024-01-21,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-25,2024-03-13,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V175,,,,,W36 visit was performed 22 days out of window,,2024-01-07,2024-02-07,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100214,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-03-06,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-02-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100237,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-28,2024-03-01,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V175,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-19,2024-01-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V197,,,,,Week 52 Tau PET performed 10 days outside of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V186,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-24,2024-02-12,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V197,,,,,W60 visit was performed 10 days out of window,,2024-01-22,2024-03-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100195,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-22,2024-04-04,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-02-19,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100199,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-03-08,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-30,2024-01-31,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100229,,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,PDIE 4JUN2020: Minor PD.,2024-01-29,2024-04-07,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100121,V84,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-04,2024-02-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V175,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-09,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V197,,,,,W64 visit was performed 1 day out of window,,2024-01-29,2024-02-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-05,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V175,,,,,Blood for Nutritional parameters not collected at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-03,2024-02-19,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V84,,,,,W108 visit was performed 4 days out of window,,2024-01-29,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V197,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-20,2024-03-11,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-29,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100258,V83,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-23,2024-04-05,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-02,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 6 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-30,2024-02-18,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-19,2024-04-18,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-04-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100232,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008006's Week 76 visit occurred 3 days out of window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-02,2024-01-15,MAJOR,17Oct22 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-02-29,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,,,,,,"Missed assessments, M-24, Patient's diary not completed regularly","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-14,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100158,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-10,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100223,V84,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,,2024-01-28,2024-04-10,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-17,2024-02-01,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100279,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-21,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100146,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-25,2024-03-11,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100136,V197,,Other _ Major Disruption,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-01-11,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V186,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-13,2024-04-12,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-02,2024-02-18,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-17,2024-03-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100171,,,,,,Missing MVV by mistake,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-18,2024-02-20,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-24,2024-03-29,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-02,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100143,V84,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-30,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100226,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-28,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-17,2024-02-09,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-14,2024-02-15,MINOR-COVID-19,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-25,2024-03-02,MINOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V83,,,,,Week 92 visit occurred 8 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-03-18,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-17,2024-03-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100158,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-01,2024-01-22,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V84,,,,,PI reported SAE greater than 24 hours of notification,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,V83,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 12 (counting breaths) on RTI form dated 11Sep2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-03-25,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100263,V197,,,,,Week 92 visit occurred 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-25,2024-03-01,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100118,,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-22,2024-02-22,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,V175,,,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-18,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V83,,Entered but did not satisfy criteria,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-30,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100152,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,,2024-01-12,2024-01-18,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-12,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-12,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100295,V84,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-22,2024-03-31,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100278,V83,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-02-28,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100158,V83,,Entered but did not satisfy criteria,,,Week 88 visit occurred 10 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-07,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V84,,,,,Week 104 MRI occurred -8 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-17,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-01-30,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Stool sample not provided at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-30,2024-02-18,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100269,V83,,,,,Stool sample not provided by the patient at M-44,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-03,2024-03-23,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V84,,Entered but did not satisfy criteria,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,,2024-01-12,2024-03-06,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-16,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100230,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-24,2024-03-08,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100229,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-24,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V175,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-07,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100229,V186,,Other*,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-03-31,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,V197,,,,,CD4 count was not completed at the JNJ-90014496 Post-infusion Day 8 Visit,,2024-01-24,2024-02-29,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,V186,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-12,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-17,2024-03-06,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-14,2024-04-07,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100269,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-18,2024-03-09,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100199,,,,,,Visit 25 / Week 76 MRI completed -5 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-21,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,V84,,,,,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,V197,,,,,Week 76 completed 12 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-04,MINOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V186,,,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-01,2024-01-17,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V83,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-03-18,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,V197,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-12,2024-01-21,MINOR-COVID-19,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100278,V197,,Other _ COVID-19,,,Week 24 completed 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V175,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-02-18,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V84,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-01-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V197,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-24,MINOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100130,,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100225,V84,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-07,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-06,2024-02-29,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100199,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",,2024-01-28,2024-04-13,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-24,2024-03-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-26,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100218,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,,2024-01-19,2024-03-15,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-09,2024-02-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,V84,,,,,Week 48 completed 2 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-02-19,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-24,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,V83,,,,,W84 visit was performed 13 days out of window,,2024-01-21,2024-02-22,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100182,V175,,,,,W48 visit was performed 16 days out of window,,2024-01-05,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100117,V197,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,,2024-01-18,2024-02-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V186,,Entered but did not satisfy criteria,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-24,2024-04-16,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W96 visit was performed 12 days out of window,,2024-01-28,2024-04-23,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100229,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-01,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,,2024-01-16,2024-03-29,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100238,V197,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-09,2024-01-25,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100202,V186,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-09,2024-03-31,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V197,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1",,2024-01-24,2024-03-07,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",,2024-01-17,2024-03-12,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-27,2024-02-10,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,V175,,Entered but did not satisfy criteria,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-24,2024-02-22,MAJOR,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V197,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,,2024-01-03,2024-03-21,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,V175,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-12,2024-03-08,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,V175,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​",,2024-01-28,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100270,,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,,2024-01-19,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-13,2024-02-11,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V175,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,,2024-01-15,2024-04-09,MINOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,V197,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-30,2024-04-15,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V197,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-14,2024-02-29,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V84,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-27,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100134,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-02-12,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100297,V197,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.",,2024-01-22,2024-02-29,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100224,V186,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@",,2024-01-23,2024-03-05,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100225,,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-12,2024-01-25,MINOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100238,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-21,2024-04-16,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,V186,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-28,2024-04-25,MINOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100151,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-16,2024-01-27,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V84,,,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-29,2024-03-02,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-11,2024-04-08,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V197,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-01,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-03,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,,,,,,Week 92 visit occurred 4 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-10,2024-02-14,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100241,V84,,Other _ COVID-19,,,Stool sample not provided by the patient at M-44,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-03,2024-03-16,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V175,,,,,Week 92 visit occurred 8 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-01,2024-01-11,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100173,V175,,,,,Week 92 visit occurred 6 days out of window.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-29,2024-02-02,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100147,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-22,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-24,2024-02-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-13,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100223,V83,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-02,2024-03-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V197,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-17,2024-03-27,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,V83,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017",,2024-01-22,2024-02-15,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V186,,,,,Week 76 completed 12 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100139,V84,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-19,2024-01-21,MINOR-COVID-19,17Oct22 - LB - LTM: Reviewed.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-03,2024-02-04,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100230,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-04,2024-03-02,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100289,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-28,2024-02-02,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-07,2024-03-21,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V175,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-30,2024-04-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100250,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V175,,,,,US10008006: Week 84 visit completed 2 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-22,2024-02-26,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,,,,,,Week 96 visit occurred 7 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-06,2024-01-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100295,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-07,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-27,2024-03-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-04-11,MAJOR,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,V175,,,,,US10008007: Week 80 visit completed 19 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-17,2024-03-04,MINOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,V197,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-30,2024-02-04,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100296,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V175,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-21,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100223,V197,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-07,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,,,,,,Week 92 visit occurred 6 days out of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-02-12,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V83,,Entered but did not satisfy criteria,,,CNS-acting con med dose change post-randomization.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-28,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V186,,Entered but did not satisfy criteria,,,Week 28 completed 1 day out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-03-28,MAJOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-14,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100225,V83,,Received wrong treatment or incorrect dose,,,W96 visit was performed 3 days out of window,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-04,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100194,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-07,2024-03-15,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-13,2024-02-28,MAJOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V84,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-11,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100227,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-25,2024-02-14,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V186,,,,,SAE report submitted to sponsor outside the 24hs window,,2024-01-11,2024-02-27,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100127,V186,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-12,2024-01-17,MINOR-COVID-19,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V84,,Other*,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,,,,,,Week 28 completed 1 day out of window.,,2024-01-14,2024-03-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 24 completed 7 days out of window.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-10,2024-02-05,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V83,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-04-23,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V84,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-29,2024-04-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100161,V83,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-25,2024-01-26,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100274,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-17,2024-03-06,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-29,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100135,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-15,2024-03-02,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-07,2024-01-17,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-02-10,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,,2024-01-15,2024-03-16,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V84,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-14,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100173,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-16,2024-03-12,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-04,2024-03-25,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V83,,Entered but did not satisfy criteria,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-09,2024-01-14,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-03-16,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100154,V83,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-19,2024-02-01,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V83,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-01-24,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Visit was performed OOVW due to subject's mother COVID-19 infection.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-04-09,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100165,V186,,Entered but did not satisfy criteria,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-02-17,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100194,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-01-25,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100250,V197,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-25,2024-02-25,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-27,2024-03-08,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100196,V197,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-01-10,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100214,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-18,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100239,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-01-24,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V197,,,,,Week 88 visit occurred 19 days out of window.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-03-15,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100169,V186,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-21,2024-04-02,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V186,,,,,Week 24 completed 7 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-19,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-19,2024-04-15,MINOR,19AUg21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-30,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100162,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-26,2024-02-19,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-01-20,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V83,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-08,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100198,V84,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-28,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100224,,,,,,Stool sample not provided at M-44,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-07,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-23,2024-03-10,MINOR-COVID-19,Sponsor and study staff were informed. Deviation was discussed with the PI.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100295,V175,,,,,Week 76 completed 12 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-11,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-20,2024-04-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-04-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V84,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-04-06,MINOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Week 52 Tau PET performed 10 days outside of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-03-30,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100281,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-01,2024-01-18,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-02-06,MINOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-28,2024-02-04,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 92 visit occurred 6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-10,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V175,,Other*,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-11,2024-01-17,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-14,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100279,V84,,Entered but did not satisfy criteria,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-30,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V83,,,,,Tummy-UC not completed at Early Termination,,2024-01-11,2024-04-03,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100188,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-26,2024-02-05,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,V83,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-18,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,,,,,,W48 visit was performed 15 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-02-01,MINOR,16Dec22: LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-01,2024-02-28,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V84,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-18,2024-03-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,V186,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-04,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100162,V197,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-19,2024-03-29,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-29,2024-02-03,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100269,V83,,Entered but did not satisfy criteria,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-03,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100276,V186,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-04,2024-02-14,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100163,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-20,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V186,,,,,Blood for Nutritional parameters not collected at M-44,,2024-01-13,2024-04-08,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-03,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,V186,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-04-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V186,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-29,2024-03-22,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-23,2024-03-15,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-01-19,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,V197,,,,,Week 88 visit occurred 14 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-03,2024-02-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V84,,,,,CNS-acting con med dose change post-randomization.,,2024-01-20,2024-02-27,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-23,2024-03-27,MAJOR,19AUg21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,,,Entered but did not satisfy criteria,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-01-11,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,V186,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-25,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,,2024-01-19,2024-03-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100118,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-02-09,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-01-09,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-20,2024-01-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-08,2024-01-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,V186,,Entered but did not satisfy criteria,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-15,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,V197,,Other*,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-10,2024-02-20,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-08,2024-02-16,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100139,V83,,Entered but did not satisfy criteria,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-30,2024-04-18,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100154,V83,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-25,2024-03-22,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100281,V83,,Other*,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-05,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100213,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-21,2024-04-18,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,V186,,Entered but did not satisfy criteria,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-02,2024-02-18,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,V175,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-02-18,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-25,2024-03-18,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,V175,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-02-23,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-15,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V186,,,,,Week 108 visit occurred 7 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-21,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100117,,,Entered but did not satisfy criteria,,,Subject US10008007- Laboratory samples were not collected at week 12.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-13,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100150,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-03-31,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V83,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-26,2024-04-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100200,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-05,2024-01-14,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,V84,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-24,2024-03-01,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100246,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-30,2024-04-20,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,,,,W84 visit was performed 13 days out of window,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-04,2024-01-25,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,,,Entered but did not satisfy criteria,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V186,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-29,2024-04-05,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100277,V84,,Other _ COVID-19,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-07,2024-01-10,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100226,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-27,2024-03-28,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-03,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,V84,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-16,2024-02-01,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V175,,Other*,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-22,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V84,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-30,2024-03-12,MAJOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100219,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-11,2024-02-16,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-12,2024-03-21,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-02,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100119,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-17,2024-02-25,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100150,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-10,2024-02-16,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,V83,,,,,Week 92 visit occurred 8 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-27,2024-04-15,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,V83,,,,,Week 92 visit occurred 6 days out of window.,,2024-01-26,2024-04-05,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V186,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-17,2024-02-06,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100121,,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-13,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,,,Other*,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-03-09,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100204,V197,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-16,2024-03-03,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100279,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-22,2024-01-30,MAJOR,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,V175,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-30,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100118,V197,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-04,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100248,V84,,Entered but did not satisfy criteria,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-17,2024-02-27,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V186,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,V186,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-19,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V175,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-04,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-15,2024-03-12,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-06,2024-03-06,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100195,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-23,2024-02-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-20,2024-02-23,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V197,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-28,2024-02-18,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-15,2024-03-26,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100300,,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-01-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-12,2024-03-15,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V197,,,,,W72 visit was performed 7 days out of window,,2024-01-04,2024-02-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V186,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-28,2024-04-11,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100226,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-24,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-03-23,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-08,2024-01-19,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-03-22,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V175,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-19,2024-02-11,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V186,,,,,W60 visit was performed 28 days out of window,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-29,2024-04-27,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100188,V83,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-16,2024-03-06,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100277,,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-09,2024-04-06,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100194,V186,,Received wrong treatment or incorrect dose,,,US10008007: Week 80 visit completed 19 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-03-09,MAJOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100298,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-20,2024-03-08,MINOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-09,MAJOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V186,,Other*,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-24,2024-04-09,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100194,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-08,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V197,,Entered but did not satisfy criteria,,,W48 visit was performed 5 days out of window,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-24,2024-03-28,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-12,2024-02-20,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100147,V186,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-03-23,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100294,V83,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-02,2024-02-27,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-03-13,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100144,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-16,2024-02-22,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100276,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",,2024-01-29,2024-02-07,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-28,2024-03-24,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V197,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,,2024-01-10,2024-02-24,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-02,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V197,,Entered but did not satisfy criteria,,,Week 88 visit occurred 19 days out of window.,,2024-01-22,2024-04-02,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100143,,,,,,Randomized but did not receive study drug,,2024-01-25,2024-02-07,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V175,,Other _ Major Disruption,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-09,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V197,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-15,2024-02-20,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100117,,,,,,Week 28 completed 1 day out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-03-24,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,V175,,,,,Subject US10008007-IP was not administered at week 12.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-02-26,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100296,V83,,Other _ COVID-19,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-21,2024-03-29,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-19,2024-01-29,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-03-09,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-02,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.",,2024-01-05,2024-02-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V197,,,,,W96 visit was performed 12 days out of window,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-12,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,V186,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-18,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100248,V84,,,,,Week 16 completed 1 day out of window.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100277,V84,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-05,2024-02-26,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100171,,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-02,MINOR,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100123,V83,,Received wrong treatment or incorrect dose,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-11,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V197,,,,,Blood for Nutritional parameters not collected at M-44,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-22,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100185,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-27,2024-01-31,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V83,,,,,W48 visit was performed 16 days out of window,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-05,2024-03-24,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V84,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-29,2024-04-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-07,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100204,V197,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-17,2024-02-15,MINOR-COVID-19,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100278,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-18,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100246,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-03-09,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V197,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100298,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-21,2024-04-06,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,,,,,,Week 108 visit occurred 7 days out of window.,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-05,2024-02-03,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-04-12,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V84,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-10,2024-03-20,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V84,,,,,Week 48 completed 2 days out of window.,,2024-01-14,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,,2024-01-25,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V175,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-10,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-24,2024-04-06,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100298,V175,,,,,Week 92 visit occurred 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-25,2024-03-28,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100278,V84,,Other*,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-21,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100219,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-26,2024-02-19,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-01-28,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-09,2024-01-28,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-28,2024-03-06,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100144,,,,,,W84 visit was performed 13 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-01-27,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100169,V84,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-04-03,MINOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-04-03,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100233,V186,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-16,2024-04-14,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100292,V197,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-11,2024-03-09,MINOR,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100188,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-03,2024-03-24,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,V186,,Entered but did not satisfy criteria,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-02,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100146,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V197,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,,2024-01-12,2024-01-22,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V197,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-27,2024-03-28,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100274,V197,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,,2024-01-24,2024-02-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,,,,,,Week 52 Tau PET performed 10 days outside of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V186,,,,,W64 visit was performed 1 day out of window,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-12,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,,,,,,W84 visit was performed 13 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-28,2024-04-04,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100123,V84,,,,,W64 visit was performed 1 day out of window,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-08,2024-01-27,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100121,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 5 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-11,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-24,2024-03-17,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.",,2024-01-30,2024-02-11,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-01,2024-03-28,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100176,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100129,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008007- Laboratory samples were not collected at week 12.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-02,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100248,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-02,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V186,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-01-26,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-21,2024-02-08,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V84,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-18,2024-02-03,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100127,,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-25,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",,2024-01-10,2024-03-15,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100276,V175,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-02,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100247,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-19,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-05,2024-02-08,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,V84,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-29,2024-03-30,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V175,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-03-24,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100182,V186,,,,,Week 92 visit occurred 8 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-18,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-07,2024-02-07,MINOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100134,V84,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-29,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-16,2024-04-03,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100137,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-08,2024-04-05,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100216,V197,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V197,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-03,2024-03-28,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100150,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-03-17,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100215,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,SAE follow up report submitted to sponsor outside the 24hs window,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-26,2024-02-05,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100200,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-26,2024-04-24,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100192,V84,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-16,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100174,,,,,,Tummy-UC not completed at Early Termination,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-02-17,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100270,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-06,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100139,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,,2024-01-08,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-06,2024-03-19,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100206,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-30,2024-03-18,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-21,2024-01-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-02-29,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,V197,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-05,2024-02-14,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-03-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100199,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-12,2024-04-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V84,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-02-27,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-15,2024-03-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,V197,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-16,2024-03-03,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-12,2024-03-31,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100231,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-01-13,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-25,2024-03-15,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-12,2024-04-10,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100136,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-09,2024-03-16,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V83,,,,,W48 visit was performed 5 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-12,2024-03-10,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,,,Other _ COVID-19,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,,,Entered but did not satisfy criteria,,,Serum biomarkers sample at I-0 was collected in error however not destroyed,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-01-27,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-09,2024-03-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100258,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-27,2024-02-12,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,V175,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,,2024-01-06,2024-01-27,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100233,V83,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-01-15,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V83,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-21,2024-01-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100233,V175,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-01,2024-01-30,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100185,V186,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-18,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100165,V197,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-23,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100246,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-06,2024-01-29,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100285,V186,,,,,W64 visit was performed 1 day out of window,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-18,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100162,V175,,,,,PI reported SAE greater than 24 hours of notification,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-02-14,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100177,V175,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-12,2024-04-02,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100163,V175,,,,,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-03-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100134,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-16,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-04,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100250,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-26,2024-03-25,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100135,V83,,,,,Week 76 completed 12 days out of window.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-23,2024-02-10,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100143,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-11,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100124,V186,,Entered but did not satisfy criteria,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-20,2024-01-23,MAJOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100182,V175,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-23,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,V186,,,,,W48 visit was performed 15 days out of window,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-25,2024-03-04,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100173,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",,2024-01-14,2024-02-14,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-08,MAJOR,17Oct22 - LB - LTM: Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V197,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,,,,,,Subject US10008007-IP was not administered at week 12.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-16,2024-03-05,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-05,2024-02-12,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-20,2024-03-18,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-03-16,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100195,V84,,Entered but did not satisfy criteria,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-21,2024-03-24,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-20,2024-01-27,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-25,2024-04-04,MAJOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V175,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-17,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100213,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-09,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-01-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,V197,,,,,Week 76 completed 12 days out of window.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-21,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100136,V186,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-23,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100206,V84,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-04-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-02-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-01,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-12,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-27,2024-03-25,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V83,,Other*,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-02,2024-02-20,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V83,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-02,2024-01-15,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V175,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,V84,,Entered but did not satisfy criteria,,,"Calprotectin not measured at I-0, Quantity not sufficient",,2024-01-19,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-22,2024-02-03,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100137,V197,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-18,2024-02-22,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V197,,Entered but did not satisfy criteria,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-26,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100281,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-20,2024-03-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V83,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,,2024-01-17,2024-04-02,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V83,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-03-15,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,V197,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.",,2024-01-01,2024-03-11,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100292,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-10,2024-01-25,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100224,,,,,,W96 visit was performed 5 days out of window,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100135,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-04-04,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-25,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100137,V197,,Received wrong treatment or incorrect dose,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-21,2024-03-30,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100166,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-29,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,,2024-01-24,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V83,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-03-10,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100165,V197,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-01,2024-01-10,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,V83,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-17,2024-02-24,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100289,,,,,,Week 84 visit occurred 21 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-02-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-01,2024-03-07,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-06,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100263,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-12,2024-02-14,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100169,,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-18,2024-03-31,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-30,2024-03-30,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V175,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-08,2024-02-10,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100200,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-14,2024-01-30,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Missing MVV by mistake,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-25,2024-03-13,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100224,,,,,,W96 visit was performed 3 days out of window,,2024-01-29,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100227,V84,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-04,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-20,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100152,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-02,MINOR,THE SITE STAFF WAS RE-TRAINING.
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100131,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-11,2024-01-13,MINOR-COVID-19,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-26,2024-02-11,MINOR-COVID-19,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-30,2024-02-28,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V186,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-17,2024-01-29,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V175,,,,,W84 visit was performed 13 days out of window,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-10,2024-01-31,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-05,2024-03-19,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-01,2024-01-16,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100129,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-12,2024-01-16,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100297,V197,,Entered but did not satisfy criteria,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-04-05,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100210,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-07,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V83,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-13,2024-02-13,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100131,V197,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-01-27,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,V175,,,,,Tummy-UC not completed at Early Termination,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-30,2024-04-17,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V186,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-06,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V175,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-22,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-08,2024-01-30,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 24 completed 7 days out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-13,2024-04-03,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V84,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-14,2024-01-25,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100124,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-04-01,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100231,,,,,,Week 92 visit occurred 4 days out of window.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-06,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100238,V84,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-29,2024-01-30,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-03-30,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-08,2024-01-29,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,V186,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-12,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,V197,,,,,Stool sample not provided at M-44,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-23,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-08,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V83,,Entered but did not satisfy criteria,,,W96 visit was performed 12 days out of window,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-17,2024-03-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-18,2024-04-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100230,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-12,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100194,V84,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-05,2024-03-24,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",,2024-01-18,2024-04-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,V84,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-04-10,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V83,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-19,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V84,,,,,W72 visit was performed 7 days out of window,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-01-25,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-11,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V84,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-04-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-24,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V175,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-24,2024-02-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,V83,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-06,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,V175,,Other*,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-01-25,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100292,V83,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-03-03,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V84,,Received wrong treatment or incorrect dose,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-16,2024-03-04,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100134,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-06,2024-02-24,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008007- Laboratory samples were not collected at week 12.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-16,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100196,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-24,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,V175,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,V186,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-03,2024-01-30,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V175,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-09,2024-03-06,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V197,,Entered but did not satisfy criteria,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-08,2024-01-29,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-20,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100247,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-22,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-02-02,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100293,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-27,2024-02-04,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-07,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100146,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-03-15,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100258,V83,,,,,Week 92 visit occurred 4 days out of window.,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-26,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V83,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-04-01,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V84,,,,,W108 visit was performed 4 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-13,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100167,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-02,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100276,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-26,2024-04-09,MINOR-COVID-19,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100210,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-22,2024-03-01,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100203,V83,,Other*,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-29,2024-03-03,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,,,,,,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-02-16,MINOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100241,V197,,,,,Week 108 visit occurred 7 days out of window.,,2024-01-04,2024-02-07,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V175,,,,,Missing MVV by mistake,,2024-01-20,2024-02-19,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V175,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-25,2024-04-20,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100236,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-02-08,MAJOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-27,2024-03-01,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100122,,,Received wrong treatment or incorrect dose,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-01-25,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-01-27,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-30,2024-02-10,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100147,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-26,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-20,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V175,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-15,2024-04-12,MAJOR,11Apr21 - LB LTM: Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100276,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-23,2024-02-24,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V186,,,,,Visit 25 / Week 76 completed 4 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-03,MINOR-COVID-19,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,V197,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,,2024-01-05,2024-02-27,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,V175,,,,,W84 visit was performed 13 days out of window,,2024-01-20,2024-02-16,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100195,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 13 days out of window.,,2024-01-25,2024-03-12,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V83,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-04,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V175,,,,,W64 visit was performed 1 day out of window,,2024-01-17,2024-03-29,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100176,,,,,,W48 visit was performed 16 days out of window,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100171,,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100130,,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-09,2024-03-17,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-10,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,V84,,Received wrong treatment or incorrect dose,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-28,2024-04-24,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100195,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-02,2024-02-15,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100137,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,,2024-01-26,2024-04-06,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V197,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-29,2024-02-18,MINOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-03,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100201,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-02-07,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V175,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-27,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100214,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-20,2024-04-06,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100193,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-20,2024-03-03,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100193,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-17,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100232,,,Other _ COVID-19,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-04-03,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-01-21,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100187,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",,2024-01-14,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,V83,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-21,2024-03-12,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100285,V84,,,,,Week 92 visit occurred 4 days out of window.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-27,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V197,,Received wrong treatment or incorrect dose,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-12,2024-01-25,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V84,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-31,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100214,V186,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-28,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100266,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-29,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100233,,,,,,Stool sample not provided at M-44,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-17,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V83,,,,,US10008007: Week 80 visit completed 19 days out of window.,,2024-01-19,2024-03-29,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,,2024-01-15,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100235,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-02,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100182,V84,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-29,2024-04-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100214,V186,,,,,"At screening, respiratory rate not captured as part of vital signs","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-15,2024-01-17,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100279,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-31,MINOR,19Aug21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100190,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-29,2024-02-15,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-03-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-02-01,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V197,,,,,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-04-01,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-01-20,MAJOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-20,2024-03-03,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100172,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-21,2024-02-13,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-01-16,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100285,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-24,2024-02-24,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100196,V197,,,,,Stool sample not provided at M-44,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-06,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100230,V83,,,,,Stool sample not provided by the patient at M-44,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-23,2024-03-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100153,,,Other*,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-19,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100296,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-04,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100289,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-02-15,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-02,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100227,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-02-09,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-26,2024-03-19,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-21,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V83,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-18,2024-01-21,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100241,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-21,MAJOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100215,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-13,2024-03-28,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100148,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-01,2024-03-16,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-10,2024-03-25,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100246,,,,,,W60 visit was performed 10 days out of window,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-04,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-22,2024-03-26,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100223,V186,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-05,2024-03-23,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100154,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-03,2024-02-26,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,,,,,,Week 52 Tau PET performed 10 days outside of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-15,2024-01-27,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100177,V175,,Received wrong treatment or incorrect dose,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-03,2024-02-04,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V175,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-26,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100219,V175,,Entered but did not satisfy criteria,,,Week 92 visit occurred 6 days out of window.,,2024-01-16,2024-03-26,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,V83,,Entered but did not satisfy criteria,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-03,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100293,V84,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-09,2024-03-06,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100294,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-26,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-01-29,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100145,V175,,,,,W108 visit was performed 4 days out of window,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100116,V175,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-18,2024-03-31,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100223,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-03,2024-01-26,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V84,,,,,US10008007: Week 80 visit completed 19 days out of window.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-05,2024-03-01,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100297,V84,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-03-28,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,V186,,,,,Week 52 Tau PET performed 10 days outside of window.,,2024-01-03,2024-02-26,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100169,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W84 visit was performed 13 days out of window,,2024-01-21,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100163,V83,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -5 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-15,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100124,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-16,2024-03-31,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V175,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-03-04,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V83,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-03-20,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100255,V83,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-14,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100275,V186,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-12,2024-02-29,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-31,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,,,Entered but did not satisfy criteria,,,Week 16 completed 1 day out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-02,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100162,V197,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,W108 visit was performed 4 days out of window,,2024-01-16,2024-02-25,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100124,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-27,2024-02-03,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100248,V83,,,,,Week 52 Tau PET performed 10 days outside of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-04-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-05,2024-03-26,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100165,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V197,,Entered but did not satisfy criteria,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-05,MAJOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100247,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-01-06,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100143,V175,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",,2024-01-01,2024-01-27,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100262,V84,,,,,W48 visit was performed 16 days out of window,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-04-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100225,,,,,,W60 visit was performed 28 days out of window,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-04-10,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-02,2024-01-16,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100139,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-11,MAJOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-20,2024-03-08,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-02-29,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-19,2024-03-30,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100300,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,W36 visit was performed 22 days out of window,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-12,2024-01-29,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-13,MAJOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100119,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-10,2024-02-28,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-12,2024-04-03,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100173,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-24,2024-03-18,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100298,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-03,2024-02-24,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100300,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-06,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100238,V197,,,,,W60 visit was performed 28 days out of window,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-16,2024-03-19,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100211,V83,,,,,Randomized but did not receive study drug,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-22,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100176,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-10,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V83,,Received wrong treatment or incorrect dose,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-01-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V186,,Entered but did not satisfy criteria,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-14,2024-03-02,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100197,V84,,,,,W48 visit was performed 16 days out of window,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-15,2024-02-02,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100121,V175,,,,,Week 88 visit occurred 10 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-01-21,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100221,V83,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-21,2024-04-20,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100133,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-12,2024-01-17,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100293,V175,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-13,2024-02-24,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100243,V175,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-14,2024-03-22,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100295,V84,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-10,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100257,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-01-31,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100285,V175,,,,,Subject US10008007-IP was not administered at week 12.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-17,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100262,V186,,,,,Stool sample not provided at M-44,,2024-01-26,2024-03-29,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100143,V186,,,,,Week 104 visit occurred 2 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-06,2024-02-09,MINOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-14,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100253,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-17,2024-04-09,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-27,2024-04-07,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample",,2024-01-21,2024-04-17,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100145,V83,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-21,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100219,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-20,2024-03-30,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100254,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-10,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-05,2024-02-10,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-21,2024-03-17,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-02-18,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",,2024-01-03,2024-01-18,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-01-11,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100128,V175,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-03-04,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V197,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-27,2024-03-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100274,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-13,2024-02-09,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100239,V84,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-01-25,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100288,,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-23,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V84,,,,,W96 visit was performed 5 days out of window,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-09,2024-02-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100285,V197,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-19,2024-03-10,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-02-06,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V186,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-25,2024-02-20,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V175,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-14,2024-01-18,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,V83,,,,,Week 104 visit occurred 2 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-26,2024-02-01,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100274,V84,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-14,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-18,2024-03-12,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 10 days out of window,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-02-14,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100145,V175,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-24,2024-03-03,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-03-22,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-06,2024-01-08,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100152,V83,,,,,W72 visit was performed 7 days out of window,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-18,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100198,V83,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-30,2024-03-21,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-27,2024-04-11,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100273,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-28,2024-04-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100224,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-02,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V197,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-21,2024-03-29,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-25,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-11,2024-03-20,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,,,Other*,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100193,,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V83,,Entered but did not satisfy criteria,,,Visit was performed OOVW due to subject's COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-30,2024-02-15,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V83,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-07,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V84,,Received wrong treatment or incorrect dose,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-04,2024-03-02,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-04-27,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100166,V197,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-18,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V186,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-14,2024-02-06,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100123,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-25,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100162,,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-04-01,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100165,V84,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-03,2024-02-21,MINOR,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100189,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-18,2024-01-26,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,V186,,,,,W72 visit was performed 7 days out of window,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-01-29,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-02,2024-01-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100271,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-15,2024-01-27,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V186,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-19,2024-03-15,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100170,V83,,,,,W108 visit was performed 4 days out of window,,2024-01-17,2024-03-09,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-27,2024-02-19,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-04-01,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V175,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-23,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-04,2024-02-20,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,,,,,,Stool sample not provided at M-44,,2024-01-21,2024-03-15,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100297,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.",,2024-01-29,2024-02-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-29,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-21,2024-04-07,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 108 visit occurred 7 days out of window.,,2024-01-06,2024-01-07,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V197,,,,,W84 visit was performed 13 days out of window,PDIE 4JUN2020: Minor PD.,2024-01-09,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,V83,,,,,Week 96 visit occurred 7 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-09,2024-04-08,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100240,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",,2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100211,V175,,,,,W60 visit was performed 10 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-04-08,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 52 Tau PET performed 10 days outside of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-05,2024-02-21,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related."
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-30,2024-02-06,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V83,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-12,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,Entered but did not satisfy criteria,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-17,2024-02-28,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,V83,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-28,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100119,,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-18,2024-03-11,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-10,2024-02-07,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,,,,,,W48 visit was performed 5 days out of window,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-29,2024-03-04,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,V175,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100204,,,,,,Missing MVV by mistake,,2024-01-21,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100146,,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100244,V186,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-22,2024-01-29,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100222,,,Other*,,,Week 92 visit occurred 6 days out of window.,,2024-01-27,2024-04-22,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100118,V175,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-04-03,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100150,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-15,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100140,V84,,Other*,,,Blood for Nutritional parameters not collected at M-44,,2024-01-27,2024-03-18,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100166,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-10,2024-02-10,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed"
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100258,,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-01,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-28,2024-04-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Week 76 completed 12 days out of window.,,2024-01-25,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100211,,,,,,W64 visit was performed 1 day out of window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-25,2024-01-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100220,V84,,Other _ Major Disruption,,,Visit 25 / Week 76 MRI completed -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-21,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-21,2024-03-13,MINOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,V175,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-26,2024-04-10,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100175,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-13,2024-01-22,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100291,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,,2024-01-11,2024-03-20,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-10,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100277,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-07,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100199,V84,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-08,2024-02-14,MINOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100274,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-22,2024-01-28,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100125,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-07,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100256,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-01,2024-03-20,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100150,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-28,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100196,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-10,2024-02-02,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V186,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-19,2024-03-30,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100237,V84,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100210,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.",,2024-01-17,2024-04-12,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100237,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-01-17,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-15,2024-02-25,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V84,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-13,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100132,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",,2024-01-10,2024-02-02,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-03-26,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100182,V83,,,,,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-08,2024-01-24,MINOR,20Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V197,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-21,2024-04-05,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-13,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100180,V84,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-07,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100138,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-25,2024-03-18,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100207,V175,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-24,2024-03-11,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100161,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-22,2024-03-09,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100262,V197,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-13,2024-03-10,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100169,,,Other*,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-03,2024-02-10,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100127,V175,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-25,2024-03-24,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100242,V175,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-21,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100280,V84,,Entered but did not satisfy criteria,,,Week 88 visit occurred 14 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-04-19,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100284,V83,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-12,2024-03-19,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-22,2024-04-21,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100155,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-25,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V84,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-18,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,Other _ Major Disruption,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-25,2024-04-21,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100183,V175,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-21,2024-02-23,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100237,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-02,2024-01-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V175,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-26,MAJOR,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100119,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-02-18,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-21,2024-04-17,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100145,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100218,V84,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-13,2024-03-12,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100287,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-04-05,MINOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100259,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-03-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100152,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100177,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-02,2024-01-04,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100215,V175,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-07,2024-03-23,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100299,,,,,,Visit 25 / Week 76 completed 4 days out of window.,,2024-01-02,2024-01-18,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V175,,,,,Week 48 completed 2 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-01-23,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V197,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-17,2024-03-14,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100282,,,,,,Week 16 completed 1 day out of window.,,2024-01-08,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.",,2024-01-21,2024-03-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-24,2024-04-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100268,V186,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-22,2024-04-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-11,2024-04-03,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100289,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-19,2024-03-05,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100292,,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100217,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,CNS-acting con med dose change post-randomization.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-02,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100245,V175,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-24,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-03-10,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100235,V83,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-14,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100251,V83,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",,2024-01-10,2024-01-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100293,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-28,2024-03-24,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100200,V83,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-09,2024-03-12,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-15,2024-03-22,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100124,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-03-22,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100136,V186,,,,,Week 84 visit occurred 21 days out of window.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-04-03,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100265,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-02-06,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100270,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",,2024-01-11,2024-01-15,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100267,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-06,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100272,V186,,,,,Week 104 MRI occurred -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-01-21,MAJOR,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100179,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-06,2024-02-14,MINOR-COVID-19,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100144,V83,,,,,SAE report submitted to sponsor outside the 24hs window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-03-13,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100130,V186,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-03-17,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100117,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",,2024-01-04,2024-03-21,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-03,2024-04-01,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100212,,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100185,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-11,2024-03-01,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V83,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",,2024-01-22,2024-02-03,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-18,2024-02-13,MAJOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V186,,,,,CNS-acting con med dose change post-randomization.,,2024-01-30,2024-03-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100261,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,,2024-01-12,2024-01-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100141,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-09,2024-01-29,MAJOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100171,V197,,Received wrong treatment or incorrect dose,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-04-06,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-06,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100228,V84,,,,,US10008005: Week 80 visit completed 6 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-20,2024-04-17,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-03,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100159,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-23,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100237,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,,2024-01-06,2024-03-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100142,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-21,2024-02-23,MINOR,11Apr21 - LB LTM: Reviewed.
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100286,,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-11,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100209,,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-02-15,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100210,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-12,2024-01-28,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100252,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-30,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-02-01,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V83,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-15,2024-04-07,MINOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100260,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-03-18,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100120,V175,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-12,2024-03-04,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100205,V197,,,,,Week 84 visit occurred 21 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-03-24,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100226,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-03-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100262,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Randomized but did not receive study drug,,2024-01-02,2024-01-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,,,,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-17,2024-01-27,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100147,V84,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-10,2024-02-13,MINOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100121,V84,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-03-21,MINOR-COVID-19,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100178,V197,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-01,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100168,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-25,2024-03-25,MINOR,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-11,MAJOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100208,V83,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-31,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,,2024-01-17,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100184,V175,,,,,Week 108 visit occurred 7 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-02-11,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100235,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-24,2024-02-20,MINOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100213,V83,,Other _ Major Disruption,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-03-22,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100149,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-13,2024-03-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100123,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-03-03,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100290,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-02-11,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100186,V197,,Entered but did not satisfy criteria,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-06,2024-02-23,MAJOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100264,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-04-06,MINOR,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100191,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-01-28,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100249,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-07,2024-03-01,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100164,V175,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-28,MINOR-COVID-19,,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100156,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-23,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100126,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-01-30,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100232,,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-02-25,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100181,V175,,Other _ Major Disruption,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-02-13,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100158,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.",,2024-01-01,2024-03-25,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100160,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100229,V84,,Entered but did not satisfy criteria,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-10,2024-01-18,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,RIVAROXHFA3001,United States of America,AR00091,Smith Adam,100234,,,,,,CNS-acting con med dose change post-randomization.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-10,2024-04-01,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,V175,,,,,SAE report submitted to sponsor outside the 24hs window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-11,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100235,V84,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-02-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,V84,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-03-12,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100246,V83,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-25,2024-03-26,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100227,V84,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-08,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100117,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-07,2024-01-29,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,V197,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-13,2024-02-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100134,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-02-23,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-05,2024-04-03,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100118,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-02-12,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-19,2024-01-25,MAJOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100300,,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-02-04,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V197,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 16 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100296,V197,,,,,W48 visit was performed 5 days out of window,,2024-01-21,2024-01-31,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V84,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-06,2024-01-23,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100153,,,,,,W96 visit was performed 3 days out of window,,2024-01-12,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100250,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-19,2024-02-01,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,,,Entered but did not satisfy criteria,,,Week 104 visit occurred 2 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-18,2024-01-24,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100269,V197,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100298,,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-16,2024-02-01,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-12,2024-01-30,MINOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100163,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-24,2024-02-24,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V186,,,,,Randomized but did not receive study drug,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-13,2024-02-25,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-25,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V175,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-03,2024-02-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V197,,Other _ Major Disruption,,,Week 88 visit occurred 19 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-17,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 28 days out of window,,2024-01-05,2024-02-08,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100176,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-06,2024-02-21,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-18,2024-03-22,MINOR-COVID-19,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-12,2024-03-08,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V197,,Entered but did not satisfy criteria,,,Subject US10008007-IP was not administered at week 12.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-02-13,MAJOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-02-27,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100196,V83,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-27,MINOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100281,,,,,,Week 88 visit occurred 14 days out of window.,"SM, Megan McMahon, 15Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-03,2024-03-26,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V186,,,,,Tummy-UC not completed at Early Termination,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-04-17,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-05,2024-03-19,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100206,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-24,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V186,,,,,Week 96 visit occurred 7 days out of window.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-26,2024-03-17,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V175,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-08,2024-03-22,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V175,,Other _ Major Disruption,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-24,MAJOR,16dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V175,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V197,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-28,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100171,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-22,2024-02-16,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100147,V197,,,,,Week 108 visit occurred 7 days out of window.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-21,2024-03-16,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100166,V84,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-21,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-30,2024-04-20,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V84,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-09,2024-02-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100293,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-23,2024-02-26,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100294,V175,,,,,US10008005: Week 80 visit completed 6 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-04-09,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,V83,,,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-15,2024-04-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100173,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-19,2024-02-20,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-18,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-03,2024-01-15,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100204,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-14,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V186,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008007 screened on 16Feb2021 and was randomized on 20May2021 which is 3 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-03-05,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,V197,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-22,2024-03-15,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100263,V186,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-02,2024-01-26,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-02-14,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100289,V186,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-15,2024-04-13,MAJOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-27,2024-02-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100177,V83,,Other*,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-03-28,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100185,,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-14,2024-02-15,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100131,V197,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-01,2024-01-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100135,V186,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,CNS-acting con med dose change post-randomization.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-03-30,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-05,2024-03-16,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100226,V186,,,,,US10008007: Week 80 visit completed 19 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-10,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-31,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100198,,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-21,2024-02-25,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-20,2024-03-29,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V186,,Developed withdrawal criteria but not withdrawn,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-01,2024-01-29,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-16,2024-01-17,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100297,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-13,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V197,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-18,2024-03-11,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-11,2024-02-23,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-01-18,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V186,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-03-18,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V83,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-11,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100154,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-04-18,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-25,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V175,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-18,2024-01-21,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-25,2024-03-13,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V175,,,,,W36 visit was performed 22 days out of window,,2024-01-07,2024-02-07,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100214,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-03-06,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-02-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100237,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-28,2024-03-01,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V175,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-19,2024-01-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V197,,,,,Week 52 Tau PET performed 10 days outside of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V186,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-24,2024-02-12,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V197,,,,,W60 visit was performed 10 days out of window,,2024-01-22,2024-03-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100195,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-22,2024-04-04,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-02-19,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100199,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-03-08,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-30,2024-01-31,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100229,,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,PDIE 4JUN2020: Minor PD.,2024-01-29,2024-04-07,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100121,V84,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-04,2024-02-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V175,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-09,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V197,,,,,W64 visit was performed 1 day out of window,,2024-01-29,2024-02-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-05,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V175,,,,,Blood for Nutritional parameters not collected at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-03,2024-02-19,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V84,,,,,W108 visit was performed 4 days out of window,,2024-01-29,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V197,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-20,2024-03-11,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-29,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100258,V83,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-23,2024-04-05,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-02,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 6 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-30,2024-02-18,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-19,2024-04-18,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-04-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100232,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008006's Week 76 visit occurred 3 days out of window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-02,2024-01-15,MAJOR,17Oct22 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-02-29,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,,,,,,"Missed assessments, M-24, Patient's diary not completed regularly","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-14,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100158,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-10,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100223,V84,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,,2024-01-28,2024-04-10,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-17,2024-02-01,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100279,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-21,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100146,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-25,2024-03-11,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100136,V197,,Other _ Major Disruption,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-01-11,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V186,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-13,2024-04-12,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-02,2024-02-18,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-17,2024-03-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100171,,,,,,Missing MVV by mistake,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-18,2024-02-20,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-24,2024-03-29,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-02,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100143,V84,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-30,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100226,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-28,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-17,2024-02-09,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-14,2024-02-15,MINOR-COVID-19,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-25,2024-03-02,MINOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V83,,,,,Week 92 visit occurred 8 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-03-18,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-17,2024-03-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100158,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-01,2024-01-22,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V84,,,,,PI reported SAE greater than 24 hours of notification,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,V83,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 12 (counting breaths) on RTI form dated 11Sep2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-03-25,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100263,V197,,,,,Week 92 visit occurred 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-25,2024-03-01,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100118,,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-22,2024-02-22,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,V175,,,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-18,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V83,,Entered but did not satisfy criteria,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-30,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100152,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,,2024-01-12,2024-01-18,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-12,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-12,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100295,V84,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-22,2024-03-31,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100278,V83,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-02-28,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100158,V83,,Entered but did not satisfy criteria,,,Week 88 visit occurred 10 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-07,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V84,,,,,Week 104 MRI occurred -8 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-17,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-01-30,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Stool sample not provided at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-30,2024-02-18,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100269,V83,,,,,Stool sample not provided by the patient at M-44,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-03,2024-03-23,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V84,,Entered but did not satisfy criteria,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,,2024-01-12,2024-03-06,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-16,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100230,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-24,2024-03-08,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100229,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-24,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V175,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-07,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100229,V186,,Other*,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-03-31,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,V197,,,,,CD4 count was not completed at the JNJ-90014496 Post-infusion Day 8 Visit,,2024-01-24,2024-02-29,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,V186,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-12,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-17,2024-03-06,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-14,2024-04-07,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100269,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-18,2024-03-09,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100199,,,,,,Visit 25 / Week 76 MRI completed -5 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-21,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,V84,,,,,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,V197,,,,,Week 76 completed 12 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-04,MINOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V186,,,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-01,2024-01-17,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V83,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-03-18,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,V197,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-12,2024-01-21,MINOR-COVID-19,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100278,V197,,Other _ COVID-19,,,Week 24 completed 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V175,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-02-18,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V84,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-01-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V197,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-24,MINOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100130,,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100225,V84,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-07,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-06,2024-02-29,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100199,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",,2024-01-28,2024-04-13,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-24,2024-03-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-26,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100218,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,,2024-01-19,2024-03-15,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-09,2024-02-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,V84,,,,,Week 48 completed 2 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-02-19,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-24,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,V83,,,,,W84 visit was performed 13 days out of window,,2024-01-21,2024-02-22,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100182,V175,,,,,W48 visit was performed 16 days out of window,,2024-01-05,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100117,V197,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,,2024-01-18,2024-02-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V186,,Entered but did not satisfy criteria,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-24,2024-04-16,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W96 visit was performed 12 days out of window,,2024-01-28,2024-04-23,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100229,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-01,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,,2024-01-16,2024-03-29,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100238,V197,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-09,2024-01-25,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100202,V186,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-09,2024-03-31,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V197,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1",,2024-01-24,2024-03-07,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",,2024-01-17,2024-03-12,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-27,2024-02-10,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,V175,,Entered but did not satisfy criteria,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-24,2024-02-22,MAJOR,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V197,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,,2024-01-03,2024-03-21,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,V175,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-12,2024-03-08,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,V175,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​",,2024-01-28,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100270,,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,,2024-01-19,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-13,2024-02-11,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V175,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,,2024-01-15,2024-04-09,MINOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,V197,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-30,2024-04-15,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V197,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-14,2024-02-29,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V84,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-27,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100134,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-02-12,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100297,V197,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.",,2024-01-22,2024-02-29,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100224,V186,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@",,2024-01-23,2024-03-05,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100225,,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-12,2024-01-25,MINOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100238,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-21,2024-04-16,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,V186,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-28,2024-04-25,MINOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100151,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-16,2024-01-27,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V84,,,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-29,2024-03-02,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-11,2024-04-08,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V197,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-01,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-03,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,,,,,,Week 92 visit occurred 4 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-10,2024-02-14,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100241,V84,,Other _ COVID-19,,,Stool sample not provided by the patient at M-44,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-03,2024-03-16,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V175,,,,,Week 92 visit occurred 8 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-01,2024-01-11,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100173,V175,,,,,Week 92 visit occurred 6 days out of window.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-29,2024-02-02,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100147,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-22,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-24,2024-02-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-13,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100223,V83,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-02,2024-03-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V197,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-17,2024-03-27,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,V83,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017",,2024-01-22,2024-02-15,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V186,,,,,Week 76 completed 12 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100139,V84,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-19,2024-01-21,MINOR-COVID-19,17Oct22 - LB - LTM: Reviewed.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-03,2024-02-04,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100230,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-04,2024-03-02,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100289,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-28,2024-02-02,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-07,2024-03-21,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V175,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-30,2024-04-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100250,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V175,,,,,US10008006: Week 84 visit completed 2 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-22,2024-02-26,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,,,,,,Week 96 visit occurred 7 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-06,2024-01-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100295,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-07,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-27,2024-03-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-04-11,MAJOR,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,V175,,,,,US10008007: Week 80 visit completed 19 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-17,2024-03-04,MINOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,V197,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-30,2024-02-04,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100296,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V175,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-21,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100223,V197,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-07,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,,,,,,Week 92 visit occurred 6 days out of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-02-12,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V83,,Entered but did not satisfy criteria,,,CNS-acting con med dose change post-randomization.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-28,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V186,,Entered but did not satisfy criteria,,,Week 28 completed 1 day out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-03-28,MAJOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-14,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100225,V83,,Received wrong treatment or incorrect dose,,,W96 visit was performed 3 days out of window,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-04,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100194,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-07,2024-03-15,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-13,2024-02-28,MAJOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V84,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-11,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100227,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-25,2024-02-14,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V186,,,,,SAE report submitted to sponsor outside the 24hs window,,2024-01-11,2024-02-27,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100127,V186,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-12,2024-01-17,MINOR-COVID-19,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V84,,Other*,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,,,,,,Week 28 completed 1 day out of window.,,2024-01-14,2024-03-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 24 completed 7 days out of window.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-10,2024-02-05,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V83,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-04-23,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V84,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-29,2024-04-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100161,V83,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-25,2024-01-26,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100274,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-17,2024-03-06,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-29,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100135,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-15,2024-03-02,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-07,2024-01-17,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-02-10,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,,2024-01-15,2024-03-16,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V84,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-14,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100173,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-16,2024-03-12,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-04,2024-03-25,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V83,,Entered but did not satisfy criteria,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-09,2024-01-14,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-03-16,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100154,V83,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-19,2024-02-01,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V83,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-01-24,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Visit was performed OOVW due to subject's mother COVID-19 infection.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-04-09,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100165,V186,,Entered but did not satisfy criteria,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-02-17,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100194,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-01-25,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100250,V197,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-25,2024-02-25,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-27,2024-03-08,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100196,V197,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-01-10,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100214,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-18,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100239,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-01-24,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V197,,,,,Week 88 visit occurred 19 days out of window.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-03-15,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100169,V186,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-21,2024-04-02,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V186,,,,,Week 24 completed 7 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-19,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-19,2024-04-15,MINOR,19AUg21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-30,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100162,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-26,2024-02-19,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-01-20,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V83,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-08,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100198,V84,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-28,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100224,,,,,,Stool sample not provided at M-44,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-07,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-23,2024-03-10,MINOR-COVID-19,Sponsor and study staff were informed. Deviation was discussed with the PI.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100295,V175,,,,,Week 76 completed 12 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-11,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-20,2024-04-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-04-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V84,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-04-06,MINOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Week 52 Tau PET performed 10 days outside of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-03-30,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100281,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-01,2024-01-18,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-02-06,MINOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-28,2024-02-04,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 92 visit occurred 6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-10,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V175,,Other*,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-11,2024-01-17,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-14,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100279,V84,,Entered but did not satisfy criteria,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-30,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V83,,,,,Tummy-UC not completed at Early Termination,,2024-01-11,2024-04-03,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100188,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-26,2024-02-05,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,V83,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-18,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,,,,,,W48 visit was performed 15 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-02-01,MINOR,16Dec22: LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-01,2024-02-28,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V84,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-18,2024-03-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,V186,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-04,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100162,V197,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-19,2024-03-29,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-29,2024-02-03,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100269,V83,,Entered but did not satisfy criteria,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-03,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100276,V186,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-04,2024-02-14,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100163,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-20,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V186,,,,,Blood for Nutritional parameters not collected at M-44,,2024-01-13,2024-04-08,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-03,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,V186,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-04-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V186,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-29,2024-03-22,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-23,2024-03-15,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-01-19,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,V197,,,,,Week 88 visit occurred 14 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-03,2024-02-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V84,,,,,CNS-acting con med dose change post-randomization.,,2024-01-20,2024-02-27,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-23,2024-03-27,MAJOR,19AUg21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,,,Entered but did not satisfy criteria,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-01-11,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,V186,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-25,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,,2024-01-19,2024-03-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100118,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-02-09,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-01-09,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-20,2024-01-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-08,2024-01-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,V186,,Entered but did not satisfy criteria,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-15,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,V197,,Other*,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-10,2024-02-20,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-08,2024-02-16,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100139,V83,,Entered but did not satisfy criteria,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-30,2024-04-18,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100154,V83,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-25,2024-03-22,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100281,V83,,Other*,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-05,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100213,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-21,2024-04-18,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,V186,,Entered but did not satisfy criteria,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-02,2024-02-18,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,V175,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-02-18,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-25,2024-03-18,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,V175,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-02-23,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-15,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V186,,,,,Week 108 visit occurred 7 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-21,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100117,,,Entered but did not satisfy criteria,,,Subject US10008007- Laboratory samples were not collected at week 12.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-13,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100150,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-03-31,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V83,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-26,2024-04-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100200,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-05,2024-01-14,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,V84,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-24,2024-03-01,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100246,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-30,2024-04-20,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,,,,W84 visit was performed 13 days out of window,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-04,2024-01-25,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,,,Entered but did not satisfy criteria,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V186,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-29,2024-04-05,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100277,V84,,Other _ COVID-19,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-07,2024-01-10,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100226,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-27,2024-03-28,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-03,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,V84,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-16,2024-02-01,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V175,,Other*,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-22,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V84,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-30,2024-03-12,MAJOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100219,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-11,2024-02-16,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-12,2024-03-21,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-02,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100119,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-17,2024-02-25,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100150,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-10,2024-02-16,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,V83,,,,,Week 92 visit occurred 8 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-27,2024-04-15,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,V83,,,,,Week 92 visit occurred 6 days out of window.,,2024-01-26,2024-04-05,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V186,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-17,2024-02-06,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100121,,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-13,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,,,Other*,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-03-09,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100204,V197,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-16,2024-03-03,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100279,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-22,2024-01-30,MAJOR,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,V175,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-30,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100118,V197,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-04,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100248,V84,,Entered but did not satisfy criteria,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-17,2024-02-27,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V186,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,V186,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-19,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V175,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-04,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-15,2024-03-12,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-06,2024-03-06,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100195,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-23,2024-02-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-20,2024-02-23,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V197,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-28,2024-02-18,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-15,2024-03-26,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100300,,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-01-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-12,2024-03-15,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V197,,,,,W72 visit was performed 7 days out of window,,2024-01-04,2024-02-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V186,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-28,2024-04-11,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100226,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-24,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-03-23,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-08,2024-01-19,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-03-22,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V175,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-19,2024-02-11,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V186,,,,,W60 visit was performed 28 days out of window,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-29,2024-04-27,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100188,V83,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-16,2024-03-06,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100277,,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-09,2024-04-06,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100194,V186,,Received wrong treatment or incorrect dose,,,US10008007: Week 80 visit completed 19 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-03-09,MAJOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100298,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-20,2024-03-08,MINOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-09,MAJOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V186,,Other*,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-24,2024-04-09,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100194,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-08,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V197,,Entered but did not satisfy criteria,,,W48 visit was performed 5 days out of window,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-24,2024-03-28,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-12,2024-02-20,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100147,V186,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-03-23,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100294,V83,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-02,2024-02-27,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-03-13,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100144,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-16,2024-02-22,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100276,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",,2024-01-29,2024-02-07,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-28,2024-03-24,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V197,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,,2024-01-10,2024-02-24,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-02,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V197,,Entered but did not satisfy criteria,,,Week 88 visit occurred 19 days out of window.,,2024-01-22,2024-04-02,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100143,,,,,,Randomized but did not receive study drug,,2024-01-25,2024-02-07,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V175,,Other _ Major Disruption,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-09,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V197,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-15,2024-02-20,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100117,,,,,,Week 28 completed 1 day out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-03-24,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,V175,,,,,Subject US10008007-IP was not administered at week 12.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-02-26,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100296,V83,,Other _ COVID-19,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-21,2024-03-29,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-19,2024-01-29,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-03-09,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-02,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.",,2024-01-05,2024-02-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V197,,,,,W96 visit was performed 12 days out of window,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-12,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,V186,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-18,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100248,V84,,,,,Week 16 completed 1 day out of window.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100277,V84,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-05,2024-02-26,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100171,,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-02,MINOR,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100123,V83,,Received wrong treatment or incorrect dose,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-11,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V197,,,,,Blood for Nutritional parameters not collected at M-44,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-22,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100185,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-27,2024-01-31,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V83,,,,,W48 visit was performed 16 days out of window,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-05,2024-03-24,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V84,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-29,2024-04-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-07,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100204,V197,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-17,2024-02-15,MINOR-COVID-19,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100278,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-18,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100246,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-03-09,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V197,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100298,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-21,2024-04-06,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,,,,,,Week 108 visit occurred 7 days out of window.,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-05,2024-02-03,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-04-12,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V84,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-10,2024-03-20,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V84,,,,,Week 48 completed 2 days out of window.,,2024-01-14,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,,2024-01-25,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V175,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-10,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-24,2024-04-06,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100298,V175,,,,,Week 92 visit occurred 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-25,2024-03-28,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100278,V84,,Other*,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-21,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100219,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-26,2024-02-19,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-01-28,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-09,2024-01-28,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-28,2024-03-06,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100144,,,,,,W84 visit was performed 13 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-01-27,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100169,V84,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-04-03,MINOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-04-03,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100233,V186,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-16,2024-04-14,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100292,V197,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-11,2024-03-09,MINOR,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100188,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-03,2024-03-24,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,V186,,Entered but did not satisfy criteria,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-02,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100146,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V197,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,,2024-01-12,2024-01-22,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V197,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-27,2024-03-28,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100274,V197,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,,2024-01-24,2024-02-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,,,,,,Week 52 Tau PET performed 10 days outside of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V186,,,,,W64 visit was performed 1 day out of window,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-12,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,,,,,,W84 visit was performed 13 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-28,2024-04-04,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100123,V84,,,,,W64 visit was performed 1 day out of window,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-08,2024-01-27,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100121,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 5 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-11,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-24,2024-03-17,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.",,2024-01-30,2024-02-11,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-01,2024-03-28,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100176,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100129,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008007- Laboratory samples were not collected at week 12.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-02,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100248,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-02,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V186,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-01-26,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-21,2024-02-08,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V84,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-18,2024-02-03,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100127,,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-25,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",,2024-01-10,2024-03-15,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100276,V175,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-02,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100247,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-19,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-05,2024-02-08,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,V84,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-29,2024-03-30,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V175,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-03-24,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100182,V186,,,,,Week 92 visit occurred 8 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-18,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-07,2024-02-07,MINOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100134,V84,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-29,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-16,2024-04-03,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100137,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-08,2024-04-05,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100216,V197,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V197,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-03,2024-03-28,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100150,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-03-17,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100215,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,SAE follow up report submitted to sponsor outside the 24hs window,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-26,2024-02-05,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100200,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-26,2024-04-24,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100192,V84,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-16,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100174,,,,,,Tummy-UC not completed at Early Termination,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-02-17,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100270,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-06,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100139,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,,2024-01-08,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-06,2024-03-19,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100206,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-30,2024-03-18,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-21,2024-01-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-02-29,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,V197,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-05,2024-02-14,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-03-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100199,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-12,2024-04-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V84,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-02-27,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-15,2024-03-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,V197,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-16,2024-03-03,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-12,2024-03-31,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100231,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-01-13,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-25,2024-03-15,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-12,2024-04-10,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100136,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-09,2024-03-16,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V83,,,,,W48 visit was performed 5 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-12,2024-03-10,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,,,Other _ COVID-19,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,,,Entered but did not satisfy criteria,,,Serum biomarkers sample at I-0 was collected in error however not destroyed,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-01-27,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-09,2024-03-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100258,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-27,2024-02-12,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,V175,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,,2024-01-06,2024-01-27,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100233,V83,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-01-15,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V83,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-21,2024-01-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100233,V175,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-01,2024-01-30,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100185,V186,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-18,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100165,V197,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-23,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100246,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-06,2024-01-29,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100285,V186,,,,,W64 visit was performed 1 day out of window,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-18,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100162,V175,,,,,PI reported SAE greater than 24 hours of notification,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-02-14,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100177,V175,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-12,2024-04-02,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100163,V175,,,,,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-03-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100134,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-16,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-04,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100250,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-26,2024-03-25,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100135,V83,,,,,Week 76 completed 12 days out of window.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-23,2024-02-10,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100143,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-11,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100124,V186,,Entered but did not satisfy criteria,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-20,2024-01-23,MAJOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100182,V175,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-23,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,V186,,,,,W48 visit was performed 15 days out of window,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-25,2024-03-04,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100173,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",,2024-01-14,2024-02-14,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-08,MAJOR,17Oct22 - LB - LTM: Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V197,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,,,,,,Subject US10008007-IP was not administered at week 12.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-16,2024-03-05,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-05,2024-02-12,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-20,2024-03-18,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-03-16,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100195,V84,,Entered but did not satisfy criteria,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-21,2024-03-24,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-20,2024-01-27,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-25,2024-04-04,MAJOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V175,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-17,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100213,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-09,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-01-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,V197,,,,,Week 76 completed 12 days out of window.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-21,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100136,V186,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-23,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100206,V84,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-04-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-02-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-01,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-12,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-27,2024-03-25,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V83,,Other*,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-02,2024-02-20,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V83,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-02,2024-01-15,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V175,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,V84,,Entered but did not satisfy criteria,,,"Calprotectin not measured at I-0, Quantity not sufficient",,2024-01-19,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-22,2024-02-03,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100137,V197,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-18,2024-02-22,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V197,,Entered but did not satisfy criteria,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-26,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100281,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-20,2024-03-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V83,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,,2024-01-17,2024-04-02,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V83,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-03-15,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,V197,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.",,2024-01-01,2024-03-11,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100292,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-10,2024-01-25,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100224,,,,,,W96 visit was performed 5 days out of window,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100135,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-04-04,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-25,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100137,V197,,Received wrong treatment or incorrect dose,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-21,2024-03-30,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100166,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-29,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,,2024-01-24,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V83,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-03-10,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100165,V197,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-01,2024-01-10,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,V83,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-17,2024-02-24,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100289,,,,,,Week 84 visit occurred 21 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-02-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-01,2024-03-07,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-06,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100263,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-12,2024-02-14,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100169,,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-18,2024-03-31,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-30,2024-03-30,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V175,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-08,2024-02-10,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100200,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-14,2024-01-30,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Missing MVV by mistake,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-25,2024-03-13,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100224,,,,,,W96 visit was performed 3 days out of window,,2024-01-29,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100227,V84,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-04,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-20,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100152,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-02,MINOR,THE SITE STAFF WAS RE-TRAINING.
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100131,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-11,2024-01-13,MINOR-COVID-19,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-26,2024-02-11,MINOR-COVID-19,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-30,2024-02-28,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V186,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-17,2024-01-29,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V175,,,,,W84 visit was performed 13 days out of window,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-10,2024-01-31,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-05,2024-03-19,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-01,2024-01-16,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100129,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-12,2024-01-16,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100297,V197,,Entered but did not satisfy criteria,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-04-05,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100210,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-07,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V83,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-13,2024-02-13,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100131,V197,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-01-27,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,V175,,,,,Tummy-UC not completed at Early Termination,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-30,2024-04-17,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V186,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-06,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V175,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-22,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-08,2024-01-30,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 24 completed 7 days out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-13,2024-04-03,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V84,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-14,2024-01-25,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100124,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-04-01,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100231,,,,,,Week 92 visit occurred 4 days out of window.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-06,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100238,V84,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-29,2024-01-30,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-03-30,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-08,2024-01-29,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,V186,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-12,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,V197,,,,,Stool sample not provided at M-44,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-23,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-08,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V83,,Entered but did not satisfy criteria,,,W96 visit was performed 12 days out of window,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-17,2024-03-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-18,2024-04-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100230,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-12,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100194,V84,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-05,2024-03-24,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",,2024-01-18,2024-04-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,V84,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-04-10,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V83,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-19,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V84,,,,,W72 visit was performed 7 days out of window,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-01-25,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-11,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V84,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-04-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-24,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V175,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-24,2024-02-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,V83,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-06,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,V175,,Other*,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-01-25,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100292,V83,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-03-03,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V84,,Received wrong treatment or incorrect dose,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-16,2024-03-04,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100134,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-06,2024-02-24,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008007- Laboratory samples were not collected at week 12.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-16,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100196,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-24,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,V175,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,V186,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-03,2024-01-30,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V175,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-09,2024-03-06,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V197,,Entered but did not satisfy criteria,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-08,2024-01-29,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-20,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100247,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-22,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-02-02,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100293,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-27,2024-02-04,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-07,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100146,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-03-15,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100258,V83,,,,,Week 92 visit occurred 4 days out of window.,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-26,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V83,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-04-01,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V84,,,,,W108 visit was performed 4 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-13,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100167,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-02,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100276,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-26,2024-04-09,MINOR-COVID-19,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100210,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-22,2024-03-01,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100203,V83,,Other*,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-29,2024-03-03,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,,,,,,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-02-16,MINOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100241,V197,,,,,Week 108 visit occurred 7 days out of window.,,2024-01-04,2024-02-07,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V175,,,,,Missing MVV by mistake,,2024-01-20,2024-02-19,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V175,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-25,2024-04-20,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100236,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-02-08,MAJOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-27,2024-03-01,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100122,,,Received wrong treatment or incorrect dose,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-01-25,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-01-27,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-30,2024-02-10,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100147,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-26,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-20,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V175,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-15,2024-04-12,MAJOR,11Apr21 - LB LTM: Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100276,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-23,2024-02-24,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V186,,,,,Visit 25 / Week 76 completed 4 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-03,MINOR-COVID-19,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,V197,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,,2024-01-05,2024-02-27,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,V175,,,,,W84 visit was performed 13 days out of window,,2024-01-20,2024-02-16,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100195,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 13 days out of window.,,2024-01-25,2024-03-12,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V83,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-04,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V175,,,,,W64 visit was performed 1 day out of window,,2024-01-17,2024-03-29,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100176,,,,,,W48 visit was performed 16 days out of window,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100171,,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100130,,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-09,2024-03-17,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-10,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,V84,,Received wrong treatment or incorrect dose,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-28,2024-04-24,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100195,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-02,2024-02-15,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100137,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,,2024-01-26,2024-04-06,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V197,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-29,2024-02-18,MINOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-03,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100201,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-02-07,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V175,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-27,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100214,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-20,2024-04-06,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100193,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-20,2024-03-03,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100193,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-17,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100232,,,Other _ COVID-19,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-04-03,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-01-21,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100187,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",,2024-01-14,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,V83,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-21,2024-03-12,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100285,V84,,,,,Week 92 visit occurred 4 days out of window.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-27,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V197,,Received wrong treatment or incorrect dose,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-12,2024-01-25,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V84,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-31,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100214,V186,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-28,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100266,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-29,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100233,,,,,,Stool sample not provided at M-44,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-17,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V83,,,,,US10008007: Week 80 visit completed 19 days out of window.,,2024-01-19,2024-03-29,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,,2024-01-15,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100235,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-02,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100182,V84,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-29,2024-04-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100214,V186,,,,,"At screening, respiratory rate not captured as part of vital signs","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-15,2024-01-17,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100279,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-31,MINOR,19Aug21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100190,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-29,2024-02-15,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-03-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-02-01,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V197,,,,,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-04-01,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-01-20,MAJOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-20,2024-03-03,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100172,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-21,2024-02-13,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-01-16,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100285,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-24,2024-02-24,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100196,V197,,,,,Stool sample not provided at M-44,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-06,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100230,V83,,,,,Stool sample not provided by the patient at M-44,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-23,2024-03-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100153,,,Other*,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-19,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100296,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-04,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100289,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-02-15,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-02,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100227,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-02-09,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-26,2024-03-19,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-21,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V83,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-18,2024-01-21,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100241,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-21,MAJOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100215,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-13,2024-03-28,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100148,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-01,2024-03-16,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-10,2024-03-25,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100246,,,,,,W60 visit was performed 10 days out of window,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-04,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-22,2024-03-26,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100223,V186,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-05,2024-03-23,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100154,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-03,2024-02-26,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,,,,,,Week 52 Tau PET performed 10 days outside of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-15,2024-01-27,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100177,V175,,Received wrong treatment or incorrect dose,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-03,2024-02-04,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V175,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-26,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100219,V175,,Entered but did not satisfy criteria,,,Week 92 visit occurred 6 days out of window.,,2024-01-16,2024-03-26,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,V83,,Entered but did not satisfy criteria,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-03,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100293,V84,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-09,2024-03-06,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100294,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-26,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-01-29,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100145,V175,,,,,W108 visit was performed 4 days out of window,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100116,V175,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-18,2024-03-31,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100223,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-03,2024-01-26,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V84,,,,,US10008007: Week 80 visit completed 19 days out of window.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-05,2024-03-01,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100297,V84,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-03-28,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,V186,,,,,Week 52 Tau PET performed 10 days outside of window.,,2024-01-03,2024-02-26,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100169,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W84 visit was performed 13 days out of window,,2024-01-21,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100163,V83,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -5 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-15,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100124,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-16,2024-03-31,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V175,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-03-04,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V83,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-03-20,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100255,V83,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-14,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100275,V186,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-12,2024-02-29,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-31,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,,,Entered but did not satisfy criteria,,,Week 16 completed 1 day out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-02,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100162,V197,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,W108 visit was performed 4 days out of window,,2024-01-16,2024-02-25,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100124,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-27,2024-02-03,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100248,V83,,,,,Week 52 Tau PET performed 10 days outside of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-04-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-05,2024-03-26,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100165,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V197,,Entered but did not satisfy criteria,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-05,MAJOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100247,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-01-06,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100143,V175,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",,2024-01-01,2024-01-27,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100262,V84,,,,,W48 visit was performed 16 days out of window,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-04-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100225,,,,,,W60 visit was performed 28 days out of window,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-04-10,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-02,2024-01-16,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100139,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-11,MAJOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-20,2024-03-08,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-02-29,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-19,2024-03-30,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100300,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,W36 visit was performed 22 days out of window,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-12,2024-01-29,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-13,MAJOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100119,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-10,2024-02-28,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-12,2024-04-03,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100173,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-24,2024-03-18,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100298,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-03,2024-02-24,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100300,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-06,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100238,V197,,,,,W60 visit was performed 28 days out of window,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-16,2024-03-19,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100211,V83,,,,,Randomized but did not receive study drug,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-22,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100176,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-10,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V83,,Received wrong treatment or incorrect dose,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-01-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V186,,Entered but did not satisfy criteria,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-14,2024-03-02,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100197,V84,,,,,W48 visit was performed 16 days out of window,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-15,2024-02-02,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100121,V175,,,,,Week 88 visit occurred 10 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-01-21,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100221,V83,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-21,2024-04-20,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100133,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-12,2024-01-17,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100293,V175,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-13,2024-02-24,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100243,V175,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-14,2024-03-22,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100295,V84,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-10,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100257,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-01-31,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100285,V175,,,,,Subject US10008007-IP was not administered at week 12.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-17,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100262,V186,,,,,Stool sample not provided at M-44,,2024-01-26,2024-03-29,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100143,V186,,,,,Week 104 visit occurred 2 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-06,2024-02-09,MINOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-14,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100253,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-17,2024-04-09,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-27,2024-04-07,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample",,2024-01-21,2024-04-17,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100145,V83,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-21,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100219,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-20,2024-03-30,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100254,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-10,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-05,2024-02-10,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-21,2024-03-17,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-02-18,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",,2024-01-03,2024-01-18,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-01-11,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100128,V175,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-03-04,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V197,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-27,2024-03-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100274,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-13,2024-02-09,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100239,V84,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-01-25,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100288,,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-23,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V84,,,,,W96 visit was performed 5 days out of window,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-09,2024-02-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100285,V197,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-19,2024-03-10,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-02-06,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V186,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-25,2024-02-20,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V175,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-14,2024-01-18,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,V83,,,,,Week 104 visit occurred 2 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-26,2024-02-01,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100274,V84,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-14,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-18,2024-03-12,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 10 days out of window,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-02-14,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100145,V175,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-24,2024-03-03,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-03-22,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-06,2024-01-08,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100152,V83,,,,,W72 visit was performed 7 days out of window,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-18,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100198,V83,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-30,2024-03-21,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-27,2024-04-11,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100273,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-28,2024-04-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100224,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-02,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V197,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-21,2024-03-29,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-25,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-11,2024-03-20,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,,,Other*,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100193,,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V83,,Entered but did not satisfy criteria,,,Visit was performed OOVW due to subject's COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-30,2024-02-15,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V83,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-07,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V84,,Received wrong treatment or incorrect dose,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-04,2024-03-02,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-04-27,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100166,V197,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-18,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V186,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-14,2024-02-06,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100123,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-25,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100162,,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-04-01,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100165,V84,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-03,2024-02-21,MINOR,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100189,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-18,2024-01-26,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,V186,,,,,W72 visit was performed 7 days out of window,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-01-29,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-02,2024-01-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100271,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-15,2024-01-27,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V186,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-19,2024-03-15,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100170,V83,,,,,W108 visit was performed 4 days out of window,,2024-01-17,2024-03-09,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-27,2024-02-19,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-04-01,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V175,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-23,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-04,2024-02-20,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,,,,,,Stool sample not provided at M-44,,2024-01-21,2024-03-15,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100297,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.",,2024-01-29,2024-02-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-29,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-21,2024-04-07,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 108 visit occurred 7 days out of window.,,2024-01-06,2024-01-07,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V197,,,,,W84 visit was performed 13 days out of window,PDIE 4JUN2020: Minor PD.,2024-01-09,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,V83,,,,,Week 96 visit occurred 7 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-09,2024-04-08,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100240,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",,2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100211,V175,,,,,W60 visit was performed 10 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-04-08,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 52 Tau PET performed 10 days outside of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-05,2024-02-21,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related."
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-30,2024-02-06,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V83,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-12,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,Entered but did not satisfy criteria,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-17,2024-02-28,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,V83,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-28,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100119,,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-18,2024-03-11,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-10,2024-02-07,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,,,,,,W48 visit was performed 5 days out of window,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-29,2024-03-04,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,V175,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100204,,,,,,Missing MVV by mistake,,2024-01-21,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100146,,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100244,V186,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-22,2024-01-29,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100222,,,Other*,,,Week 92 visit occurred 6 days out of window.,,2024-01-27,2024-04-22,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100118,V175,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-04-03,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100150,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-15,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100140,V84,,Other*,,,Blood for Nutritional parameters not collected at M-44,,2024-01-27,2024-03-18,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100166,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-10,2024-02-10,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed"
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100258,,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-01,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-28,2024-04-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Week 76 completed 12 days out of window.,,2024-01-25,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100211,,,,,,W64 visit was performed 1 day out of window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-25,2024-01-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100220,V84,,Other _ Major Disruption,,,Visit 25 / Week 76 MRI completed -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-21,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-21,2024-03-13,MINOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,V175,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-26,2024-04-10,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100175,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-13,2024-01-22,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100291,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,,2024-01-11,2024-03-20,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-10,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100277,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-07,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100199,V84,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-08,2024-02-14,MINOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100274,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-22,2024-01-28,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100125,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-07,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100256,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-01,2024-03-20,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100150,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-28,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100196,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-10,2024-02-02,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V186,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-19,2024-03-30,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100237,V84,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100210,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.",,2024-01-17,2024-04-12,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100237,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-01-17,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-15,2024-02-25,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V84,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-13,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100132,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",,2024-01-10,2024-02-02,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-03-26,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100182,V83,,,,,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-08,2024-01-24,MINOR,20Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V197,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-21,2024-04-05,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-13,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100180,V84,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-07,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100138,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-25,2024-03-18,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100207,V175,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-24,2024-03-11,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100161,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-22,2024-03-09,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100262,V197,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-13,2024-03-10,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100169,,,Other*,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-03,2024-02-10,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100127,V175,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-25,2024-03-24,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100242,V175,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-21,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100280,V84,,Entered but did not satisfy criteria,,,Week 88 visit occurred 14 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-04-19,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100284,V83,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-12,2024-03-19,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-22,2024-04-21,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100155,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-25,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V84,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-18,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,Other _ Major Disruption,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-25,2024-04-21,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100183,V175,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-21,2024-02-23,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100237,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-02,2024-01-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V175,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-26,MAJOR,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100119,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-02-18,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-21,2024-04-17,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100145,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100218,V84,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-13,2024-03-12,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100287,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-04-05,MINOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100259,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-03-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100152,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100177,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-02,2024-01-04,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100215,V175,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-07,2024-03-23,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100299,,,,,,Visit 25 / Week 76 completed 4 days out of window.,,2024-01-02,2024-01-18,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V175,,,,,Week 48 completed 2 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-01-23,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V197,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-17,2024-03-14,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100282,,,,,,Week 16 completed 1 day out of window.,,2024-01-08,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.",,2024-01-21,2024-03-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-24,2024-04-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100268,V186,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-22,2024-04-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-11,2024-04-03,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100289,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-19,2024-03-05,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100292,,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100217,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,CNS-acting con med dose change post-randomization.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-02,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100245,V175,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-24,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-03-10,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100235,V83,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-14,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100251,V83,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",,2024-01-10,2024-01-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100293,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-28,2024-03-24,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100200,V83,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-09,2024-03-12,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-15,2024-03-22,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100124,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-03-22,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100136,V186,,,,,Week 84 visit occurred 21 days out of window.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-04-03,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100265,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-02-06,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100270,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",,2024-01-11,2024-01-15,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100267,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-06,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100272,V186,,,,,Week 104 MRI occurred -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-01-21,MAJOR,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100179,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-06,2024-02-14,MINOR-COVID-19,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100144,V83,,,,,SAE report submitted to sponsor outside the 24hs window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-03-13,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100130,V186,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-03-17,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100117,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",,2024-01-04,2024-03-21,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-03,2024-04-01,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100212,,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100185,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-11,2024-03-01,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V83,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",,2024-01-22,2024-02-03,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-18,2024-02-13,MAJOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V186,,,,,CNS-acting con med dose change post-randomization.,,2024-01-30,2024-03-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100261,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,,2024-01-12,2024-01-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100141,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-09,2024-01-29,MAJOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100171,V197,,Received wrong treatment or incorrect dose,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-04-06,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-06,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100228,V84,,,,,US10008005: Week 80 visit completed 6 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-20,2024-04-17,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-03,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100159,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-23,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100237,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,,2024-01-06,2024-03-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100142,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-21,2024-02-23,MINOR,11Apr21 - LB LTM: Reviewed.
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100286,,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-11,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100209,,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-02-15,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100210,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-12,2024-01-28,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100252,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-30,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-02-01,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V83,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-15,2024-04-07,MINOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100260,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-03-18,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100120,V175,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-12,2024-03-04,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100205,V197,,,,,Week 84 visit occurred 21 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-03-24,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100226,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-03-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100262,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Randomized but did not receive study drug,,2024-01-02,2024-01-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,,,,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-17,2024-01-27,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100147,V84,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-10,2024-02-13,MINOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100121,V84,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-03-21,MINOR-COVID-19,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100178,V197,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-01,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100168,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-25,2024-03-25,MINOR,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-11,MAJOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100208,V83,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-31,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,,2024-01-17,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100184,V175,,,,,Week 108 visit occurred 7 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-02-11,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100235,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-24,2024-02-20,MINOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100213,V83,,Other _ Major Disruption,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-03-22,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100149,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-13,2024-03-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100123,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-03-03,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100290,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-02-11,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100186,V197,,Entered but did not satisfy criteria,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-06,2024-02-23,MAJOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100264,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-04-06,MINOR,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100191,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-01-28,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100249,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-07,2024-03-01,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100164,V175,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-28,MINOR-COVID-19,,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100156,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-23,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100126,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-01-30,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100232,,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-02-25,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100181,V175,,Other _ Major Disruption,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-02-13,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100158,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.",,2024-01-01,2024-03-25,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100160,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100229,V84,,Entered but did not satisfy criteria,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-10,2024-01-18,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,90014496LYM1001,United States of America,BV7-US10007,Smith Adam,100234,,,,,,CNS-acting con med dose change post-randomization.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-10,2024-04-01,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,V175,,,,,SAE report submitted to sponsor outside the 24hs window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-11,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100235,V84,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-02-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,V84,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-03-12,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100246,V83,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-25,2024-03-26,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100227,V84,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-08,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100117,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-07,2024-01-29,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,V197,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-13,2024-02-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100134,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-02-23,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-05,2024-04-03,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100118,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-02-12,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-19,2024-01-25,MAJOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100300,,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-02-04,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V197,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 16 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100296,V197,,,,,W48 visit was performed 5 days out of window,,2024-01-21,2024-01-31,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V84,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-06,2024-01-23,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100153,,,,,,W96 visit was performed 3 days out of window,,2024-01-12,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100250,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-19,2024-02-01,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,,,Entered but did not satisfy criteria,,,Week 104 visit occurred 2 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-18,2024-01-24,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100269,V197,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100298,,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-16,2024-02-01,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-12,2024-01-30,MINOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100163,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-24,2024-02-24,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V186,,,,,Randomized but did not receive study drug,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-13,2024-02-25,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-25,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V175,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-03,2024-02-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V197,,Other _ Major Disruption,,,Week 88 visit occurred 19 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-17,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 28 days out of window,,2024-01-05,2024-02-08,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100176,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-06,2024-02-21,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-18,2024-03-22,MINOR-COVID-19,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-12,2024-03-08,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V197,,Entered but did not satisfy criteria,,,Subject US10008007-IP was not administered at week 12.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-02-13,MAJOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-02-27,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100196,V83,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-27,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100281,,,,,,Week 88 visit occurred 14 days out of window.,"SM, Megan McMahon, 15Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-03,2024-03-26,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V186,,,,,Tummy-UC not completed at Early Termination,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-04-17,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-05,2024-03-19,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100206,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-24,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V186,,,,,Week 96 visit occurred 7 days out of window.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-26,2024-03-17,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V175,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-08,2024-03-22,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V175,,Other _ Major Disruption,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-24,MAJOR,16dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V175,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V197,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-28,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100171,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-22,2024-02-16,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100147,V197,,,,,Week 108 visit occurred 7 days out of window.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-21,2024-03-16,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100166,V84,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-21,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-30,2024-04-20,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V84,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-09,2024-02-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100293,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-23,2024-02-26,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100294,V175,,,,,US10008005: Week 80 visit completed 6 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-04-09,MAJOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,V83,,,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-15,2024-04-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100173,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-19,2024-02-20,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-03,2024-01-15,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100204,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-14,2024-03-16,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V186,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"07Nov2023 M McMahon, SM: Subject US10008007 screened on 16Feb2021 and was randomized on 20May2021 which is 3 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-03-05,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,V197,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-22,2024-03-15,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100263,V186,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-02,2024-01-26,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-02-14,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100289,V186,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-15,2024-04-13,MAJOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-27,2024-02-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100177,V83,,Other*,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-03-28,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100185,,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-14,2024-02-15,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100131,V197,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-01,2024-01-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100135,V186,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,CNS-acting con med dose change post-randomization.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-03-30,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-05,2024-03-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100226,V186,,,,,US10008007: Week 80 visit completed 19 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-10,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-16,2024-03-31,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100198,,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-21,2024-02-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-20,2024-03-29,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V186,,Developed withdrawal criteria but not withdrawn,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-01,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-16,2024-01-17,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100297,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-13,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V197,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-18,2024-03-11,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-11,2024-02-23,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-01-18,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V186,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-03-18,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V83,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-11,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100154,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-04-18,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-25,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V175,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-18,2024-01-21,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-25,2024-03-13,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V175,,,,,W36 visit was performed 22 days out of window,,2024-01-07,2024-02-07,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100214,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-25,2024-03-06,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-02-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100237,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-28,2024-03-01,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V175,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-19,2024-01-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V197,,,,,Week 52 Tau PET performed 10 days outside of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V186,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-24,2024-02-12,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V197,,,,,W60 visit was performed 10 days out of window,,2024-01-22,2024-03-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100195,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-22,2024-04-04,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-02-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100199,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-03-08,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-30,2024-01-31,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100229,,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,PDIE 4JUN2020: Minor PD.,2024-01-29,2024-04-07,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100121,V84,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-04,2024-02-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V175,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-09,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V197,,,,,W64 visit was performed 1 day out of window,,2024-01-29,2024-02-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-05,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V175,,,,,Blood for Nutritional parameters not collected at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-03,2024-02-19,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V84,,,,,W108 visit was performed 4 days out of window,,2024-01-29,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V197,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-20,2024-03-11,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-29,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100258,V83,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-23,2024-04-05,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-02,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 6 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-30,2024-02-18,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-19,2024-04-18,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-04-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100232,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008006's Week 76 visit occurred 3 days out of window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-02,2024-01-15,MAJOR,17Oct22 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-02-29,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,,,,,,"Missed assessments, M-24, Patient's diary not completed regularly","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-14,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100158,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-10,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100223,V84,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,,2024-01-28,2024-04-10,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-17,2024-02-01,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100279,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-21,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100146,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-25,2024-03-11,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100136,V197,,Other _ Major Disruption,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-01-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V186,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-13,2024-04-12,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-02,2024-02-18,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-17,2024-03-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100171,,,,,,Missing MVV by mistake,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-18,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-24,2024-03-29,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-02,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100143,V84,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-30,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100226,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-28,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-17,2024-02-09,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-14,2024-02-15,MINOR-COVID-19,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-25,2024-03-02,MINOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V83,,,,,Week 92 visit occurred 8 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-03-18,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-17,2024-03-25,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100158,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-01,2024-01-22,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V84,,,,,PI reported SAE greater than 24 hours of notification,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-28,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,V83,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 12 (counting breaths) on RTI form dated 11Sep2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-03-25,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100263,V197,,,,,Week 92 visit occurred 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock the deviation",2024-01-25,2024-03-01,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100118,,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-22,2024-02-22,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,V175,,,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-18,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V83,,Entered but did not satisfy criteria,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-30,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100152,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,,2024-01-12,2024-01-18,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-12,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-12,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100295,V84,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-22,2024-03-31,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100278,V83,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-02-28,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100158,V83,,Entered but did not satisfy criteria,,,Week 88 visit occurred 10 days out of window.,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-07,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V84,,,,,Week 104 MRI occurred -8 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-17,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-01-30,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Stool sample not provided at M-44,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-30,2024-02-18,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100269,V83,,,,,Stool sample not provided by the patient at M-44,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-03,2024-03-23,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V84,,Entered but did not satisfy criteria,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,,2024-01-12,2024-03-06,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-16,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100230,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-24,2024-03-08,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100229,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-24,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V175,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-07,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100229,V186,,Other*,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-03-31,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,V197,,,,,CD4 count was not completed at the JNJ-90014496 Post-infusion Day 8 Visit,,2024-01-24,2024-02-29,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,V186,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-12,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-17,2024-03-06,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-14,2024-04-07,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100269,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-18,2024-03-09,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100199,,,,,,Visit 25 / Week 76 MRI completed -5 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-21,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,V84,,,,,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-03-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,V197,,,,,Week 76 completed 12 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-04,MINOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V186,,,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-01,2024-01-17,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V83,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-03-18,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,V197,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-12,2024-01-21,MINOR-COVID-19,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100278,V197,,Other _ COVID-19,,,Week 24 completed 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V175,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-02-18,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V84,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-01-29,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V197,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-02-24,MINOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100130,,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100225,V84,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-07,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-06,2024-02-29,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100199,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",,2024-01-28,2024-04-13,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-24,2024-03-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100218,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,,2024-01-19,2024-03-15,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-09,2024-02-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,V84,,,,,Week 48 completed 2 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-02-19,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V84,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-24,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,V83,,,,,W84 visit was performed 13 days out of window,,2024-01-21,2024-02-22,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100182,V175,,,,,W48 visit was performed 16 days out of window,,2024-01-05,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100117,V197,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,,2024-01-18,2024-02-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V186,,Entered but did not satisfy criteria,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-24,2024-04-16,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W96 visit was performed 12 days out of window,,2024-01-28,2024-04-23,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100229,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-01,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,,2024-01-16,2024-03-29,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100238,V197,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-09,2024-01-25,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100202,V186,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-09,2024-03-31,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V197,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1",,2024-01-24,2024-03-07,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",,2024-01-17,2024-03-12,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-27,2024-02-10,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,V175,,Entered but did not satisfy criteria,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-24,2024-02-22,MAJOR,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V197,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,,2024-01-03,2024-03-21,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,V175,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-12,2024-03-08,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,V175,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​",,2024-01-28,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100270,,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,,2024-01-19,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-13,2024-02-11,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V175,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,,2024-01-15,2024-04-09,MINOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,V197,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-30,2024-04-15,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V197,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-14,2024-02-29,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V84,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-27,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100134,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-02-12,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100297,V197,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.",,2024-01-22,2024-02-29,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100224,V186,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@",,2024-01-23,2024-03-05,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100225,,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-12,2024-01-25,MINOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100238,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-21,2024-04-16,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,V186,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-28,2024-04-25,MINOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100151,V83,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-16,2024-01-27,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V84,,,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-29,2024-03-02,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-11,2024-04-08,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V197,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-03,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,,,,,,Week 92 visit occurred 4 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-10,2024-02-14,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100241,V84,,Other _ COVID-19,,,Stool sample not provided by the patient at M-44,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-03,2024-03-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V175,,,,,Week 92 visit occurred 8 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-01,2024-01-11,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100173,V175,,,,,Week 92 visit occurred 6 days out of window.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-29,2024-02-02,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100147,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-22,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-24,2024-02-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-13,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100223,V83,,,,,"The HGB on 22July2019 before C1D1 for subject No.86028012 is 81g/L,the HGB on 13Aug2019 in screening is 74g/L, it doesn't meet inclusion criterion 5.1","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-02,2024-03-11,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V197,,,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-17,2024-03-27,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,V83,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017",,2024-01-22,2024-02-15,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V186,,,,,Week 76 completed 12 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100139,V84,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-19,2024-01-21,MINOR-COVID-19,17Oct22 - LB - LTM: Reviewed.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-03,2024-02-04,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100230,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-04,2024-03-02,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100289,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-28,2024-02-02,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V84,,,,,Visit 25 / Week 76 completed 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-07,2024-03-21,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V197,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-04-09,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V175,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-30,2024-04-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100250,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-04-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V175,,,,,US10008006: Week 84 visit completed 2 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-22,2024-02-26,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,,,,,,Week 96 visit occurred 7 days out of window.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-06,2024-01-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100295,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-07,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-27,2024-03-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-04-11,MAJOR,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,V175,,,,,US10008007: Week 80 visit completed 19 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-17,2024-03-04,MINOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,V197,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-30,2024-02-04,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100296,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-20,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V175,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-21,MAJOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100223,V197,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-07,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,,,,,,Week 92 visit occurred 6 days out of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-02-12,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V83,,Entered but did not satisfy criteria,,,CNS-acting con med dose change post-randomization.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-03-28,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V186,,Entered but did not satisfy criteria,,,Week 28 completed 1 day out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-03-28,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-14,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100225,V83,,Received wrong treatment or incorrect dose,,,W96 visit was performed 3 days out of window,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-04,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100194,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-07,2024-03-15,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-13,2024-02-28,MAJOR,14Sep 21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V84,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-15,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100227,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-25,2024-02-14,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V186,,,,,SAE report submitted to sponsor outside the 24hs window,,2024-01-11,2024-02-27,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100127,V186,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-12,2024-01-17,MINOR-COVID-19,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V84,,Other*,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,,,,,,Week 28 completed 1 day out of window.,,2024-01-14,2024-03-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Week 24 completed 7 days out of window.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-10,2024-02-05,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V83,,,,,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-04-23,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V84,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-29,2024-04-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100161,V83,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-25,2024-01-26,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100274,V84,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 27-Mar-2020) and this PD. If there are appropriate corrective actions, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa the following route causes to the deviation. - The man power of investigators decreased due to employee movement. - The site scheduled the Week 0 Visit with the latest date within the screening window because anti-MDA5 antibody will be detected approximately 5 weeks later. - The investigator who planned to perform efficacy tests was suddenly absent due to an acute disease. SM confirmed from Ms. Kurumizawa the following corrective actions. - The site will not schedule the Week 0 Visit during the season of employee movement. - Anti-MDA5 test result in screening period will be used by the data of the site, not by central laboratory(Covance) according to Clinical Protocol Amendment 2 and the site will set Week 0 Visit at earlier date. - The site will confirm if there are any back-up investigators at the scheduled Week 0 Visit. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-17,2024-03-06,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-29,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100135,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-15,2024-03-02,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-07,2024-01-17,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-02-10,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,,2024-01-15,2024-03-16,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V84,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-14,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100173,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-16,2024-03-12,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-04,2024-03-25,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V83,,Entered but did not satisfy criteria,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-09,2024-01-14,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-03-16,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100154,V83,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,,2024-01-19,2024-02-01,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V83,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-01-24,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Visit was performed OOVW due to subject's mother COVID-19 infection.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-04-09,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100165,V186,,Entered but did not satisfy criteria,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-02-17,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100194,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-01-25,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100250,V197,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-25,2024-02-25,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-27,2024-03-08,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100196,V197,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-01-10,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100214,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-18,2024-04-01,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100239,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-01-24,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V197,,,,,Week 88 visit occurred 19 days out of window.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-03,2024-03-15,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100169,V186,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-21,2024-04-02,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V186,,,,,Week 24 completed 7 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-19,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-19,2024-04-15,MINOR,19AUg21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-04,2024-03-30,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100162,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-26,2024-02-19,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V175,,,,,Visit 25 / Week 76 completed 4 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-01-20,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V83,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-16,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-08,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100198,V84,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-28,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100224,,,,,,Stool sample not provided at M-44,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-11,2024-02-07,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-23,2024-03-10,MINOR-COVID-19,Sponsor and study staff were informed. Deviation was discussed with the PI.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100295,V175,,,,,Week 76 completed 12 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-11,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,,,,,,SAE follow up report submitted to sponsor outside the 24hs window,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-20,2024-04-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-20,2024-04-18,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V84,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-22,2024-04-06,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Week 52 Tau PET performed 10 days outside of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-04,2024-03-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100281,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-01,2024-01-18,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-02-06,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V175,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-28,2024-02-04,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 92 visit occurred 6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-03-10,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V175,,Other*,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-11,2024-01-17,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-14,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100279,V84,,Entered but did not satisfy criteria,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-30,MAJOR,"LTM, W. Sult, reviewed PD during MVR on 25Mar2024; per central team review this can be downgraded to minor and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V83,,,,,Tummy-UC not completed at Early Termination,,2024-01-11,2024-04-03,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100188,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-26,2024-02-05,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,V83,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-30,2024-03-18,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,,,,,,W48 visit was performed 15 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-02-01,MINOR,16Dec22: LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-01,2024-02-28,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V84,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-18,2024-03-06,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,V186,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-04,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100162,V197,,Entered but did not satisfy criteria,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-19,2024-03-29,MAJOR,19Aug21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V83,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-29,2024-02-03,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100269,V83,,Entered but did not satisfy criteria,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-03,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100276,V186,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-04,2024-02-14,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100163,V83,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V186,,,,,Blood for Nutritional parameters not collected at M-44,,2024-01-13,2024-04-08,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-03,2024-03-31,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,V186,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-04-02,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V186,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-29,2024-03-22,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-23,2024-03-15,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-01-19,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,V197,,,,,Week 88 visit occurred 14 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-03,2024-02-16,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V84,,,,,CNS-acting con med dose change post-randomization.,,2024-01-20,2024-02-27,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-23,2024-03-27,MAJOR,19AUg21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,,,Entered but did not satisfy criteria,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-01-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,V186,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-25,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Serum biomarkers sample at I-0 was collected in error however not destroyed,,2024-01-19,2024-03-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100118,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-02-09,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 28 completed 1 day out of window.,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-01-09,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",,2024-01-20,2024-01-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-08,2024-01-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,V186,,Entered but did not satisfy criteria,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-15,MAJOR,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,V197,,Other*,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-10,2024-02-20,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V186,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-08,2024-02-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100139,V83,,Entered but did not satisfy criteria,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-30,2024-04-18,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100154,V83,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-25,2024-03-22,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100281,V83,,Other*,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-05,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100213,V197,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-21,2024-04-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,V186,,Entered but did not satisfy criteria,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-02,2024-02-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,V175,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-02-18,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-25,2024-03-18,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,V175,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-02-23,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-15,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V186,,,,,Week 108 visit occurred 7 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-02-21,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100117,,,Entered but did not satisfy criteria,,,Subject US10008007- Laboratory samples were not collected at week 12.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-13,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100150,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-05,2024-03-31,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V83,,,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-26,2024-04-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100200,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-05,2024-01-14,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,V84,,,,,Participant 20001092 randomized at site T30-US10193 on 29Dec2023 after already being randomized at site T30-US10129 on 10Jul2023 as subject 10007017 and randomized at site T30-US10121 on 03Aug2023 as subject 10007629. Subject was detected using ERT Serial Numbers report and confirmed via driver's license.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-24,2024-03-01,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100246,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-30,2024-04-20,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,,,,W84 visit was performed 13 days out of window,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-04,2024-01-25,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,,,Entered but did not satisfy criteria,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V186,,,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-29,2024-04-05,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100277,V84,,Other _ COVID-19,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-07,2024-01-10,MAJOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100226,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-27,2024-03-28,MAJOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-03,2024-02-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,V84,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-16,2024-02-01,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V175,,Other*,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-22,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V84,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-30,2024-03-12,MAJOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100219,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-11,2024-02-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",,2024-01-12,2024-03-21,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-02,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100119,V175,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-17,2024-02-25,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100150,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-10,2024-02-16,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,V83,,,,,Week 92 visit occurred 8 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-27,2024-04-15,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,V83,,,,,Week 92 visit occurred 6 days out of window.,,2024-01-26,2024-04-05,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V186,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-17,2024-02-06,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100121,,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-01,2024-03-13,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,,,Other*,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-03-09,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100204,V197,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,,2024-01-16,2024-03-03,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100279,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-22,2024-01-30,MAJOR,16Dec22 - LB - LTM: reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,V175,,Received wrong treatment or incorrect dose,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-30,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100118,V197,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-04,2024-03-28,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100248,V84,,Entered but did not satisfy criteria,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-17,2024-02-27,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V186,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-05,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,V186,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-19,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V175,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-07,2024-03-04,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V186,,,,,SAE follow up report submitted to sponsor outside the 24hs window,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-15,2024-03-12,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-06,2024-03-06,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100195,V197,,,,,W96 visit was performed 5 days out of window,,2024-01-23,2024-02-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-20,2024-02-23,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V197,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-28,2024-02-18,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-15,2024-03-26,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100300,,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-01-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-12,2024-03-15,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V197,,,,,W72 visit was performed 7 days out of window,,2024-01-04,2024-02-01,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V186,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-28,2024-04-11,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100226,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-24,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,,,,,,"Subject randomized at multiple sites on study, and received more than one dose of study vaccine. Subject 20000817 enrolled at site T30-US10193 on 18-Dec-23 after previously being randomized at site T30-US10142 on 17AUG2023. ​","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-03-23,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V197,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-08,2024-01-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-03-22,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V175,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-19,2024-02-11,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V186,,,,,W60 visit was performed 28 days out of window,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-29,2024-04-27,MINOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-01-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100188,V83,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-16,2024-03-06,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100277,,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-09,2024-04-06,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100194,V186,,Received wrong treatment or incorrect dose,,,US10008007: Week 80 visit completed 19 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-03-09,MAJOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100298,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: This is a minor deviation due to protocol wording noting ""preferably"" collected within 72 hours of onset. Potential impact on RSV testing; no impact on immuno.",2024-01-20,2024-03-08,MINOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-09,MAJOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V186,,Other*,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-24,2024-04-09,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100194,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-08,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V197,,Entered but did not satisfy criteria,,,W48 visit was performed 5 days out of window,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-24,2024-03-28,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-12,2024-02-20,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100147,V186,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-10,2024-03-23,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100294,V83,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-02,2024-02-27,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-03-13,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100144,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-16,2024-02-22,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100276,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",,2024-01-29,2024-02-07,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-28,2024-03-24,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V197,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,,2024-01-10,2024-02-24,MINOR-COVID-19,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-02-02,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V197,,Entered but did not satisfy criteria,,,Week 88 visit occurred 19 days out of window.,,2024-01-22,2024-04-02,MAJOR,"LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100143,,,,,,Randomized but did not receive study drug,,2024-01-25,2024-02-07,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V175,,Other _ Major Disruption,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-09,2024-04-06,MAJOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V197,,,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-15,2024-02-20,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100117,,,,,,Week 28 completed 1 day out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-05,2024-03-24,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,V175,,,,,Subject US10008007-IP was not administered at week 12.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-02-26,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100296,V83,,Other _ COVID-19,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-21,2024-03-29,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-19,2024-01-29,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-03-09,MAJOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-02,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V175,,,,,"Subject started CNS-acting medication, SEROQUEL 25 MG PO QD, post-randomization.",,2024-01-05,2024-02-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V197,,,,,W96 visit was performed 12 days out of window,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-12,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,V186,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-24,2024-02-18,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100248,V84,,,,,Week 16 completed 1 day out of window.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-13,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100277,V84,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-05,2024-02-26,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100171,,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-02-02,MINOR,20Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100123,V83,,Received wrong treatment or incorrect dose,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-11,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V197,,,,,Blood for Nutritional parameters not collected at M-44,"SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here. SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-22,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100185,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-27,2024-01-31,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-10,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V83,,,,,W48 visit was performed 16 days out of window,"14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-05,2024-03-24,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V84,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-29,2024-04-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-07,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100204,V197,,,,,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-17,2024-02-15,MINOR-COVID-19,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100278,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-18,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100246,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-20,2024-03-09,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V197,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100298,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.","SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-21,2024-04-06,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,,,,,,Week 108 visit occurred 7 days out of window.,"Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-05,2024-02-03,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-04,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-04-12,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V84,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-10,2024-03-20,MINOR-COVID-19,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V84,,,,,Week 48 completed 2 days out of window.,,2024-01-14,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,,2024-01-25,2024-03-07,MINOR,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V175,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,,2024-01-10,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-24,2024-04-06,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100298,V175,,,,,Week 92 visit occurred 4 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-25,2024-03-28,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100278,V84,,Other*,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-21,MAJOR,A reminder was done to the SC during IMV7 to have it signed by the patient at his next on-site visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100219,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-26,2024-02-19,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>, <Specify which assessments weren't done>, <Reason why - if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M24, platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD). LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-27,2024-01-28,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V186,,,,,During the OMV on 25/26Nov2021 it was noted by the CRA that a number of AEs were not reported for patients enrolled into the study. Patient GB10003001:Constipation documented in clinic letter 11Jun2018Athralgia documented in clinic letter 03Aug2020,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-09,2024-01-28,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-28,2024-03-06,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100144,,,,,,W84 visit was performed 13 days out of window,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-01-27,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100169,V84,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-04-03,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-28,2024-04-03,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100233,V186,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"3JAN2018, LTM, Yael Pomeraniec: please confirm if there is no additional kits lost at the site - if not, please close the PD",2024-01-16,2024-04-14,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100292,V197,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-11,2024-03-09,MINOR,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100188,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-03,2024-03-24,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,V186,,Entered but did not satisfy criteria,,,Platels were not analyzed by the Labcorp. Subject was not asked to come for the retest. SM preformed training for the PI regarding retest requirements. TL has been signed.,"SM, M.Juchimiuk, 13Jul2023: As clarified with the Yprime team - there was not sufficient number of eligible diaries for the system to calculate MAYO score. It was the last patient's visit in the study, thus no patient's re-training was possible. The SM sent an email to investigators on 13Jul2023 reminding that they should check if at least 3 eligible MAYO diaries were completed within 7 days prior to the visit. If there is less than 3, the visit should be re-scheduled. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-02,2024-01-30,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100146,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V197,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,,2024-01-12,2024-01-22,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V197,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"Although the initial SAE report from pat 30010990 was submitted on time, the follow up was submitted with a 24hs delay (AoR on 22-Jul-15, follow up report on 24-Jul-15). The investigators were reminded that adherence to the sponsor requirements for SAE reporting is part of their responsibilities.",2024-01-27,2024-03-28,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100274,V197,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,,2024-01-24,2024-02-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,,,,,,Week 52 Tau PET performed 10 days outside of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-04,2024-01-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V186,,,,,W64 visit was performed 1 day out of window,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-03-12,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,,,,,,W84 visit was performed 13 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-28,2024-04-04,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100123,V84,,,,,W64 visit was performed 1 day out of window,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-08,2024-01-27,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100121,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 5 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-11,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-24,2024-03-17,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V83,,,,,"Telephone Contact Report with Ms. Kurumizawa, 01-MAY-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the LDH of the subject# 105003 at Week 4(28-APR-2020) was not resulted because of hemolysis.",,2024-01-30,2024-02-11,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-01,2024-03-28,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100176,V197,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100129,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008007- Laboratory samples were not collected at week 12.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document. 01Feb24 - MM - SM: It was noted that PD end date had not been entered in CTMS by the previous SM. Current SM updated PD with end date.",2024-01-02,2024-03-17,MAJOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100248,V83,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-27,2024-04-02,MINOR,14Sep21 - LB - LTM: reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V186,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-01-26,MINOR-COVID-19,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V186,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-21,2024-02-08,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V84,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-18,2024-02-03,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100127,,,,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-25,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V175,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.",,2024-01-10,2024-03-15,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100276,V175,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-02,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100247,V186,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-19,2024-03-06,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,V175,,,,,W72 visit was performed 7 days out of window,,2024-01-05,2024-02-08,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,V84,,,,,"Subject US30140703 signed ICF version 6.0 at visit 3 (Day29). However, subject did not have time to complete all the study procedures related to unblinding and vaccination. Therefore, subject was not unblinded until the next visit which was visit 4 (Day 57) on 12April2021.",,2024-01-29,2024-03-30,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V175,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-03-24,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100182,V186,,,,,Week 92 visit occurred 8 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-01-18,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V84,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-07,2024-02-07,MINOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100134,V84,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008005 screened on 26Jan2021 and was randomized on 12May2021 which is 16 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2024: I Karuga, LTM: PD reviewed an can be closed.",2024-01-29,2024-02-06,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-16,2024-04-03,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100137,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008005 Week 104 MRI occurred -6 days out of window.,"6 Jul 17, LTM confirmed minor PD as part of the SMV report review",2024-01-08,2024-04-05,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100216,V197,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-30,2024-03-20,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V197,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-03,2024-03-28,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100150,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-03-17,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100215,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,SAE follow up report submitted to sponsor outside the 24hs window,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-26,2024-02-05,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100200,V197,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-26,2024-04-24,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100192,V84,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-16,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100174,,,,,,Tummy-UC not completed at Early Termination,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-02-17,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100270,V197,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-06,2024-03-08,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100139,,,,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,,2024-01-08,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-06,2024-03-19,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100206,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-30,2024-03-18,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-21,2024-01-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,V83,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-02-29,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,V197,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-05,2024-02-14,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-12,2024-03-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100199,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",,2024-01-12,2024-04-07,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V84,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-25,2024-02-27,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-15,2024-03-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,V197,,,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-16,2024-03-03,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM addressed the importance of performing the study procedures as per protocol requirements. They verbalized understanding. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update 12May2022- SM trained site staff on the importance of conducting procedures as per protocol design. 17Jun2022 M McMahon, SM: The PI assessed the protocol deviation as not reportable to IRB. SM confirms the deviation was documented in subject source including PI's assessment. 21Jun22 - LB - LTM: SM to close and lock deviation.",2024-01-12,2024-03-31,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100231,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-01-13,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-25,2024-03-15,MINOR,THE SITE STAFF WAS RE-TRAINING.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-12,2024-04-10,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100136,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-09,2024-03-16,MAJOR,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V83,,,,,W48 visit was performed 5 days out of window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-12,2024-03-10,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,,,Other _ COVID-19,,,Minor PD- Subject 10008005- a different rater conducted week 24 psychometric assessments.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,,,Entered but did not satisfy criteria,,,Serum biomarkers sample at I-0 was collected in error however not destroyed,"SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-01-27,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,,2024-01-09,2024-03-29,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100258,V175,,,,,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-27,2024-02-12,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,V175,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,,2024-01-06,2024-01-27,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100233,V83,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,"Blood oversampling, Week I-0, Due to the site staff mistake","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-01-15,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V83,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-21,2024-01-25,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100233,V175,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-01,2024-01-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100185,V186,,Other*,Administration of IP deemed unacceptable for use,Administration of IP deemed unacceptable for use,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-18,2024-02-19,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100165,V197,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-23,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100246,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-06,2024-01-29,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100285,V186,,,,,W64 visit was performed 1 day out of window,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-11,2024-03-18,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100162,V175,,,,,PI reported SAE greater than 24 hours of notification,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-02-14,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100177,V175,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"16Oct2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 15 days prior to Week 104 visit, which is -8 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023 I Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking PD per LTM review and comments.",2024-01-12,2024-04-02,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100163,V175,,,,,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-23,2024-03-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100134,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-16,2024-03-21,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-04,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100250,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-26,2024-03-25,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100135,V83,,,,,Week 76 completed 12 days out of window.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-23,2024-02-10,MINOR,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100143,V83,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-03-11,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100124,V186,,Entered but did not satisfy criteria,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-20,2024-01-23,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100182,V175,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-29,2024-03-23,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,V186,,,,,W48 visit was performed 15 days out of window,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-25,2024-03-04,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100173,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",,2024-01-14,2024-02-14,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-08,MAJOR,17Oct22 - LB - LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V197,,,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,,,,,,Subject US10008007-IP was not administered at week 12.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-16,2024-03-05,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-05,2024-02-12,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-20,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-17,2024-03-16,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100195,V84,,Entered but did not satisfy criteria,,,CD4 count and phosphate level were not completed at the JNJ-90014496 Infusion Day 1 Visit,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-21,2024-03-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-20,2024-01-27,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-25,2024-04-04,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V175,,,,,"Blood oversampling, Week I-0, Due to the site staff mistake",,2024-01-17,2024-03-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-20,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100213,,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-09,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-01-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,V197,,,,,Week 76 completed 12 days out of window.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-02-21,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100136,V186,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-23,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100206,V84,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-23,2024-04-04,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-02-26,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V186,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-01,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-03,2024-02-12,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete RTI form dated 19Jul2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-27,2024-03-25,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V83,,Other*,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-02,2024-02-20,MAJOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V83,,,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-02,2024-01-15,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-27,2024-02-12,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V175,,,,,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.","PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-30,2024-03-05,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,V84,,Entered but did not satisfy criteria,,,"Calprotectin not measured at I-0, Quantity not sufficient",,2024-01-19,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-22,2024-02-03,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100137,V197,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-18,2024-02-22,MAJOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V197,,Entered but did not satisfy criteria,,,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-29,2024-04-26,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100281,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-20,2024-03-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V83,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,,2024-01-17,2024-04-02,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V83,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-11,2024-03-15,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V175,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-15,2024-04-13,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,V197,,,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.",,2024-01-01,2024-03-11,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100292,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-10,2024-01-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100224,,,,,,W96 visit was performed 5 days out of window,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100135,V175,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-04-04,MINOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-25,2024-04-15,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100137,V197,,Received wrong treatment or incorrect dose,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-21,2024-03-30,MAJOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100166,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-29,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,,2024-01-24,2024-04-02,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-02-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V83,,,,,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-27,2024-03-10,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100165,V197,,,,,Week 96 visit occurred 7 days out of window.,,2024-01-01,2024-01-10,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,V83,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside of RSV season and contact required every 30 days. Contact was OOW by 8 Days.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-17,2024-02-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100289,,,,,,Week 84 visit occurred 21 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-04,2024-02-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V197,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.",,2024-01-01,2024-03-07,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-15,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,V84,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-02-06,MAJOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100263,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-12,2024-02-14,MINOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100169,,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-18,2024-03-31,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-03-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.",,2024-01-30,2024-03-30,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V175,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-08,2024-02-10,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100200,V84,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-14,2024-01-30,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Missing MVV by mistake,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-25,2024-03-13,MAJOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100224,,,,,,W96 visit was performed 3 days out of window,,2024-01-29,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100227,V84,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Classifying as Major PD as they missed 3 overall days of completion of data point. No immunogenicity impact. SM, Erica Diezmos, 18Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-04,2024-02-14,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-22,2024-04-20,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100152,V83,,,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-03-02,MINOR,THE SITE STAFF WAS RE-TRAINING.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100131,V84,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-11,2024-01-13,MINOR-COVID-19,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-26,2024-02-11,MINOR-COVID-19,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-30,2024-02-28,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V186,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-17,2024-01-29,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V175,,,,,W84 visit was performed 13 days out of window,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-05,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-10,2024-01-31,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-05,2024-03-19,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,V197,,Other*,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Non-delegated personnel or non-study personnel at the site performed study-related assessments or procedures,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-01,2024-01-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100129,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-12,2024-01-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100297,V197,,Entered but did not satisfy criteria,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-26,2024-04-05,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100210,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-04-07,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V83,,,,,Subject did not bring stoll sample for analysis. Subject was not able to provide stool sample during I-4 on site visit. In SD PI provided a comment that she informed subject and subject's parent that on I-4 she must bring a stoll sample for analysis.,,2024-01-13,2024-02-13,MINOR-COVID-19,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100131,V197,,,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-01,2024-01-27,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,V175,,,,,Tummy-UC not completed at Early Termination,"LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-30,2024-04-17,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V186,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-06,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V175,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-03-22,MINOR,"SM, KG 29OCT22: SM asked PI to provide a comment why the retest was not done LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: PD reviewed, reason pending SM, 9DEC22: Information was provided to the description. LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-08,2024-01-30,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 24 completed 7 days out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-13,2024-04-03,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V84,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-14,2024-01-25,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100124,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question for body temperature, time temp taken and location temp taken on RTI form dated 20Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-04-01,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100231,,,,,,Week 92 visit occurred 4 days out of window.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-06,2024-02-19,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100238,V84,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-29,2024-01-30,MINOR-COVID-19,"The EDC was updated on 06Aug2021 with the known information, however the SCs and PI have been reminded multiple times of the reporting guidelines for SAEs/AESIs. All reporting to be done within 24 hours of awareness to Sponsor through the safety gateway in EDC.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V175,,,,,Week 104 visit occurred 2 days out of window.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-13,2024-03-30,MINOR,28Apr21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V197,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-08,2024-01-29,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-29,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,V186,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-12,2024-01-22,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,V197,,,,,Stool sample not provided at M-44,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-03-23,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-05,2024-03-08,MINOR-COVID-19,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V83,,Entered but did not satisfy criteria,,,W96 visit was performed 12 days out of window,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-17,2024-03-21,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-18,2024-04-17,MINOR-COVID-19,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100230,V83,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-12,2024-02-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100194,V84,,,,,Subject US10008005 Week 104 MRI occurred -6 days out of window.,,2024-01-05,2024-03-24,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",,2024-01-18,2024-04-03,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,V84,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-04-10,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V83,,,,,3.00|38| Subjects treatment was unblinded | blinded CRA saw Randomization Confirmation (Unblinded) email from IWRS while reviewing blinded source documents @@@ NO IMMUNO/ NO EFFICACY @@@,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-19,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V84,,,,,W72 visit was performed 7 days out of window,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-01-25,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V197,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-11,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V84,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-04-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V197,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-30,2024-02-24,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V175,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,,2024-01-24,2024-02-14,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,V83,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-06,2024-03-28,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,V175,,Other*,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-01-25,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100292,V83,,,,,Subject US10008006's Week 76 visit occurred 3 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-03-03,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V84,,Received wrong treatment or incorrect dose,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-16,2024-03-04,MAJOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100134,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-06,2024-02-24,MAJOR,THE SITE STAFF WAS RE-TRAINING.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject US10008007- Laboratory samples were not collected at week 12.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-16,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100196,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-03-24,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,V175,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-03-31,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,V186,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-03,2024-01-30,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V175,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-09,2024-03-06,MAJOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V197,,Entered but did not satisfy criteria,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@","SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-08,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-11,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100247,V175,,,,,Visit was performed OOVW due to subject's COVID-19 infection.,,2024-01-22,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-02-02,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100293,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"EMC, GDM per PDIE meeting 20APR2023, this is an MPD and can be closed. SM to retrain and confirm on the Sponsor comments in OneCTMS before closing. LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Out of visit window, <Visit id>, <Reason why***- if known by the site>. Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Out of visit window, I8, Subject was not able to come to the clinic according to the timeliness (subject's personal reason) LTM, Marta Jakubczak, 15-Mar-2023: This OOW vitis - was it agreed with the Central Team, that it should be reported as minor PD? Please close and lock PD once confirmed. SM, Karolina Grabowska, 16-MAR-2023: The status has been changed to potentially major LTM, Marta Jakubczak, 3-Apr-2023: Please wait for the central team revision. As the potentially MPD was caused due to parents/patients circumstances, no more action can be done. Please close and lock PD once central team revision will be done. SM, M. Juchimiuk, 19May2023 - No training required as it was patient's personal reason. PD severity changed to Major, closed date added and PD closed.",2024-01-27,2024-02-04,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-07,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100146,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-15,2024-03-15,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100258,V83,,,,,Week 92 visit occurred 4 days out of window.,"SM discussed finding with Dr. Goldstein and SC. Jessica Chacon. SM reminded them that the C-SSRS has two different versions the ""Baseline"" version and the ""Since the Last Visit"" version. They verbalized this issue was an involuntary error. Mrs. Chacon verbalized that moving forward she will double check the C-SSRS version to ensure the correct one is completed by the raters. 14Sep21 - LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-14,2024-03-27,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V83,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-26,2024-02-18,MINOR-COVID-19,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V83,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-04-01,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V84,,,,,W108 visit was performed 4 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-13,MINOR,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100167,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-02,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100276,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-26,2024-04-09,MINOR-COVID-19,"LTM ‐ Katia Villa, MVR 17‐Aug‐2021, Reviewed on 06-sep-2021",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100210,,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-22,2024-03-01,MINOR-COVID-19,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100203,V83,,Other*,,,"Missed Assessment, Early Termination, Lactoferrin result not available, Due to central lab unable to calculate","LTM, Jansen Tan, 27Jun2019: noted as part of MVR review, awaiting PDIE meeting. 27JUN2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No immunogenicity impact.",2024-01-29,2024-03-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,,,,,,Subject US10008005-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-23,2024-02-16,MINOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100241,V197,,,,,Week 108 visit occurred 7 days out of window.,,2024-01-04,2024-02-07,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V175,,,,,Missing MVV by mistake,,2024-01-20,2024-02-19,MAJOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V175,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-25,2024-04-20,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100236,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-02-08,MAJOR,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-27,2024-03-01,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100122,,,Received wrong treatment or incorrect dose,,,"10008006: Day 1- C-SSRS scale used at this visit was the incorrect version. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-02,2024-01-25,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V83,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-21,2024-01-27,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,platelets were not analyzed by Labcorp and no retest was done since subject was not able to come to the clinic.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-30,2024-02-10,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100147,V83,,,,,"Ferritin level, IgG level, and CD4 count were not completed at the JNJ-90014496 Post-infusion Day 15 Visit",PDIE meeting 05MAR2020: Major PD. No impact on immunogenicity. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-26,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,"Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-20,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V175,,Other*,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,Accidental unblinding of treatment group of a subject or a blinded staff member prior to final analyses,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-15,2024-04-12,MAJOR,11Apr21 - LB LTM: Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100276,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-23,2024-02-24,MINOR-COVID-19,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V186,,,,,Visit 25 / Week 76 completed 4 days out of window.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to add MM guidance here and close and lock once rec'd/added SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-03,MINOR-COVID-19,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,V197,,,,,platelets were not analyzed (Platelet clumps present) by the Central Laboratory (Labcorp). Subject was asked to come to the clinic for the retest but subject's mother with the subject did not agree on the retest. Subject performed local hematology test on 7 NOV 22. platelets were analyzed and no abnormalities were found (assessed local lab report is available in SD).,,2024-01-05,2024-02-27,MINOR-COVID-19,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log),
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,V175,,,,,W84 visit was performed 13 days out of window,,2024-01-20,2024-02-16,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100195,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 13 days out of window.,,2024-01-25,2024-03-12,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V83,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-04,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V175,,,,,W64 visit was performed 1 day out of window,,2024-01-17,2024-03-29,MINOR,"21Feb2018, Julian Otaegui (SM): during last IMV it was confirmed no new kits were lost",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100176,,,,,,W48 visit was performed 16 days out of window,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-20,2024-03-28,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100171,,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-14,2024-04-05,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100130,,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-09,2024-03-17,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-23,2024-02-10,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,V84,,Received wrong treatment or incorrect dose,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-28,2024-04-24,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100195,V175,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete RTI forms dated 14Sep2019 and 15Sep2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-02,2024-02-15,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100137,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,,2024-01-26,2024-04-06,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V197,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-29,2024-02-18,MINOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V197,,,,,Site staff by omission took lab kit from I-2 instead I-4. No similar deviation observed in next subject's visit.,"Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-03,2024-03-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100201,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Site research assistant emailed SM on 28Jan2020 to report an error in PBMC processing for samples collected during the screening visit. During the processing of the specimen a step in the protocol was missed, which is where PBMCs are rested on ice for 10 minutes prior to adding freezing media. The error was noticed once processing had been completed, and the cryovial had been put in the -80 freezer. Site assistant has placed a file note in the TCF to document this at site. Site assistant has also stated that in order to avoid this error in the future, the VTG Laboratory Co-ordinator will review the protocol with laboratory staff and ensure that all staff are re-educated on the importance of each step of the protocol.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-15,2024-02-07,MAJOR,Site staff was retrained on COVID-19 procedures on 28Sep2021 (recorded on training log)
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V175,,,,,"Subject ES30050124: Subject signed ICF V5.0 ESP (27Jan 2021) and Vaccine ICF Addendum for Spain_V1.0ESP(es)1.0, 29Jan2021 however in signature page subject wrote a wrong date. Site staff to request ICF update during next SMV.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-27,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100214,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-20,2024-04-06,MAJOR,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100193,V186,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","Subject 30011473 ""Randomized but did not receive study drug"" did not take 1st IP dose in Baseline visit under instruction of Dr. Sarjanovich because patient had to be subjected to a coronary angiography which required suspending all medication that he was taking. According to protocol procedures patient should take first dose at the site. Site staff was re trained in protocol procedures during MV conducted 25& 26 Mar 2015. Hardik Patel, GDM this is an MPD per SRP Review 09Dec17",2024-01-20,2024-03-03,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100193,V84,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-17,2024-02-07,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100232,,,Other _ COVID-19,,,"Subject US1008005-the post dose blood draw at week 16, was done within 10 minutes after the IP IV Bag Administration stop time instead of the end time of infusion, including flush.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-04-03,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-01-21,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100187,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"SC notified SM by email on 26Dec2019 that for RTI start date 23Dec2019, site will not be contacting parent during their Christmas shutdown period (24Dec2019-03Jan2020). According to RAVE, the next phone contact after the on-site RTI assessment visit on 26Dec2019 occurred on 07Jan2020. Protocol amendment 5 states that 'the RTI episode is still ongoing, a follow-up phone call (or other communication) to the parents/legal guardians or caregivers will be made once every 2 working days (Â±1 day) until symptom resolution'. Global team has been informed. Email from GTL on 24Jan2020 confirmed that the occurrence is a PD.",,2024-01-14,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,V83,,,,,"3.00|38| Subjects treatment was unblinded at subject, site personnel and Sponsor representative level | Subject had been withdrawn from the study before unblinding. PI requested the unblinding, but informed the rest of the blinded team about the treatment arm @@@ NO IMMUNO/YES EFFICACY @@@",,2024-01-21,2024-03-12,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100285,V84,,,,,Week 92 visit occurred 4 days out of window.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-09,2024-03-27,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V197,,Received wrong treatment or incorrect dose,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-12,2024-01-25,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V84,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-03-31,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100214,V186,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-08,2024-03-28,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100266,V197,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"PDIE 05MAR2020: This is a Major PD, with possible impact on immunogenicity only for this sample. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-29,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100233,,,,,,Stool sample not provided at M-44,"LTM, Masato Yuzawa, 21-Aug-2020: Reviewed Telephone Contact Report (Date of Contact: 09-Jul-2020) and this PD. It was confirmed that the cause of this PD and corrective actions were described properly. This PD can be closed. When missing of SP-D occurs again, report it as PD anew and examine the cause. SM Shinya Fukuda, 21-AUG-2020: SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: LTM confirmed that the Deviation Closed Date had been entered properly. No further actions required.",2024-01-21,2024-04-17,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V83,,,,,US10008007: Week 80 visit completed 19 days out of window.,,2024-01-19,2024-03-29,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,,2024-01-15,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100235,V83,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-28,2024-02-02,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100182,V84,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-29,2024-04-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100214,V186,,,,,"At screening, respiratory rate not captured as part of vital signs","Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-15,2024-01-17,MINOR,LTM PZ reviewed. LTM PZ 28Feb2024 Reviewed.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100279,V186,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-24,2024-03-31,MINOR,19Aug21 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100190,V186,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-29,2024-02-15,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-03-11,MAJOR,"The SC who called the patients during D29 didn't inform the datamanger about this SAE as normally data are entered in the system within 24 hours. Due to unforeseen other priorities, data was entered with some delay and therefore also the SAE. SC have been retrained to immediatly retrain the datamanger in case of SAEs."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-10,2024-02-01,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V197,,,,,"MVR, 12-JAN-2021, 105002 was not performed the IP administration on Week8 due to AE#3. The same handling as in 124003 cases has been reported. This was the current report because the SM had forgotten to report it. SM confirmed the following PDs from the source data. - Dr. skipped week 8 IP administration for 105002 on 01-MAY-2020. [Cause] - Dr.Kishida judged that the risk of aggravation of infection was greater when the active drug was used than when it was not used. [Correction] These deviations had been caused by medical needs, the site did not conduct correction and corrective action.",14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-04-01,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,,,Other*,Subject consented with incorrect initial main ICF,Subject consented with incorrect initial main ICF,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-16,2024-01-20,MAJOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-20,2024-03-03,MINOR,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100172,,,,,,Week 84 visit occurred 13 days out of window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-21,2024-02-13,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-03,2024-01-16,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100285,V197,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,,2024-01-24,2024-02-24,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100196,V197,,,,,Stool sample not provided at M-44,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-25,2024-04-06,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100230,V83,,,,,Stool sample not provided by the patient at M-44,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-23,2024-03-24,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100153,,,Other*,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-19,2024-02-20,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100296,V84,,,,,"Subject US1008007-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as required per protocol requirements.",,2024-01-04,2024-03-08,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100289,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 17 April 20 and 13 May 20 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 26 Days. Site noted that this was due to RSV Season start date confusion","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-07,2024-02-15,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,V175,,,,,"Site was aware of the GGT value of the subject which was below the normal range and therefore reached out to the Sponsor prior to administration of IP/PBO. A NTF was created by the sponsor to explain the medical correct interpretation of protocol inclusion criteria #4. Based on this correct interpretation, the Sponsor gave approval of randomization even though value was too low.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-02,2024-03-14,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100227,V186,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-10,2024-02-09,MINOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V84,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-26,2024-03-19,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,V83,,,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-26,2024-03-21,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V83,,,,,Tummy Obs was not completed by the subject. Site staff did not enter information on a Yprime that subject is less that 8 years old and subject's parents needs to complete this questionnaires on a device. No issue observed on the next subject's visits.,,2024-01-18,2024-01-21,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100241,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W48 visit was performed 15 days out of window,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-09,2024-02-21,MAJOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100215,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 92 visit occurred 8 days out of window.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-13,2024-03-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100148,V84,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-01,2024-03-16,MINOR,"LTM-Natalia Rodriguez 16-Apr-15: Protocol deviation MVR 25,26-Mar-15 reviewed and confirmed as well.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V175,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-10,2024-03-25,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100246,,,,,,W60 visit was performed 10 days out of window,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-04,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-22,2024-03-26,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100223,V186,,,,,"60 | MPD v3.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Pt BE30040458 had an appendicitis with surgery needed 27 Jan 2021. Patient left the hospital 29 jan2021 in good condition. SAE has been reported too late (call on 16Feb2021, reported 22Feb2021)",,2024-01-05,2024-03-23,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100154,V84,,,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"SM, Megan McMahon, 08Dec2022: During the monitoring visit it was discovered the subject had been started on Seroquel (Quetiapine) 25 mg PO QD as of 01-Nov-2022 for AE of AGITATION. Seroquel is a CNS acting medication (antipsychotic) which is prohibited per protocol if started post-randomization. The med was prescribed by the subject's PCP. The site reached out to the medical monitor for discussion and the subject was approved to continue in the study. During the visit on 30-Nov-2022, the SM had re-trained the PI and SC on concomitant medication requirements per protocol. The SC and PI verbally acknowledged understanding and agreement to comply moving forward. 16Dec22 LB - LTM: SM to close and lock deviation SM, Megan McMahon, 19Dec2022: Closing and locking PD per LTM review and approval.",2024-01-03,2024-02-26,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,,,,,,Week 52 Tau PET performed 10 days outside of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-15,2024-01-27,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100177,V175,,Received wrong treatment or incorrect dose,,,Subject US10008002-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-03,2024-02-04,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V175,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-08,2024-03-12,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-07,2024-01-26,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100219,V175,,Entered but did not satisfy criteria,,,Week 92 visit occurred 6 days out of window.,,2024-01-16,2024-03-26,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-01,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,V83,,Entered but did not satisfy criteria,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-02-03,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100293,V84,,,,,Subject US10008012-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-09,2024-03-06,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100294,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-10,2024-02-26,MINOR-COVID-19,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 09-JUL-2020 SM found the SP-D test of Subject #105003 at Week 12(24-JUN-2020) was cancelled due to insufficient sample volume. Corrective action was not performed. SM advised Ms. Kurumizawa as a Corrective Action to inform laboratory staff of the minimum required volume of the SP-D sample. Ms. Kurumizawa understood it.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 05-Mar-2020) and this PD. If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. I agree that there are no any conceivable causes at present. This PD can be closed. When missing data due to hemolysis occurs again, report it as PD anew and examine the cause. SM, Shinya Fukuda, 19-AUG-2020: SM closed this PD.",2024-01-12,2024-01-29,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100145,V175,,,,,W108 visit was performed 4 days out of window,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-01-11,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100116,V175,,,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm","9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-18,2024-03-31,MINOR-COVID-19,28 Dec 2023 WParker LTM Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100223,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V197,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-03,2024-01-26,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V84,,,,,US10008007: Week 80 visit completed 19 days out of window.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-05,2024-03-01,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100297,V84,,,,,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-26,2024-03-28,MINOR,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,V186,,,,,Week 52 Tau PET performed 10 days outside of window.,,2024-01-03,2024-02-26,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100169,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,W84 visit was performed 13 days out of window,,2024-01-21,2024-03-17,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100163,V83,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -5 days out of window.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-15,2024-03-31,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100124,V197,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-16,2024-03-31,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V175,,,,,IgG level was not completed at the JNJ-90014496 Post-infusion Day 15 Visit,"This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-03-04,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V83,,,,,Hb sample has not been collected at Week 12 or Week 24. SM reminded site staff about this requirement of the protocol amendment INT-1 during the visit conducted on 25 & 26 Mar 2015.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-03-20,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100255,V83,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-14,MINOR-COVID-19,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100275,V186,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",,2024-01-12,2024-02-29,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,V175,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-21,2024-03-31,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,,,Entered but did not satisfy criteria,,,Week 16 completed 1 day out of window.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-02,2024-01-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100162,V197,,Other*,Re-consent of subjects not done,Re-consent of subjects not done,W108 visit was performed 4 days out of window,,2024-01-16,2024-02-25,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100124,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-27,2024-02-03,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100248,V83,,,,,Week 52 Tau PET performed 10 days outside of window.,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-13,2024-04-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,,2024-01-05,2024-03-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100165,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-11,2024-02-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V197,,Entered but did not satisfy criteria,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,,2024-01-25,2024-02-05,MAJOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100247,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-03,2024-01-06,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100143,V175,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",,2024-01-01,2024-01-27,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100262,V84,,,,,W48 visit was performed 16 days out of window,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-11,2024-04-01,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100225,,,,,,W60 visit was performed 28 days out of window,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-04-10,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.",,2024-01-02,2024-01-16,MAJOR,16dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100139,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Patient 100014 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100014 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","SM, Megan McMahon, 02Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-22,2024-03-11,MAJOR,19AUg21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",,2024-01-20,2024-03-08,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V84,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, I8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection. Retest is not possible since subject had already M-4 visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-28,2024-02-29,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-19,2024-03-30,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100300,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent has completed RTI forms, however, did not complete a form for 11May2019. Protocol amendment 3 mandates that RTI symptoms forms are completed daily until symptoms resolve. SM has raised the occurrence with the SC who will retrain the parent.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-01-26,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,W36 visit was performed 22 days out of window,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD, NO IMMUNO IMPACT",2024-01-12,2024-01-29,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V197,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-26,2024-02-13,MAJOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100119,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"SM, M.Juchimiuk, 08Jul2023: The sample was provided by the site but central lab was not able to calculate the lactoferrin. No other action expected, the patient withdrew the consent. LTM, Marta Jakubczak, 18-Jul-2023: Please close and lock PD. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-10,2024-02-28,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V84,,,,,Uric Acid and C-reactive Protein levels were not completed at the JNJ-90014496 Post-infusion Day 29 Visit,,2024-01-12,2024-04-03,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100173,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-24,2024-03-18,MINOR,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100298,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-03,2024-02-24,MAJOR,14Sep21: LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100300,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,"Missed assessment, Week M-44, MAYO score not calculated in Yprime due to not sufficient number of eligible patient diaries","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-05,2024-03-06,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100238,V197,,,,,W60 visit was performed 28 days out of window,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. SM, M.Juchimiuk, 24-May-2023: The patient did not completed Tummy-UC on the tablet for 2 days before the study-site visit (last Tummy-UC completed on 26Mar2023, ET visit performed 11May2023). Per verbal explanation from PI the patient was no longer dedicated to the study, as the patient knew it would be the last visit. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-16,2024-03-19,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100211,V83,,,,,Randomized but did not receive study drug,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-10,2024-01-22,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100176,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-10,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V83,,Received wrong treatment or incorrect dose,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-18,2024-01-25,MAJOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V186,,Entered but did not satisfy criteria,,,US10008006: Week 84 visit completed 2 days out of window.,"15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-14,2024-03-02,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100197,V84,,,,,W48 visit was performed 16 days out of window,"SM, M.Juchimiuk, 24-May-2023: The sample for serum biomarkers analysis was taken during screening and at I-0, whereas it should be taken only at one of these timepoints. The SM discussed it with PI during the MV 17-18May2023, trained her on the sampling requirements per protocol's schedule of assessment and asked to train the site personnel responsible for the oversampling. The site should also inform the patient about this issue and document it in source. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 01-Jun-2023: Data added, deviation closed and locked.",2024-01-15,2024-02-02,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100121,V175,,,,,Week 88 visit occurred 10 days out of window.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-13,2024-01-21,MINOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100221,V83,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-21,2024-04-20,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100133,V83,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"LTM, Marta Jakubczak, 25-Jan-2023: Please try to write minor PDs with accordance to Description Writing Guidance for Deviations and Issues, it should go this way: Missed Assessment, <Visit id>,<Specify which assessments weren't done>, <Reason why - if known by the site>. Please confirm whether retest has been possible? Please close and lock PD once done. SM, Karolina Grabowska, 25-Jan-2023: Missed Assessment, M8, Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Retest is not possible since subject is not able to bring the subject between site's visit. LTM, Marta Jakubczak, 15-Mar-2023: Please close and lock PD.",2024-01-12,2024-01-17,MAJOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100293,V175,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-13,2024-02-24,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100243,V175,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-14,2024-03-22,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100295,V84,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-10,MINOR-COVID-19,"Subject ES30050124: to update (correct, date and sign) the signature date during next SMV.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100257,,,,,,Screening echocardiogram was completed out of the 28-day screening window. Echocardiogram was completed on 11-Mar-2024, Enrollment occurred on 18-Apr-24,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-20,2024-01-31,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100285,V175,,,,,Subject US10008007-IP was not administered at week 12.,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-11,2024-03-17,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100262,V186,,,,,Stool sample not provided at M-44,,2024-01-26,2024-03-29,MAJOR,"After knowing the TE, the CRA, the CTA and study team managed the purchase of a new calibrated thermometer to send it to the site. On 18Jul2022 the site received the new device calibrated and the CRA supported them to configurate the device according to the study requirements. Once the new thermometer was calibrated, the CRA requested them the new records to review it and no more temperature excursion occurred by the moment until the SMV on 27Jul2022.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100143,V186,,,,,Week 104 visit occurred 2 days out of window.,"Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-06,2024-02-09,MINOR,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,V175,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-24,2024-03-14,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100253,V83,,,,,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-17,2024-04-09,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023 LTM, M. Songiso re-reviewed on the 17 Oct 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-27,2024-04-07,MINOR,Sponsor and study staff were informed. Deviation was discussed with the PI.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V186,,,,,"Missed assessment, M-44, Platelets count not performed by central lab due to clumped platelets in the sample",,2024-01-21,2024-04-17,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100145,V83,,,,,"Patient 100110 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100110 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper right arm","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-14,2024-03-21,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100219,V175,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.","15OCT2020 PDIE Meeting: This date range is not considered ""in season"" for this site. However, the length of time between contacts is considered a Major PD; no immuno impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-20,2024-03-30,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100254,,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,,2024-01-10,2024-03-25,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V175,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.","Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-05,2024-02-10,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V175,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-21,2024-03-17,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 14-Nov-2019",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V175,,,,,"Safety assessments were not performed according to Schedule of Activities: At JNJ-90014496 Infusion Day 1 visit, the ECG was not completed prior to infusion. Of note, the ECG was completed on Day 2 (09-Jan-24).","AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-24,2024-02-18,MINOR-COVID-19,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",,2024-01-03,2024-01-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-05,2024-01-11,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100128,V175,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-08,2024-03-04,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V197,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-27,2024-03-13,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100274,V186,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-13,2024-02-09,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100239,V84,,,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 76 completed 12 days out of window. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-15,2024-01-25,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100288,,,,,,visit was done out of visit window. Subject was not able to come to the clinic in a visit window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-22,2024-03-23,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V84,,,,,W96 visit was performed 5 days out of window,"SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. . Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Update- SM-CCR-11May2022 o PD was reported in eSource. As per eSource, sample was not collected due to several failed attempts. PI assessed PD and determined it was non reportable to the IRB. o Subject withdraw Optional Sample consent after v-5. A NTF was created to document consent withdrawal. o SM reviewed eSource and confirmed PD documentation. o Copy of the completed training log was set to the SM. o SM updated PD information in CTMS. 18May22 - LB - LTM: SM to close deviation. CC-SM re-trained site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Training log was completed by the site staff and a copy sent to the SM.",2024-01-09,2024-02-03,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100285,V197,,,,,Visit 6 (06Apr2020) is out-of-window by one day (Visit 5 Vaccine 2 Visit 01Apr2020). Protocol amendment 5 states that visit 6 needs to occur Vaccine 2 date + 3 days (+ - 1 day).,"9-Sep-15, SM: During this IMV #4, it was confirmed that this patient has been using sponsor provided ASA during all scheduled visits monitored during this IMV (W48 and W60).",2024-01-19,2024-03-10,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V175,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-02-06,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V186,,Entered but did not satisfy criteria,,,Visit 25 / Week 76 MRI completed -8 days out of window.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-25,2024-02-20,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V175,,,,,Other:SITE STAFF COLLECTED AND SEND TO CENTRAL LAB SAMPLE FOR STORAGE OF SAMPLE FOR FUTURE RESEARCH BUT THE PATIENT WITHDREW OF CONSENT. This is the aliquot that is stored when d-dimer collected,Site documented this missing procedure in the source. Dr. Goldstein assessed this protocol deviation and deemed it as non-reportable to the IRB based on the Sterling IRB reporting guidelines. 18May22 - LB - LTM: SM to close deviation,2024-01-14,2024-01-18,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,V83,,,,,Week 104 visit occurred 2 days out of window.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-26,2024-02-01,MINOR-COVID-19,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100274,V84,,,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-07,2024-03-14,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.","14Oct2022 M McMahon, SM: The subject's visit occurred out of window due to scheduling difficulties with the subject and the site staff rater availability. The site will document the deviation in the subject's source documents. The SM reminded the Site Staff Supervisor of the importance of completing visits as scheduled per protocol. The site has recently added two additional raters to the study which they expect will minimize scheduling difficulties moving forward. 17Oct22 - LB - LTM: SM to close and lock deviation. 17Oct2022 M McMahon, SM: Closing and locking deviation per instruction from LTM.",2024-01-18,2024-03-12,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V84,,Entered but did not satisfy criteria,,,W60 visit was performed 10 days out of window,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-29,2024-02-14,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100145,V175,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please update description as such: ""Visit was not performed as per protocol schedule"". And move all other text to the sponsor response field. This is a major PD due to it being the I8 visit. Please update to major and close the PD.",2024-01-24,2024-03-03,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V175,,,,,"Site successfully contacted parent of participant 100008 on 12Sep2019. Site attempted to contact parent on 24Sep, 26Sep, 27Sep but was unsuccessful. Next successful contact was on 08 Oct which is 27 days since previous contact, which is out of window. Protocol 5 mandates that site contacts parent every 14 days Â±3 days within the RSV season.","SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-09,2024-03-22,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days","Follow up: LTM, SM, 10APR2015 meeting 9-Sep-15 (SM): The form requesting the destruction of the sample (#Y011974) was sent on 23-Apr-15 and the process of disposal was completed on 14-May-15.",2024-01-06,2024-01-08,MINOR-COVID-19,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100152,V83,,,,,W72 visit was performed 7 days out of window,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-30,2024-02-18,MAJOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100198,V83,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.",PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-30,2024-03-21,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V84,,,,,ICF v5.0 was not signed by the patient since site has been notified of PA3 on 07Jun2023 by SMA. PI signed PA3 page on 03Jul2023.,"SM, Megan McMahon, 21Apr2023: The subject's Week 96 visit occurred out of window due to on the initially scheduled visit date, the subject's husband experienced a fall and had to go to the hospital. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-27,2024-04-11,MINOR-COVID-19,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD. SM, R. Santos, 23Apr24: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100273,,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,,2024-01-28,2024-04-11,MINOR,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100224,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-02,2024-02-18,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V197,,,,,"Subject 10008006- Day 1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version.",,2024-01-21,2024-03-29,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V83,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-01,2024-01-25,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,,,,,,Subject US10008003-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-11,2024-03-20,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,,,Other*,,,"Patient 100015 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 10001 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper right arm","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-23,2024-04-01,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100193,,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V83,,Entered but did not satisfy criteria,,,Visit was performed OOVW due to subject's COVID-19 infection.,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-30,2024-02-15,MAJOR,"25 Apr 2024 WParker LTM Reviewed 25-Apr-2024, SM R. Santos: Minor PD closed",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V83,,,,,"Missed assessments, M-24, Patient's diary not completed regularly",SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-07,2024-03-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V84,,Received wrong treatment or incorrect dose,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-04,2024-03-02,MAJOR,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete time on RTI forms for the following dates - 16Jul2019, 21Jul2019, 22Jul2019. Site is approved on protocol amendment 5.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-29,2024-04-27,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100166,V197,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-22,2024-03-18,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V186,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-14,2024-02-06,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100123,V197,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.",,2024-01-19,2024-03-25,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100162,,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, this is a Minor PD and can be closed once severity is updated. SM, M. Juchimiuk, 06Nov2023: The serum biomarkers sample was collected at screening and unnecessarily at I-0. The SN responsible for oversampling at I-0 was not present at site when the deviation was identified by the SM, so SM discussed the finding with the PI. The SM asked PI to re-train the nurse on the blood samples collection schedule. The nurse was trained by PI on 06-Nov-2023, which is documented on training log (a copy was provided to SM via email). LTM PZ reviewed.",2024-01-13,2024-04-01,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100165,V84,,,,,"60 | MPD v7.0 | @@@NO IMMUNO, NO EFFICACY@@@ |SAE #BILATERAL INGUINAL HERNIA SURGERY was reported with delay. Patient was enrolled into the study on 15 Mar 2021 and was diagnosed with inguinal hernia since 22 Jan 2021. Patient had a surgery on the 22 Mar 2021 and discharged on next day with resolution date as for 22 Mar 2021. Since subject had this MH and hospitalization was less than 24h, site staff had overlooked to report this event as SAE. This was done during monitoring visit.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-02-05,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.",14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-03,2024-02-21,MINOR,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100189,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,PDIE Meeting 06AUG2020: This is a Minor PD.,2024-01-18,2024-01-26,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,V186,,,,,W72 visit was performed 7 days out of window,"07Nov2023 M McMahon, SM: Subject US10008016 screened on 13May2021 and was randomized on 20Sep2021 which is 40 days outside of the 90 day screening window per protocol schedule of activities. The site and study team are unable to locate any documentation of medical monitor approval for a screening extension. The SM has instructed the site to document the protocol deviation in the subject source documents including assessment of IRB reportability. Re-training will not be completed due to not applicable / enrollment has ended for this study. 21Dec2023 M McMahon, SM: The SM confirmed the protocol deviation is recorded in the subject source documents. Per site assessment, not reportable to IRB. 08Jan2023, I Karuga. LTM: PD reviewed and can be closed.",2024-01-19,2024-01-29,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,,,,,,"Missed assessment, M-12, Level of calcium, phosphorus and urea in blood not measured",25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-02,2024-01-30,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100271,V84,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-15,2024-01-27,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V186,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-19,2024-03-15,MINOR-COVID-19,17May22 - LB - LTM: reviewed as part of the 3May22 OSMV report,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100170,V83,,,,,W108 visit was performed 4 days out of window,,2024-01-17,2024-03-09,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-27,2024-02-19,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V83,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"LTM, Masato Yuzawa, 20-Feb-2021: This PD should have been reviewed in parallel with the review of the MVR dated 12-Jan-2021. However, as LTM forgot to review this PD, the review of this PD was delayed. It is understandable that there are no Corrections or Corrective Actions because this PD was based on the medical needs considering the safety of the subject 105002. This PD can be closed. SM,Mayu Horie,15-MAR-2021 SM closed this PD due to instruction of LTM.",2024-01-09,2024-04-01,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V175,,Entered but did not satisfy criteria,,,Subject US10008005 Week 100 IP infusion occurred 6 days out of window.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-23,2024-02-10,MAJOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V197,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"14Jun2023 M McMahon, SM: Per protocol, if not performed on same day, the MRI should be performed within 7 days prior to the visit. MRI was completed 13 days prior to Week 104 visit, which is -6 days out of window. The PD was not documented in eSource. Action item added. LTM, M. Songiso 19 JUN 2023: Has the site confirmed whether PD will be reported to the IRB (if applicable). Please confirm with the site that the PD has been added to the eSource. Document site's understanding regarding the allowable window for MRI completion. Did they supply a rationale behind the OOW visit and potential corrective actions to prevent in the future. 19Jun2023 M McMahon, SM: An action item has been recorded for site to update source with PD details and provide the above mentioned details. SM to update PD upon site's completion of action item. 08Aug2023 M McMahon, SM: The PD has been documented in eSource. Per eSource, the MRI occurred out of window due to the subject's availability. Per site assessment, not reportable to IRB. The site understands the window for MRI completion and are using a visit window calculator to avoid out of window visits and procedures moving forward. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-04,2024-02-20,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,,,,,,Stool sample not provided at M-44,,2024-01-21,2024-03-15,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100297,V175,,,,,"For subject US10008002,the Screening III RBANS and Screening IV ADAS-Cog were done on the same date.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.",,2024-01-29,2024-02-05,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-04-06,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,,,,,,"The subject forgot to take study drug on 03-OCT-2019 and 21-OCT-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.","29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-29,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,V197,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,,2024-01-21,2024-04-07,MINOR-COVID-19,SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021. PI said that she created the SAE on the 25Jun2021 and that she does not know why there is a delay. She said that it is probably related to the functioning of the CRF.CRA retrained the PI by email the 13Jun2021 regarding the SAE reporting process.CRA will document this training on the training log at the next monitoring visit.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,V175,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 108 visit occurred 7 days out of window.,,2024-01-06,2024-01-07,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V197,,,,,W84 visit was performed 13 days out of window,PDIE 4JUN2020: Minor PD.,2024-01-09,2024-01-23,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,V83,,,,,Week 96 visit occurred 7 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-09,2024-04-08,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100240,,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm",,2024-01-04,2024-04-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100211,V175,,,,,W60 visit was performed 10 days out of window,"26Dec2022 M McMahon, SM: Site to document in source including PI's assessment of IRB reportability. SM to verify at next monitoring visit. SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: MM aware of this out of window? SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-19,2024-04-08,MINOR-COVID-19,"LTM M. Songiso, MVR 13-16 JUN 2023, reviewed on 19 JUN 2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 52 Tau PET performed 10 days outside of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-05,2024-02-21,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related."
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,V84,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"PDIE 14MAY2020: 4 days out of protocol window of 3 days. For visit 5, major when >4 days out of protocol window. This is a minor PD.",2024-01-30,2024-02-06,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. Site has entered in EDC the mentioned AEs and issue is resolved",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V83,,,,,"The subject forgot to take study drug on 15-SEP-2019 and 22-SEP-2019.
SM requested to the site that the site staff reeducate the subject about followings study drug administration.
- The capsules are to be taken around the same time each day and quickly record on subject diary.
- If a dose is not taken at the scheduled time, it can be taken as soon as possible on the same day with a return to the normal schedule the following day.
- The site staff explain the study drug administration guidance to the wife of subject.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-12,2024-03-03,MINOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,Entered but did not satisfy criteria,,,Subject US10008006-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-17,2024-02-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,V83,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-28,2024-03-30,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100119,,,Received wrong treatment or incorrect dose,,,Subject BR10007030001 completed visit day 28 on 13Dec2023 which was out of window period for 1 day due to subject's unavailability.,,2024-01-18,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,V175,,,,,Subject US10008010- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-10,2024-02-07,MINOR,"LTM, Iwona Malarowska-Janik, MVR 7Dec2022, Reviewed on 20Dec2022: PD can be closed and locked",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,,,,,,W48 visit was performed 5 days out of window,"14Jun2023 M McMahon, SM: Week 100 IP infusion occurred 6 days out of window due to subject experiencing neurological symptoms and follow-up with subject's PCP and medical monitor was required. The PI discussed with medical monitor and the decision to proceed with out of window infusion was made. The site documented in source. No further action required. LTM, M. Songiso 19 JUN 2023: Can you please add to your comment whether, per investigator, this PD is reportable to the IRB. 19Jun2023 M McMahon, SM: Update to comment from 14Jun2023- Per CRIO/eSource documentation, Investigator determined the minor PD is not reportable to IRB. LTM, M. Songiso 19 JUN 2023: This deviation can now be closed and locked.",2024-01-29,2024-03-04,MINOR-COVID-19,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,V175,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 12 (counting breaths) on RTI form dated 14Aug2019. Site is approved on protocol amendment 5.,"20Dec2022 M McMahon, SM: The Week 16 post-dose blood draw was collected at 11:04. IV bag stop time was 11:02; Infusion including flush completion time was 11:24. Per protocol, blood draw should be collected within 10 minutes of the completion of infusion including the flush. Site to document the PD in source and PI to assess IRB reportability. The site was previously re-trained re: timing of post-dose blood collection by the previous SM 11-May-2022 and documented on a training log. This SM will review this training with new site staff. 20Dec22 - LB - LTM: Once SM confirms deviation has been documented by the site, SM can close and lock deviation 3Feb23 - LB - LTM: Has this deviation been recorded by the site in source? 16Mar2023 M McMahon, SM: The SM verified the PD is documented in source and not reportable to IRB. Closing and locking the PD.",2024-01-16,2024-02-10,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100204,,,,,,Missing MVV by mistake,,2024-01-21,2024-01-31,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100146,,,,,,Subject US10008013- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 8 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is rec'd and added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100244,V186,,Entered but did not satisfy criteria,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,SM- Julian Otaegui- 05 Sep 17 SAE pneumonia was not reported on time. Patient experienced pneumonia on 12 Dec 16 while was hospitalized for a RHCV and was reported on 17 Jul 17. PI was retrained on the importance of reporting SAEs on time. LTM- Natalia Rodriguez- 05 Sep 17 confirmed minor PD.,2024-01-22,2024-01-29,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100222,,,Other*,,,Week 92 visit occurred 6 days out of window.,,2024-01-27,2024-04-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100118,V175,,,,,"Patient 100008 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100008 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm","SM-C.Clemente-23Apr2021-SM discussed MPD with Dr. Goldstein and SC, Jessica Chacon. Both were trained in the mandatory 7 days between the ADAS-COG and RBANS with special emphasis on Screening Visit 5 and Week 0. SM asked Dr. Goldstein to document the major protocol deviation in the source document. SM provided Dr. Goldstein and Mrs. Chacon a training log to document re-training. Dr. Goldstein and his regulatory team did not agree that this MPD was reportable to the IRB as there is no safety issue. SM escalated Dr. Goldstein decision to the study team for feedback. SM also reached out to Claudia Pascua, Lead Rater, and requested Mrs. Pascua to retrain the other raters on the the mandatory 7 days between the ADAS-COG and RBANS. SM provided Mrs. Pascua a training log to document the raters training. Once the training is completed Mrs. Pascua agreed to send me copy of the training log. Update SM-C.Clemente- 4/27/2021-CRC Supervisor indicated the site will implement more rigorous CAPA procedures including staff protocol retraining, utilizing a visit calculator for every subject visit and adjusting the eSource to ask the question of whether the visit is being conducted in the proper visit window. 28Apr21 - LB - LTM: Site to report this deviation to IRB IF it meets the IRB reporting criteria. Update-C.Clemente-06May2021-Dr. Goldstein informed the SM that he met with his regulatory team. After further discussion, they decided to proceed and report the MPD to the IRB. Lori Yost - DM - 13May2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. Lori Yost - DM - 08Jul2021 - Reviewed by the team and agreed that the status of this PD is Major. Please close this PD. 20Apr2023 M McMahon, SM: Updated category to 'Other' following feedback from LTM and GTM.",2024-01-27,2024-04-03,MINOR,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100150,,,,,,Blood for SM04/serum biomarkers were taken by the subject on screening and on I-0. PI was trained by the SM regarding SM04 requirements. TL has been signed.,,2024-01-15,2024-02-19,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100140,V84,,Other*,,,Blood for Nutritional parameters not collected at M-44,,2024-01-27,2024-03-18,MAJOR,Site collected Day 3-5 and continue COVID episode procedures. PD reported to IRB.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100166,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,14NOV2019 PDIE Meeting: Keep as Minor, no immuno impact.,2024-01-10,2024-02-10,MINOR,"LTM, W. Sult, reviewed minor PD during MVR review on 25Mar2024; SM can close minor PD SM, R. Santos, 23Apr24: Minor PD closed"
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100258,,,Entered but did not satisfy criteria,,,Missing MVV by mistake,"SM, Megan McMahon, 01Dec2022: Week 16 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit and had not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here and AI closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-13,2024-02-01,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V83,,,,,"60| MPD v6.0 | @@@NO IMMUNO, NO EFFICACY@@@ | SAE not reported in timely manner - within 24hours of study-site staff knowledge of the event.SAE was created on the CRF the 25Jun2021 but only submitted the 28Jun2021.","Sunny Li, DMCRO per PDIE meeting 17Oct2023, this is a Minor PD and can be closed once severity is updated. Esau Moreno, GDM per PDIE meeting 18JUL2023, please combine both PDs in one. Severity will depend on the outcome of the test if done directly after LOR confirmation. SM, M.Juchimiuk, 08Jul2023: No stool sample was provided for enteric pathogens at LOR1 visit. During MV 5-6Jul2023 the SM discussed the finding with PI and reminded that visit procedures specified in protocol and laboratory manual should be strictly followed. The training was recorded in training log. The SM asked PI to train all SubIs and SNs on the protocol requirements for procedures at patient visits. The PI decided that the patient should provide stool sample for analysis as soon as possible. LTM, Marta Jakubczak, 18-Jul-2023: Please wait for the central team revision prior PD closure. SM, M.Juchimiuk, 25Aug2023: PDs combined. PD description modified - added ""and at M-32/LOR2"". The material for stool pathogens taken at M-36 (31-Jul-2023). Results for C. difficile toxin, ova and parasites are negative. LTM, Marta Jakubczak, 3-Oct-2023: Please wait for the central team revision prior PD closure - it seems that severity will be downgraded to minor. SM, M.Juchimiuk, 26Oct2023 - Severity changed to minor, PD closed.",2024-01-28,2024-04-25,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Week 76 completed 12 days out of window.,,2024-01-25,2024-03-13,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100211,,,,,,W64 visit was performed 1 day out of window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-25,2024-01-26,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100220,V84,,Other _ Major Disruption,,,Visit 25 / Week 76 MRI completed -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-21,2024-01-29,MAJOR,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V84,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-21,2024-03-13,MINOR,19Aug21 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,V175,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-26,2024-04-10,MAJOR,19Aug21 - LTM - LB: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100175,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","SM, Mateusz Juchimiuk, 24-May-2023: The chemistry in the central lab was not measured at M12 (per Labcorp annotation the sample amount was insufficient to perform analysis) so it was made locally, but there are 3 parameters missing (calcium, phosphorus and urea) when compared to the chemistry panel from Labcorp. Per PI the subject's parents were informed which blood parameters should be assessed. PI confirmed that missing results do not affect the patientâ€™s safety evaluation. Per SRP and Medical Monitor there are no concerns about these missing labs. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-13,2024-01-22,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100291,V186,,,,,Minor PD- For subject 10008005 a different rater conducted week 36 psychometric assessments.,,2024-01-11,2024-03-20,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,V175,,Other*,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Video ileocolonoscopy was not performed at Week 12 and/or Week 48 unless not feasible based on medical decision,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 01Dec2022: Week 24 completed 7 days out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb 23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-12,2024-03-01,MAJOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V175,,,,,"Patient 100089 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100089 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper left arm - Dose 3 in upper left arm",,2024-01-10,2024-03-31,MINOR-COVID-19,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100277,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not fill out RTI form dated 11Jun2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-07,2024-01-26,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100199,V84,,,,,Subject US10008001- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-08,2024-02-14,MINOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100274,V84,,,,,Week 84 visit occurred 13 days out of window.,,2024-01-22,2024-01-28,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100125,V186,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"SM, Megan McMahon, 16Mar2023: The subject's dose of ESCITALOPRAM was increased to 20mg on 22-FEB-2023 for AE of WORSENING OF DEPRESSION. The site learned of the dose change during the subject's Week 4 visit. The PI reached out to the medical monitor for discussion as required per protocol. The SM re-trained the PI and SC on concomitant medication requirements per protocol. 27Mar23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-07,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100256,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 13Aug2019 RTI form. Site is approved on protocol amendment 5.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno impact. PDIE meeting 2APR2020: Only 3 not consequtive days. Not Major, downgraded to minor.",2024-01-01,2024-03-20,MAJOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100150,,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: This is a Major PD as 30% data is missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact. SM, Erica Diezmos, 22Aug2019: HREC and RGO submission not required as PD did not affect patient safety, or have ethical considerations of the project or significant disruption to the project. NO IMMUNO IMPACT - VL - 20211115",2024-01-28,2024-04-09,MINOR-COVID-19,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100196,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,,2024-01-10,2024-02-02,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V186,,,,,Participant 100014 experienced an RTI between 05Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Per laboratory report quantity was not sufficient to perform the analysis. Per site it is barely possible, as patients usually provide large samples.",2024-01-19,2024-03-30,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100237,V84,,,,,"Hb sample has not been collected at week 12 or week 24, however it has been collected during unscheduled visit 1 and 2. SM reminded site staff of this protocol requirement during the visit conducted on 14 Apr 2017","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-03-18,MINOR-COVID-19,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100210,V84,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 12 (counting breaths) on RTI forms dated 12Jul2019 (only the third triplicate was not answered), 13Jul-16Jul2019, 18Jul-30Jul2019, and 01Aug2019-09Aug2019. Site is approved on protocol amendment 5.",,2024-01-17,2024-04-12,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100237,V197,,,,,Participant 100014 experienced an RTI between 04Aug2019 and 23Aug2019. Parent did not complete RTI forms dated 04Aug2019 and 09Aug2019. Protocol amendment 5 mandates RTI forms are completed on each day there are symptoms until they resolve.,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-01-17,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,V175,,,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"SM discussed the issue with study coordinator, Jessica Chacon. She indicated the subject and subject caregiver misunderstood her instructions regarding the upcoming site visit scheduled for 05Feb2021.The subject was informed that the RBANS needed to be administered before the Screening III MRI. On February 5, 2021, the subject did not show up at the site for the RBANS. Instead the subject went to the imaging facility for his scheduled MRI.The next site visit was scheduled for 05Apr2021. During that visit, the Rater administered the Screening III RBANS and the Screening IV ADAS-Cog.Therefore, did not meet the 7 daysâ€™ time frame criteria between the screening visits.SM reminded SC Mrs. Chacon that the administration of the Screening III RBANS and Screening IV ADAS-Cog did not meet the 7 daysâ€™ time frame criteria between the screening visits and therefore was deemed a protocol deviation. Mrs. Chacon confirmed the protocol deviation was not due to the lack of understanding of the timeframe criteria and that this was taken into consideration when scheduling the subject visit and MRI. However, the subject misunderstood the instructions given by Mrs. Chacon and missed the RBANS. 11Apr21 - LB - LTM: Please ensure this retraining is documented on-site. 11Apr2021-CCR-SM: SM reminded the SC about the 7 days timeframe. Mrs. Chacon confirmed they were aware of this requirement and that it was due to the subject misunderstanding of the given instruction. Lori Yost - DM - 15Apr2021 - The team reviewed this PD and agreed that this is a Minor PD. Please close this PD.",2024-01-15,2024-02-25,MINOR,"LTM, M. Songiso reviewed on 17 Oct20223",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V84,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-14,2024-02-13,MINOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100132,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days.",,2024-01-10,2024-02-02,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,V83,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.","Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-30,2024-03-26,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100182,V83,,,,,"Subject 30010666 did not received ASA from the site in his W24 visit, So he was taken medication provided by his own means. Site staff was re trained in protocol procedures, during MV 25 & 26.",,2024-01-08,2024-01-24,MINOR,20Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V197,,,,,"Telephone Contact Report with Ms. Kurumizawa, 05-MAR-2020 SM received from Ms. Kurumizawa the covance result via email. The result described the Aldolase of the subject# 105002 at Week 0(28-FEB-2020) was not resulted because of hemolysis. SM contacted Covance and requested to retest by the rest sample. However the result was not change because of hemolysis. SM shared the preventive measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures on 30-MAR-2020.",The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-16,2024-03-07,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-21,2024-04-05,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100283,V197,,Entered but did not satisfy criteria,,,"7.0|58| SAE \ Adverse Events of Special Interest not reported within 24 hours within Safety Gateway (Or if Paper used due to system failure| SAE was reported late, PD was submitted to IRB WCG for late reportingSAE is Colorectal Cancer @@@NO IMMUNO/NO EFFICACY@@@","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-13,2024-01-16,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100180,V84,,,,,"At screening, respiratory rate not captured as part of vital signs",,2024-01-07,2024-02-06,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100138,V175,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","16-APR-2021 SM was reported by Ms.Kurumozawa via telephone as follows. - MVV for pulmonary function test was not performed at Week 80 of 105001. - When it was found, the 105001 had already gone home. - PI-Dr.Shimojima could confirm that there was no marked change in ILD based on the results of other tests, and judged that there was no need to re-test immediately. - Dr. Shimojima decided to measure only MVV of 105001 at the next Week 88. [cause] - The order was entered properly, but the person in charge of testing forgot to perform MVV only. [Correction] - At the discretion of Dr. Shimojima, only MVV of 105001 will be measured at the next Week 88. [Corrective action] -SM is checking. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. Corrective action ""SM is checking"" is vague. It should be rewritten more clearly. SM, Mayu Horie, 18-MAY-2021 SM updated the following information; [Corrective action] Ms. Kurumizawa does the following; - to confirm that there is no omission in the test items already ordered. - to have the department in charge of testing reconfirm that there is no omission in the order. - to confirm the test report to check for any omissions before the subject goes home. LTM, Masato Yuzawa, 18-May-2021: Reviewed this PD. As it was confirmed that the ""Corrective action"" was properly described, this PD can be closed. SM, Mayu Horie, 19-MAY-2021 SM closed this PD. LTM, Masato Yuzawa, 28-May-2021: Re-opened this PD and fixed garbled texts described by LTM. SM should describe causes of this PD in more detail and corrective actions for the person in charge of pulmonary lung function tests according to the instructions from the PD meeting held on 21-May-2021. SM, Mayu Horie, 16-JUN-2021",2024-01-25,2024-03-18,MINOR,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100207,V175,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.","Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€ 23Feb22 - LB - LTM: Was site staff retrained? SM discussed deviation with Site Director, Claudia Gomes and the site staff. Mrs. Gomes indicated this was an involuntary error. SM addressed the importance of using the correct version of the C-SSRS at each visit. They verbalized understanding. Dr. Goldstein to documented and assessed if this PD is reportable or non-reportable to Sterling IRB based on their reportable guidelines. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that the PD is not reportable to the IRB and documented in the source. 18May22 - LB - LTM: SM to close deviation.",2024-01-24,2024-03-11,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100161,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",,2024-01-22,2024-03-09,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100262,V197,,,,,Week 104 visit occurred 2 days out of window.,,2024-01-13,2024-03-10,MINOR,16Dec22 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100169,,,Other*,,,PI did not informed new insurance certificate number. Subject already did end of Study visit.,"25SEP2020 PDIE Meeting: Minor Protocol Deviation, no Immuno Impact",2024-01-03,2024-02-10,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100127,V175,,,,,Subject US10008004-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-25,2024-03-24,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V186,,,,,Visit 6 / Day 1 / Randomization occurred 16 days out of window without medical monitor approval for screening extension.,"Week 52 Tau PET performed 10 days outside of window. Per protocol, there is a +/- 14 day window for PET imaging. As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-03-26,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100242,V175,,,,,Week 96 visit occurred 7 days out of window.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-21,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100280,V84,,Entered but did not satisfy criteria,,,Week 88 visit occurred 14 days out of window.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-28,2024-04-19,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100284,V83,,,,,Visit 6 / Day 1 / Randomization occurred 3 days out of window without medical monitor approval for screening extension.,"Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information. Major PD; NO IMMUNO IMPACT",2024-01-12,2024-03-19,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V197,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,"08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-22,2024-04-21,MINOR,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100155,V197,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-25,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V84,,,,,"At JNJ-9001496 Infusion Day 1 Visit, phosphate level not completed as part of biochemistry panel",,2024-01-18,2024-01-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,Other _ Major Disruption,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,06FEB2020 PDIE Meeting: This is a minor PD, no immuno impact.,2024-01-25,2024-04-21,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023"
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100183,V175,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,"AK 13Sep2022: The guidelines for sites are not really clear. Sites will be re-trained. It's a minor issue. But it will need to be discussed with the study team. LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: As confirmed by Central Team PD should be considered Minor. As site was retrained PD can be closed and locked. AK 15Sep2022: The guidelines will be updated. Site issue, not a PD, as per PDIE meeting. SM to inactivate this PD.",2024-01-21,2024-02-23,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100237,,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,"23May2018 Site Manager (GF): PI contacted subjects during Monitoring Visit, indicated new insurance number and clarify action on medical chart.",2024-01-02,2024-01-08,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V175,,Entered but did not satisfy criteria,,,Post-infusion Day 90 visit completed out-of-window due to subject's availability. Visit expected on 07-Apr-24 (+/- 7 days), Visit completed on 16-Apr-24.,"29-Jun-2020, Masato Yuzawa, LTM: Reviewed Telephone Contact Report (Date of Contact: 01-May-2020) and this PD. The following should be described: - Corrections and corrective actions of the PD - Causes of the PD: If the PD is thought to be caused by blood sampling procedures or the subjectâ€™s predisposition, describe them according to the PD meeting instructions. SM, Shinya Fukuda, 19-AUG-2020: SM confirmed from Ms. Kurumizawa that there were not any conceivable causes to the hemolysis. LTM, Masato Yuzawa, 19-Aug-2020: Reviewed this PD. The following should be described: Corrections and corrective actions of the PD. SM, Shinya Fukuda, 21-AUG-2020: Only LDH is described in the description, but ALD at the same Week 4 is also missing due to hemolysis, and therefore, is added. Correction was not performed. SM shared the preventive the measures for hemolysis with Ms. Kurumizawa and request to inform the laboratory staff of the preventive measures as Corrective actions on 26-MAY-2020. ãƒ»After skin preparation, wait until the antiseptic solution has dried sufficiently before puncturing. ãƒ»Needles smaller than 23 gauge should not be used. ãƒ»Blood will not be collected from the haematoma site. ãƒ»For syringe blood draw, ensure that the needle is securely attached to the syringe to avoid inclusion of air bubbles. ãƒ»For syringe blood draws, do not pull the plunger (plunger) too hard. ãƒ»A specified amount of blood will be collected and aliquoted into a blood collection tube. ãƒ»Avoid foaming the blood when mixing by inverting the blood collection tube. Ms. Kurumizawa understood it. LTM, Masato Yuzawa, 21-Aug-2020: Reviewed this PD. It was confirmed that LTM review comments had been appropriately addressed by SM. This PD can be closed. SM, Shinya Fukuda, 21-AUG-2020: SM closed this PD.",2024-01-17,2024-02-26,MAJOR,27Mar23 - LB - LTM: Reviewed
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100119,V197,,,,,Week 76 MRI completed -26 days earlier than the allowable window per protocol.,"SM, Mateusz Juchimiuk, 24-May-2023: The patient came for the visit M-24 on 24Apr2023, but it turned out that diaries were not completed regularly, so the MAYO score could not be calculated. The patient was reminded by the site to complete diaries regularly and the visit was rescheduled to 27Apr2023. The rescheduled visit was performed as planned and it was done within the visit window. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 06-Jun-2023: SM data added in Sponsor Response field, PD closed and locked.",2024-01-20,2024-02-18,MINOR-COVID-19,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100144,V83,,Entered but did not satisfy criteria,,,"Patient 100107 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100107 was dosed as follows: - Dose 1 in Upper left arm - Dose 2 in upper right arm - Dose 3 in upper right arm",,2024-01-21,2024-04-17,MAJOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100145,,,,,,Subject US10008009-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,,2024-01-07,2024-03-04,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100218,V84,,Other*,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,CDAI calculated in error at Week 0 or Week 12 which impacts the clinical response/ non-response,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 4 (01Jul2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.",,2024-01-13,2024-03-12,MAJOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100287,,,,,,Subject US10008015-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 MRI was completed 5 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. An action item was added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The medical monitor provided clarification The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-08,2024-04-05,MINOR,"LTM PZ reviewed. LTM PZ re-reviewed, status updated and PD closed acording to DMCRO.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100259,V83,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-03-19,MINOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100152,V186,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required.,"Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-21,2024-02-17,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100177,V186,,,,,Subject US10008008-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-02,2024-01-04,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100215,V175,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"Sunny Li/Alexandra Motrea, DMCRO per PDIE meeting 16Apr2024, Please inactivate PD as this is already covered in the PD created for study visit not within window.",2024-01-07,2024-03-23,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100299,,,,,,Visit 25 / Week 76 completed 4 days out of window.,,2024-01-02,2024-01-18,MINOR,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023 LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V175,,,,,Week 48 completed 2 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-01-23,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V197,,,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"Subject US10008007- IP was not administered at week 12.Subject was dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the infusion for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to administer the IP on a different day. On 19Aug2021, Dr. O'Neill approved the delay IP administration. On 20Aug2021, subject came back to the site and was administered the IP without issues. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close deviation 14Sep2021- C.Clemente-closed PD",2024-01-17,2024-03-14,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100282,,,,,,Week 16 completed 1 day out of window.,,2024-01-08,2024-03-16,MINOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Hepatitis B surface antigen and antibody were not completed at screening. Of note, the Hepatitis B core antibody was completed with a negative result and transaminases (ALT/AST) were normal at screening.",,2024-01-21,2024-03-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V84,,,,,"Patient 100004 was not administered IP in alternate arms per protocol. Per protocol, patients were to have IP administered in alternate arms. It was confirmed that patient 100004 was dosed as follows: - Dose 1 in upper right arm - Dose 2 in upper right arm - Dose 3 in upper left arm","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-24,2024-04-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100268,V186,,,,,Visit was done out of visit window (last day for the visit was 26 DEC 22). Subject was not able to come to the clinic according to the AM 4 requirements.,"2024-03-20 GDM SDW: Per central review, no major severity classification item is met, thereby this is a minor deviation. 2024-04-01 SM Santos: Per central team review, PD evaluated and downgraded to minor PD. PD is now closed",2024-01-22,2024-04-19,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023 LTM - Marta Jakubczak, MVR 22-23-Mar-2023, reviewed on 3-Apr-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,V83,,,,,Stool sample was not provided by the subject. Subject was not able to provide stool sample during the clinic visit. Subject was instructed on the previous site's visit that stool sample is required. Subject was instructed about the requirements regarding stool sample collection.,"Sunny Li, DMCRO per PDIE meeting 21Nov2023, ok to be closed. Sunny Li, DMCRO per PDIE meeting 17Oct2023, Pending retaining to be completed to be a minor PD. SM M.Juchimiuk, 25Sep2023: Per source the patient did not provide the stool sample despite a reminder from the investigator at previous visit. The patient declared to bring the sample as soon as possible after the visit, but it has not been done as of MV 20-21Sep2023. LTM, Marta Jakubczak, 3-Oct-2023: Please confirm whether sample has been finally delivered. Please wait for the central team revision prior PD closure. SM M.Juchimiuk, 26Oct2023: The re-training is not applicable, as the site is aware of the protocol requirements and they were reminding the patient to bring the sample. Severity changed to minor and PD closed.",2024-01-11,2024-04-03,MAJOR,The protocol calendar of events & allowed windows for each visit were reviewed with the staff investigators,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100289,V186,,,,,Minor PD-Subject 10008016-SCR II: Rater used C-SSRS form â€œsince last visitâ€ instead of â€œbaseline.â€,"Subject 10008006- Day-1 visit-The incorrect version of the C-SSRS scales was administered during this visit. The site used the ""Baseline"" version instead of the ""Since the Last visit"" version. SM discussed deviation with Dr. Goldstein and SC, Jessica Chacon. Dr. Goldstein indicated this was an involuntary error. However, he stated that no critical information was missing since both versions capture the same information. SM reminded SC, Mrs. Chacon to make sure the correct version is used for each visit. She verbalized agreement without concerns. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-19,2024-03-05,MAJOR,"As soon as detected, site staff reported SAE.Site staff was reminded that besides a stay less than 24h, if patient remained at site overnight it was considered a hospitalization and thus, a SAE.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100292,,,,,,Subject US10008016- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Major PD, No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-12,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close."
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100217,,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,CNS-acting con med dose change post-randomization.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-08,2024-02-02,MAJOR,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100245,V175,,,,,Subject US10008014-The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-20,2024-01-24,MINOR,23Feb22 - LB - LTM: Reviewed as part of the 01-03Feb22 MVR review.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V186,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-13,2024-03-10,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100235,V83,,,,,Participant 100015 experienced an RTI between 01Sep2019 and 15Sep2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 12Sep2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-04-14,MINOR,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100251,V83,,,,,"I-8/M-0 visit: Study Visits not performed, or Visit was not performed within the allowed window as per the protocol. Visit I-8/M-0 visit was performed on 12Feb2024, whereas visit window +-4days was on 9Feb2024. The delay in the visit happened because there was no possibility to perform endoscopy due to endoscopist sickness.",,2024-01-10,2024-01-17,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100293,V83,,,,,"Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. On RTI form 24Jul2019, parent answered 'yes' to question 6 'Did the child have any breathing problems'. Question 6.1. 'Does the child have any of these breathing problems' was not answered, which is required to be answered if question 6 was a yes answer. Site is approved on protocol amendment 5.","Rater's variability was identified as a repetitive issue during a previous MV. This issue was addressed with PI, Dr. Goldstein, and Lead Rater Claudia Pascua at the time. Site staff was re-trained. The site also developed a Corrective Action Preventive Action (CAPA) to minimize the rater's variability. Since the CAPA implementation, the rater variability is no longer a trend at the site. However, this occurrence cannot be avoided completely since this is affected by the original rater availability on the day of the visit, the subject/caregiver availability and keeping the visits within the visit window. Site staff to document PD in source document. Dr. Goldstein to assess PD as reportable or non-reportable as per Sterling IRB. 03Mar2022 K Lawton, SM: Dr. Goldstein confirmed that this is not reportable to the IRB and documented this in the source. 18May222 - LB - LTM: SM to close deviation.",2024-01-28,2024-03-24,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100200,V83,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not complete question 12 (counting breaths) on RTI form dated 13Jun2019. SC will retrain parent on how to complete the question.,"16Oct2023 M McMahon, SM: The subject's Week 104 visit occurred 2 days out of window. The site reports that the Week 104 visit and imaging scheduling had to be adjusted due to Rayus Radiology issues with obtaining the tracer for the Week 104 PET. The protocol deviation is recorded in the subject eSource. Per documentation, the PD is not reportable to the IRB. The site understands the importance of adhering to the visit schedule per protocol but cites the tracer issue as being beyond the site control. 01Nov2023: I. Karuga, LTM: PD reviewed and can be closed. 01Nov2023 M McMahon, SM: Closing and locking per LTM review and comments.",2024-01-09,2024-03-12,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,,,,,,"60 | MPD v9.0 | @@@NO IMMUNO/ NO EFFICACY@@@ |Subject hospitalized for Gastroenteritis on 03 Aug 2021 . Site made aware of SAE on 04 Aug 2021. This was documented in source documents at site, but not reported to Sponsor within 24 hours of site staff knowledge of the event, only reported on 06Aug2021.",,2024-01-15,2024-03-22,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100124,V84,,,,,"Subject contact not done within 14 +/- 3 days within the RSV season. SM Abbey Caldwell, 02 Sep 2020: Subject contact not done between 21 Oct 19 and 11 Dec 19 not done despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 days.","08Aug2023 M McMahon, SM: The Week 108 visit occurred 7 days out of window due to subject's availability. During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. An action item was created for the site to document their discussion with the subject re: importance of adherence to visit windows per protocol. 24Aug2023 M McMahon, SM: Per the SC, Sakaiya Jackson, eSource has been updated to explain action taken to prevent future out of window visits including their discussion with the subject re: importance of adherence to visit windows per protocol. LTM, M. Songiso 17OCt2023: This deviation can be closed and locked.",2024-01-08,2024-03-22,MINOR-COVID-19,"CRA discussed the noted AEs with the Data Manager. Data Manager does not have clinical background so requires assistance from the PI to enter the adverse events. CRA will follow-up with the PI to get these Adverse Events added to the EDC. PI to review the AEs, assess severity and causality and add relevant data to the EDC. CRA will provide re-training to the PI regarding AE reporting and this will be documented on study specific training logs. Site has entered in EDC the mentioned AEs and issue is resolved.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100136,V186,,,,,Week 84 visit occurred 21 days out of window.,The Baseline D-Dimer sample was collected before randomization occurred (randomization 13:20 while D-dimer collection 13:00hs),2024-01-11,2024-04-03,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100265,V186,,,,,Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete questions 14-17 on form dated 24Jun2019. SM has made SC aware of incidence. SC confirms that the parent has been retrained on how to answer the questions.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-24,2024-02-06,MINOR,"LTM - Iwona Malarowska-Janik, MVR 16May2022, Reviewed on 1Jun2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100270,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 18 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 54 Days",,2024-01-11,2024-01-15,MAJOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100267,V84,,,,,"Calprotectin not measured at I-0, Quantity not sufficient","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-02,2024-02-06,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100272,V186,,,,,Week 104 MRI occurred -8 days out of window.,25SEP2020 PDIE Meeting: This is a Minor Protocol Deviation, no immuno impact.,2024-01-13,2024-01-21,MAJOR,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100179,,,,,,"Participant experienced an RTI between 06May2019 and 09May2019. Parent has completed RTI forms, however, did not complete a form for 06May2019. Site was approved on protocol amendment 3 at the time, which mandates that RTI symptoms forms are completed daily until symptoms resolve.",15OCT2020 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-06,2024-02-14,MINOR-COVID-19,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100144,V83,,,,,SAE report submitted to sponsor outside the 24hs window,"LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Pending global review. 03OCT2019 PDIE Meeting: Upgrade to Major; 3 consecutive days of data was missed. No Immuno Impact. NO IMMUNO IMPACT - VL - 20211115",2024-01-02,2024-03-13,MINOR,"LTM - Marta Jakubczak, MVR 5-6-Jul-2023, reviewed on 18-Jul-2023 LTM - Marta Jakubczak, MVR 20-21-Sep-2023, reviewed on 3-Oct-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100130,V186,,,,,"Participant 100004 experienced an RTI between 11May2019 and 18May2019. Parent had filled out RTI symptoms form daily, however, did not complete question 12 (counting breaths) on all the forms. SM has made SC aware of incidence. SC will retrain the parent on how to complete question 12.","SM, Megan McMahon, 01Dec2022: Visit 17 / Week 48 completed 2 days out of window. The minor PD has not been recorded in subject's source documents. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-30,2024-03-17,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 18-19-Jan-2023, reviewed on 25-Jan-2023 LTM - Marta Jakubczak, MVR 8-9-Mar-2023, reviewed on 15-Mar-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100117,V84,,,,,"Visit 8 Post dose vitals were obtained 28 minutes post dose. Patient was dosed at 9.56am, Vitals taken were taken 10.24 This is -2 mins ahead of window.",,2024-01-04,2024-03-21,MINOR,3Feb23 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V83,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-03,2024-04-01,MINOR-COVID-19,"LTM Shihoko Shimizu, PDIE Meeting was hold and reviewed on 18-Oct-2019",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100212,,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-15,2024-02-21,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100185,V197,,,,,At week 4 dated 26Apr2021) site staff dispensed to subject 4 IP kits (192 tabs). At Week 8 the subject returned 12 tabs. Based on compliance calculation (considering that on 26Apr2021 in the morning the subjcet taken the IP at home and prior to visit form kits dispensed at Week 2) the subject taken 183 IP tabs instead of 180 tabs. The patient took 3 more IP tablets.,,2024-01-11,2024-03-01,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V83,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.",,2024-01-22,2024-02-03,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100157,V83,,Entered but did not satisfy criteria,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 21 Oct 19 and 11 Dec 19 despite being partially within RSV season and contact required every 14 days. Contact was OOW by 51 Days.",,2024-01-18,2024-02-13,MAJOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V186,,,,,CNS-acting con med dose change post-randomization.,,2024-01-30,2024-03-08,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100261,V186,,,,,Visit was performed OOVW due to subject's mother COVID-19 infection.,,2024-01-12,2024-01-27,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100141,V175,,,,,Subject US10008011- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-09,2024-01-29,MAJOR,11Apr21 - LB LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100171,V197,,Received wrong treatment or incorrect dose,,,Participant's vaccine 2 (visit 5) expected date is 10Apr2020. Actual vaccine 2 date is 17Apr2020 due to public holidays and accommodating the parent's schedule. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-19,2024-04-06,MAJOR,16Dec22: LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V186,,,,,Week 108 visit occurred 7 days out of window.,"SM, Megan McMahon, 01Dec2022: Visit 25 / Week 76 completed 4 days out of window. The minor protocol deviation was documented in the subject eSource and had been reported to the medical monitor but eSource does not include explanation of why deviation occurred and medical monitor correspondence is not filed. Per the eSource, PD is not IRB reportable. Action item added. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB - LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-06,MINOR,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100228,V84,,,,,US10008005: Week 80 visit completed 6 days out of window.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-20,2024-04-17,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,V175,,,,,"At screening, respiratory rate not captured as part of vital signs","SM discussed deviation with PI, Dr. Goldstein and the site staff. SM re-trained the site staff on the importance of adhering to the protocol design. They verbalized understanding. SM sent a Training log to document this re-training. Site will document this missing procedure in the source. Dr. Goldstein will assess if this protocol deviation is reportable to the IRB based on the Sterling IRB reporting guidelines. Post Visit Note- 11May2022- SM reviewed the site eSource system and confirmed that the missing procedure was reported in the eSource. PI assessed PD and determined it was non reportable to the IRB. Site completed training log sent by the SM and sent SM a copy. Update-SM-CCR-11May2022: o US10008006- PD was reported in eSource. PI assessed PD and determined it was non reportable to the IRB. o SM reviewed eSource and confirmed PD documentation. o SM updated PD information in CTMS. o SM verified that the re-training was documented in a training log. 18May22 - LB - LTM: SM to close deviation.",2024-01-13,2024-02-03,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100159,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 13 May 20 and 16 June 20 despite being within RSV season and contact required every 14 days. Contact was OOW by 34 Days. Site noted that this was due to RSV Season start date confusion.","This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-16,2024-02-23,MINOR-COVID-19,27Mar23 - LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100237,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,,2024-01-06,2024-03-05,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100142,V83,,,,,Subject US10008007- The Medical History was collected at Screening Visit I instead of Screening II as per protocol.,14NOV2019 PDIE Meeting: Keep as minor, No immuno impact.,2024-01-21,2024-02-23,MINOR,11Apr21 - LB LTM: Reviewed.
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100286,,,Entered but did not satisfy criteria,,,Participant 100015 experienced an RTI with a start date of 01Sep2019. Nasal swab was taken on 06Sep2019. Protocol amendment 5 instructs that swabs should preferably be taken within 72 hours of onset of RTI symptoms.,"SM, Megan McMahon, 01Dec2022: Week 76 MRI completed -26 days earlier than the allowable window per protocol. Per protocol, ""If not performed on the same day, the MRI should be performed within 7 days prior to the visit (ie, -7 day visit window)."" As of the monitoring visit 30Nov2022-01Dec2022, the deviation had not been recorded in source documentation. ACTION ITEM ADDED. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining documented? SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here and action item closed SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-10,2024-03-11,MAJOR,Investigators explained that the visit was pushed forward to return the patient to his original calendar after W48 oow event.,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100209,,,,,,Subject US1008006 signed optional lumbar puncture ICF but sample was not collected at screening visit 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-11,2024-02-15,MINOR-COVID-19,28Apr21 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100210,V84,,Other*,Deviations from approved IPPI process for preparation and administration of study drug,Deviations from approved IPPI process for preparation and administration of study drug,Subject BR10007025002 completed visit day 28 on 29Nov2023 which was out of window period for 1 day due to subject's unavailability.,"LTM - Iwona Malarowska-Janik, MVR 31Aug2022, Reviewed on 16Sep2022: PD can be closed and locked.",2024-01-12,2024-01-28,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100252,V83,,,,,"COVID-19 Related: Due to Perth lockdown spanning from Tuesday, 29June at 12.01am until 03Jul to 12.01am RTI 2 (29June2021) visit was not done but the parent was able to collect nasal swabs and RTI diary information.","2024-01-17 GDM SDW: Per central review, this data interfaces with an inclusion/exclusion criterion. Can you please clarify which results were produced and are available. Were any DNA tests performed? Item escalated to potentially major. 2024-02-06 SM Santos: As the SM notified the site during the December MV, before lymphodepletion on 03-Jan-2024, the site completed the Hep B surface antigen and the antibody tests which both had a negative result. 2024-02-21 GDM SDW: Per central review, subject was safe for lymphodepletion requirements, but exclusion criteria 12 could not be evaluated at time of apheresis. Follow-up with business owner of TV-SOP-04282 ongoing. 2024-03-04 GDM SDW: Per discussion with business owner, SRP, quality, GDM: Minor deviation against the serology assessment described in the protocol and no deviation against exclusion 12 (as this was not met), but it was inconclusive when it should not have been. The latter is a major issue as this is a violation of the trial conduct. Consider asking site to fill list of inclusion/exclusion criteria to circle that this has been assessed fully. Add that ""transaminases (ALT/AST) at screening was normal"" to the description. 2024-04-01 SM Santos: SM spoke with SC, C. Lee, and the site has agreed to include Appendix 16 (Hep B Virus Screening) as part of your eligibility packet and check-off list for site sign-off prior to the subject being enrolled in the study to help ensure all applicable Hep B serology testing has been completed. As noted above, an issue will be added along with this information.",2024-01-30,2024-02-28,MINOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V197,,,,,"Participant 100014 experienced an RTI between 26May2019 and 18Jun2019. RTI form dated 13Jun2019 showed a 'yes' answer to question 8 which relates to if child vomited/spit up more than usual. Question 8.1 was not answered on this form, which is required to be answered if 8 was a 'yes' answer (question relates to if vomiting occurred only when coughing). SC will retrain the parent on how to answer this question.","SM, Megan McMahon, 01Dec2022: Week 28 completed 1 day out of window. The minor PD which occurred prior to my assignment to the study had not been recognized prior to my visit. The PD is recorded in source and PI has assessed not reportable to IRB. Added to OneCTMS. 16Dec22 - LB - LTM: Is medical monitor aware? Retraining conducted with site staff? Retraining document SM, Megan McMahon, 01Feb2023: During the monitoring visit Jan 24-25, 2023, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The site reached out to the medical monitor 26-Jan-2023 to inform and request guidance re: the OOW visits. The SM re-trained site staff and documented on training log. 3Feb23 - LB -LTM: SM to close and lock deviation once MM guidance is added here SM, Megan McMahon, 06Feb2023: The medical monitor provided the following guidance to the site via email for bringing subjects back in window, ""It is correct that visit window is 28 +/- 7 days and if it is possible we would recommend to come back to regular schedule but at the end will be investigator final determination. You can adjust visit subject windows reducing interval between doses to come back to subject original schedule. Minimum interval using visit windows is 14 days."" The PD will be closed and locked.",2024-01-27,2024-02-01,MINOR,"LTM, W. Sult, reviewed minor PD on 25Mar2024; SM can close PD 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V83,,,,,Ferritin level was not completed at the JNJ-90014496 Infusion Day 1 Visit,,2024-01-15,2024-04-07,MINOR,"CRA, Jessica Newman, was unintentionally unblinded on 14Mar2022.  Clinical lead Deana Hunley was informed and CRA was instructed to cease monitoring after the blind was broken.  CRA discussed the unblinding situation in a manner that did not unblind any further site staff.  CRA observed pharmacist migrate the unblinding document to the unblinded binder, and confirmed that neither the primary SC, nor the SC that conducted the visit were unblinded.  After confirmation of no further unblinding and the migration of the document the CRA left the site, and did not return for the second day of monitoring.  CRA emailed PI, primary SC, and regulatory coordinator on 15Mar2022 to provide clinical lead, Deanna Hunley, contact information for future assistance until a new CRA is provided by resourcing.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100260,V83,,,,,"Subjects US1008006-the post dose blood draw at week 16, was not done within 10 minutes of the completion of infusion as per protocol requirement.",15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-01,2024-03-18,MINOR-COVID-19,19AUg21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100120,V175,,,,,Visit 6 / Day 1 / Randomization occurred 40 days out of window without medical monitor approval for screening extension.,,2024-01-12,2024-03-04,MINOR,19Aug21 - LB - LTM: Reviewed. SM to move comments above to Sponsor Response field. 03Sep2021- CCR- SM- Done.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100205,V197,,,,,Week 84 visit occurred 21 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-18,2024-03-24,MINOR-COVID-19,"CRA to discuss this Protocol deviation in the next monitoring visit report. Additionally, CRA will document the discussion of this PD along with the PD log generated for the next monitoring.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100226,V197,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.","LTM, Jansen Tan, MVR 10Sep2019: Reviewed on 18Sep2019. Please close. 24OCT2019 PDIE Meeting: Reviewed; Keep as Minor. No immunogenicity impact.",2024-01-09,2024-03-25,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100262,V84,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Randomized but did not receive study drug,,2024-01-02,2024-01-03,MAJOR,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Pending global team review.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,,,,,,I-8/M-0 visit:Participant was not administered dose of study treatment ustekinumab/placebo within scheduled time window. I-8/M-0 visit was performed on 12Feb2024 which was outside the visit window (+-4days deadline was on 9Feb2024) and study treatment was administered on that delayed visit outside the visit window.,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-17,2024-01-27,MINOR-COVID-19,"LTM, Ilona Tay, MVR 06Aug2020: Reviewed on 20Aug2020. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100147,V84,,,,,Subject US10008007- Laboratory samples were not collected at week 12.,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-10,2024-02-13,MINOR,"TM Veronique Mathijssen, reviewed as part of MVR20, 4Apr2018. TM, Veronique Mathijssen, 19Apr2018, reviewed as part of MVR review. TM, Veronique Mathijssen, 24Apr2018, please be referred to the actions field regarding PD description. TM, Veronique Mathijssen, 26Apr2018, reviewed following requested update.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100121,V84,,,,,Subject 100519 on week OLE week 19 (13jUL2022) was dispensed with the IP affected by the Temperature Excursion occurred on 10-11July2022.,14NOV2019 PDIE Meeting: Keep as Minor PD, no immuno impact.,2024-01-05,2024-03-21,MINOR-COVID-19,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100178,V197,,,,,Stoll sample was not provided by the subject on I0. Subject was not able to provide the stoll sample during the I0.,,2024-01-01,2024-01-18,MINOR-COVID-19,"LTM, Jansen Tan reviewed on 29Jan2020. Please close",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100168,V175,,,,,CRA noted unreported Adverse Events for patient GB10003002 during the OMV on 02Nov2021. Chest Infection recorded in patient EMR in December 2019. Nausea and Odd Taste in Mouth reported in EMR Sep2019.,"For this patient the missing result due to platelets clump occurred several times through the study. PI explained that it is the patient's blood feature and that missing results at M-44 have no impact on the patient's safety. The local retest to be performed. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please close and lock PD once done. SM, M.Juchimiuk, 07Aug2023: PD closed and locked.",2024-01-25,2024-03-25,MINOR,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V83,,Other*,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Clinical laboratory assessments not taken for two or more consecutive visits up to and including Week 48,Week 96 visit occurred 7 days out of window.,14NOV2019 PDIE Meeting: This is a Major PD, no immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-26,2024-02-11,MAJOR,28 Dec 2023 WParker LTM Reviewed
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100208,V83,,,,,Week 88 visit occurred 19 days out of window.,,2024-01-25,2024-03-31,MINOR,16Dec22 - LB - LTM: Reviewed,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V83,,Entered but did not satisfy criteria,,,Week 84 visit occurred 21 days out of window.,,2024-01-17,2024-03-07,MAJOR,"25 Apr 2024 WParker LTM Reviewed. 25-Apr-2024, SM R. Santos: Minor PD closed",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100184,V175,,,,,Week 108 visit occurred 7 days out of window.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-28,2024-02-11,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100235,V197,,,,,Participant 100015 experienced an RTI between 27May2019 and 18Jun2019. Parent did not fill out RTI form dated 31May2019. Protocol mandates that RTI forms are to be collected daily until symptoms resolve. SC will retrain parent on the daily collection of forms.,,2024-01-24,2024-02-20,MINOR,19Aug21 - LB - LTM: Reviewed.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100213,V83,,Other _ Major Disruption,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-12,2024-03-22,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100149,V186,,,,,"Subject contact not done within 14 days +/- 3 days within RSV season. SM, Abbey Caldwell, 02 Sep 2020: Subject Contact not done between 07 Jan 20 and 14 Feb 20 despite being outside RSV season and contact required every 30 days. Contact was OOW by 8 Days.",25SEP2020 PDIE Meeting: This is a Major Protocol Deviation. NO IMMUNO IMPACT - VL - 20211115,2024-01-13,2024-03-16,MINOR-COVID-19,"LTM - Marta Jakubczak, MVR 17-18-May-2023, reviewed on 24-May-2023",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100123,V186,,,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Subject US10008007- Laboratory samples were not collected at week 12.Subject was very dehydrated. Site staff was unable to gain vein access after multiple attempts. Dr. Goldstein decided to delay the samples collection for the benefit of the subject. On 18Aug2021, SC. Mrs. Chacon emailed Medical Monitor, Dr. Santiago O'Neill to request approval to collect the laboratory samples on a different day. On 19Aug2021, Dr. O'Neill approved this request. Dr. Goldstein documented and assessed the PD in the SD. He deemed this PD as not reportable to the IRB. 14Sep21: LB - LTM: SM to close 14Sep2021- C.Clemente-closed PD",2024-01-01,2024-03-03,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100290,V175,,,,,CD4 count and ferritin level were not completed at Post-infusion Day 11 Visit,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-17,2024-02-11,MINOR-COVID-19,"LTM, Jansen Tan, MVR 31Oct2019: Reviewed on 7Nov2019. Please close.",
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100186,V197,,Entered but did not satisfy criteria,,,Patient 30013838 lost kit 2100369. PI retrained patient in the importance to keep kits and return them during study visits. This minor PD was reported to the EC on 18 Aug 2017,"SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-06,2024-02-23,MAJOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100264,V83,,,,,Test for enteric pathogens was not done at LOR1 and at M-32/LOR2,"LTM, Jansen Tan, MVR 1Aug2019: Reviewed on 12Aug2019. Pending PDIE meeting. Mary Sweeney (GTL) reviewed during 21AUG2019 PDIE Meeting: Keep as Minor; would upgrade to Major if 30% missing (individual parameters or entire form) or 3 consecutive days are missed. No Immunogenicity impact.",2024-01-08,2024-04-06,MINOR,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100191,,,,,,COVID-19-related: Subject qualified for suspected COVID-19 episode. Day 1-2 was performed on 10 May2021 but nasal swab sample was not taken (participant forgot). Samples from Day 3-5 were all collected correctly.,,2024-01-04,2024-01-28,MINOR,CRA oriented the site staff to reinforce to the subject the importance of complying with study timelines. Site was oriented to report the deviation to IRB/IEC.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100249,V83,,,,,"Baseline RBANS on Screen 5 and Baseline ADAS Cog on Week 0 did not meet the mandatory 7 days between Screening Visit 5 and Week 0.The reason for the deviation was due to an oversight by the SC, Jessica Chacon when the Day 1 visit was rescheduled from a Wednesday to a Monday as a result of scheduling conflicts.",,2024-01-07,2024-03-01,MINOR-COVID-19,19Aug21 - LB - LTM: Reviewed 07Sep2021- C.Clemente-closed PD,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100164,V175,,,,,Participant 100004 experienced an RTI between 12Jul2019 and 09Aug2019. Parent did not complete question 'How sick has the child felt in the last 24 hours' on 16Jul2019 RTI form. Site is approved on protocol amendment 5.,"This deviation was due to an error in the site EMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the EMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-04,2024-01-28,MINOR-COVID-19,,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100156,,,,,,"77 | MPD v7.0 | @@@NO IMMUNO/ NO EFFICACY@@@ | Subject US30140719 reported having symptoms on 4May2021. Site contacted subject and subject agreed to collect Day 1-2 samples and come to clinic for Day 3-5. However, at day 3-5 subject did not provide the Day 1-2 samples as it was not collected.","SM, Megan McMahon, 16Mar2023: During the monitoring visit, the SM confirmed the PD has been recorded in the subject eSource. Per site assessment, not reportable to IRB. The out of window visits have previously been reported as a site finding and the site had reached out to the medical monitor for guidance to bring the subjects back in window. All subjects are targeted to be back in window by their next scheduled visit. 27Mar23 - LB - LTM: Site staff retrained on protocol adherence to visit windows? 21Apr2023 M McMahon, SM: Site staff were retrained on protocol adherence to visit windows and the importance of documenting their discussion with subjects about the importance of adherence to visits per protocol. 21Apr23 - LB - LTM: SM to close and lock deviation",2024-01-08,2024-03-23,MINOR,"LTM - Iwona Malarowska-Janik, MVR 21Oct2022, Reviewed on 7Nov2022: Per the Central Team guidance PD should be reported as Minor if patient weights more than 25kg. Please confirm patient's weight, if >25kg PD should be downgraded to minor and closed. SM, KG 7NOV22: Subject's weight was 58 kg. According to the Central Team decision PD is locked and closed.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100126,V186,,,,,Participant 100015 experienced an RTI between 05Aug2019 and 30Aug2019. Parent did not complete question 13 (temperature) on RTI form dated 28Aug2019. Site is approved on protocol amendment 5.,15OCT2020 PDIE Meeting: This date range falls partially in the RSV season. It is a Major PD given the length of time between contacts. No immuno impact. NO IMMUNO IMPACT - VL - 20211115,2024-01-17,2024-01-30,MINOR,17May22 - LB - LTM: Reviewed as part of the 3May22 OSMV report,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100232,,,,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,,2024-01-09,2024-02-25,MINOR-COVID-19,14Sep21 - LB - LTM: Reviewed 14Sep2021- C.Clemente-closed PD,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100181,V175,,Other _ Major Disruption,,,"Telephone Contact Report with Ms. Kurumizawa, 27-MAR-2020 SM confirmed the following from Ms. Kurumizawa via telephone. - The subject #105003 will administer IP at Week 0 on 01-APR-2020 - However the Investigator who perform efficacy test at Week 0 will be absent on 01-APR-2020 - There is no investigator who can perform efficacy tests on behalf of the investigator on 01-APR-2020 - The screening window is until 31-MAR-2020 Ms. Kurumizawa confirmed to SM whether it is possible or not to perform the efficacy tests on 31-MAR-2020 and initial IP administration on 01-APR-2020. SM confirmed the following from Clinical Scientist on 30-MAR-2020 via email. - In case that the efficacy tests as Week 0 is performed on 31-MAR-2020 and IP administration on 01-APR-2020, this case is exception. - This case is protocol deviation because there was no window at Week0. - It is preferable to perform the interval will be shorter between efficacy tests and IP administration - Investigator should confirm there are no AE which affect efficacy tests before IP administration - The starting points of PSL tapering and Standard of Care is IP administration date(01-APR-2020) SM tell the above confirmed handling to Ms. Kurumizawa via email. In fact, the efficacy tests of week 0 were performed on 31-MAR-2020 and initial IP administration was performed on 01-APR-2020.","Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. The patient did not bring the sample for the visit (per PI's verbal explanation - the patient just forgot) and was not able to provide it during the visit. Per note in SD the parents planned to provide the stool sample after the visit but they were not able to do it eventually. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-21,2024-02-13,MAJOR,"LTM, Jansen Tan, reviewed on 26Nov2021. GDM confirmed closure after confirming update to MPD and COVID-19 Related.",
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100158,,,Entered but did not satisfy criteria,,,"Participant 100004 experienced an RTI between 04Jun2019 and 02Jul2019. Parent did not complete question 12 (counting breaths) on forms dated 12Jun-18Jun2019 inclusive and 21Jun-02Jul2019 inclusive. SM has made SC aware of incidence. SC had already retrained the patient beforehand, and will emphasise to the parent the importance of collecting this data.",,2024-01-01,2024-03-25,MAJOR,16Dec22: LB - LTM: Reviewed,
IH,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100160,V84,,,,,"Subj US10008016 - The post-dose blood draw at week 16 was not done within 10 minutes of the completion of infusion, including flush.","This deviation was due to an error in the site eMR design. This error affected all subjects that have been screened at the site prior to 15Jul2021. Before the end of this MV, the site had updated the eMR. PI and SC, Jessica Chacon confirmed that moving forward the Medical History will be captured at Screening II and this will be reflected in the updated source document.",2024-01-24,2024-04-09,MINOR-COVID-19,,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100229,V84,,Entered but did not satisfy criteria,,,On Laboratory results from Labcorp Plates were not analyzed. Subject was asked to come to the clinic for the retest. Platels from the retest were also not analyzed. Subject due to vacation's trip was not able to come to the clinic for the second retest.,"Esau Moreno, GDM per PDIE meeting 18JUL2023, this is a Minor PD and can be closed once severity is updated. At MV 17-18May2023 PI declared to investigate the case with the site staff and to provide explanation in source documentation. The SM reminded PI that blood should be taken per protocol schedule of assessments (it is documented in the training log) and asked PI to train the personnel responsible for missing samples. LTM, Marta Jakubczak, 24-May-2023: In a Sponsor Response, any clarification must be prefixed with your data, such as: SM, Mateusz Juchimiuk, 17-May-2023. Please wait for the central team revision. SM, M.Juchimiuk, 07Aug2023: PD downgraded, closed and locked.",2024-01-10,2024-01-18,MAJOR,Subject was unblinded at v4 on 12Apr2021 and received vaccine on that day. Site reminded subject about study requirements and this was documented in chart.,
Programmable PD,17000139BLC3002,CNTO1275PUC3001,United States of America,P73-PL10008,Smith Adam,100234,,,,,,CNS-acting con med dose change post-randomization.,23May2018 Site Manager (GF): Pending contact subject to inform new insurance certificate number. 31JUL: it was confirmed that the subject received the information on 30may2018. This is registered in the patient medical records,2024-01-10,2024-04-01,MINOR,"LTM - Iwona Malarowska-Janik, MVR 24Jun2022, Reviewed on 11Jul2022 during MVR check: PD can be closed and locked.",
,,,,,,,,,,,,SAE report submitted to sponsor outside the 24hs window,SAE initial report (pneumonia) ocurred on 01 sep 2016 was reported to the sponsor on 18 Jan 2017. PI and SC were reminded that adherence to the sponsor requirements for SAE reporting is par ot their responsibilities.,2024-01-11,2024-03-16,MINOR-COVID-19,,
